<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006267" GROUP_ID="COLOCA" ID="491006040418525447" MERGED_FROM="" MODIFIED="2008-11-06 11:21:06 +0100" MODIFIED_BY="Henning Keinke Andersen" NOTES="&lt;p&gt;Exported from Review Manager 4.2.9&lt;/p&gt;" NOTES_MODIFIED="2008-11-06 11:18:29 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="105" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.3">
<COVER_SHEET MODIFIED="2008-11-06 11:18:29 +0100" MODIFIED_BY="[Empty name]">
<TITLE>Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis</TITLE>
<CONTACT>
<PERSON ID="FD38C03482E26AA200426E05102E2781" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Usama</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Ahmed Ali</LAST_NAME>
<SUFFIX/>
<POSITION>MD, PhD</POSITION>
<EMAIL_1>U.ahmedali@gmail.com</EMAIL_1>
<EMAIL_2>u.ahmedali@umcutrecht.nl</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>Dutch Pancreatitis Study Group, University Medical Center Utrecht</ORGANISATION>
<ADDRESS_1>Heidelberglaan 100</ADDRESS_1>
<ADDRESS_2>P.O. Box 85500</ADDRESS_2>
<CITY>Utrecht</CITY>
<ZIP>3508 GA</ZIP>
<REGION>Utrecht</REGION>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+ 31 88 7568031</PHONE_1>
<PHONE_2/>
<FAX_1>+ 31 30 2541944</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-06 11:18:29 +0100" MODIFIED_BY="[Empty name]">
<PERSON ID="FD38C03482E26AA200426E05102E2781" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Usama</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Ahmed Ali</LAST_NAME>
<SUFFIX/>
<POSITION>MD, PhD</POSITION>
<EMAIL_1>U.ahmedali@gmail.com</EMAIL_1>
<EMAIL_2>u.ahmedali@umcutrecht.nl</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>Dutch Pancreatitis Study Group, University Medical Center Utrecht</ORGANISATION>
<ADDRESS_1>Heidelberglaan 100</ADDRESS_1>
<ADDRESS_2>P.O. Box 85500</ADDRESS_2>
<CITY>Utrecht</CITY>
<ZIP>3508 GA</ZIP>
<REGION>Utrecht</REGION>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+ 31 88 7568031</PHONE_1>
<PHONE_2/>
<FAX_1>+ 31 30 2541944</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="FD38C2C482E26AA200426E05FD2FE84C" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Frederik</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Keus</LAST_NAME>
<SUFFIX/>
<POSITION>Surgical registrar</POSITION>
<EMAIL_1>erickeus@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Surgery</DEPARTMENT>
<ORGANISATION>Diakonessenhuis</ORGANISATION>
<ADDRESS_1>Bosboomstraat 1</ADDRESS_1>
<ADDRESS_2/>
<CITY>Utrecht</CITY>
<ZIP>3582 KE</ZIP>
<REGION>Utrecht</REGION>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 30 2 566 566 ext: 6054</PHONE_1>
<PHONE_2>+31 30 2 566 225</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="FD38C52682E26AA200426E05380E807E" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Joost</FIRST_NAME>
<MIDDLE_INITIALS>T</MIDDLE_INITIALS>
<LAST_NAME>Heikens</LAST_NAME>
<SUFFIX/>
<POSITION>Resident</POSITION>
<EMAIL_1>j.heikens@elisabeth.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Surgery</DEPARTMENT>
<ORGANISATION>St Elisabeth Hospital</ORGANISATION>
<ADDRESS_1>Hilvarenbeekseweg 60</ADDRESS_1>
<ADDRESS_2/>
<CITY>Tilburg</CITY>
<ZIP>5000 LC</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 13 5392922</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="67E5A2C182E26AA20077BCD59305E3FF" MODIFIED="2008-11-06 11:17:47 +0100" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Willem</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Bemelman</LAST_NAME>
<SUFFIX/>
<POSITION>Professor in Gastrointestinal surgery</POSITION>
<EMAIL_1>W.A.Bemelman@amc.uva.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>Academic Medical Centre, Amsterdam</ORGANISATION>
<ADDRESS_1>Meibergdreef 9</ADDRESS_1>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP>1105 AZ</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="67E942CB82E26AA20077BCD5335D31EF" MODIFIED="2008-11-06 11:18:29 +0100" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Stephane</FIRST_NAME>
<MIDDLE_INITIALS>V</MIDDLE_INITIALS>
<LAST_NAME>Berdah</LAST_NAME>
<SUFFIX/>
<POSITION>Professor in Gastrointestinal Surgery</POSITION>
<EMAIL_1>stephane.berdah@ap-hm.fr</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Digestive Surgery</DEPARTMENT>
<ORGANISATION>Höpital Nord - Marseille</ORGANISATION>
<ADDRESS_1>Chemin des Bourrely</ADDRESS_1>
<ADDRESS_2/>
<CITY>Marseille</CITY>
<ZIP>13915</ZIP>
<REGION>Cedex 20</REGION>
<COUNTRY CODE="FR">France</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="F326B31082E26AA20078D4E642BA8894" MODIFIED="2008-11-06 11:18:29 +0100" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Prof. dr.</PREFIX>
<FIRST_NAME>H</FIRST_NAME>
<MIDDLE_INITIALS>G</MIDDLE_INITIALS>
<LAST_NAME>Gooszen</LAST_NAME>
<SUFFIX/>
<POSITION>Professor in Gastro Intestinal Surgery</POSITION>
<EMAIL_1>H.Gooszen@umcutrecht.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Surgery</DEPARTMENT>
<ORGANISATION>University Medical Center</ORGANISATION>
<ADDRESS_1>Heidelberglaan 100</ADDRESS_1>
<ADDRESS_2/>
<CITY>Utrecht</CITY>
<ZIP>3584 CX</ZIP>
<REGION>Utrecht</REGION>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31-30-2506968</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="18271" MODIFIED="2008-11-06 11:18:25 +0100" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Cees</FIRST_NAME>
<MIDDLE_INITIALS>JHM</MIDDLE_INITIALS>
<LAST_NAME>van Laarhoven</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>c.v.laarhoven@elisabeth.nl</EMAIL_1>
<EMAIL_2>c.v.laarhoven@home.nl</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Surgery 690</DEPARTMENT>
<ORGANISATION>University Medical Centre Nijmegen</ORGANISATION>
<ADDRESS_1>P.O. Box 9101</ADDRESS_1>
<ADDRESS_2/>
<CITY>HB Nijmegen</CITY>
<ZIP>6500</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 13 5392 922</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-04 15:32:44 +0100" MODIFIED_BY="Henning Keinke Andersen" NOTES="&lt;p&gt;Minor update: 01/11/2008&lt;/p&gt;" NOTES_MODIFIED="2008-11-04 15:32:44 +0100" NOTES_MODIFIED_BY="Henning Keinke Andersen">
<UP_TO_DATE>
<DATE DAY="4" MONTH="11" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="4" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="29" MONTH="11" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2008-11-01 14:31:24 +0100" MODIFIED_BY="Usama Ahmed Ali">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-01 14:31:24 +0100" MODIFIED_BY="Usama Ahmed Ali">
<DATE DAY="1" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Editorial comments have been incorporated into the review</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="24" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="24" MONTH="11" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-05 22:42:57 +0100" MODIFIED_BY="Usama Ahmed Ali">
<SUMMARY MODIFIED="2008-11-04 14:24:33 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-11-04 14:24:33 +0100" MODIFIED_BY="[Empty name]">Open versus laparoscopic approach to pouch surgery in patients with ulcerative colitis and familial adenomatous polyposis showed no significant differences in mortality and complications, but the laparoscopic approach resulted in better cosmesis.</TITLE>
<SUMMARY_BODY MODIFIED="2008-11-04 14:22:36 +0100" MODIFIED_BY="[Empty name]">
<P>Resection of the entire colon and creation of an ileal pouch by means of an ileo pouch anal anastomosis (IPAA) is a last resort for many patients with ulcerative colitis and familial adenomatous polyposis. In recent years this operation has increasingly being performed laparoscopically. In this review we compared the open versus laparoscopic IPAA. We found no significant differences in mortality and complications between the two techniques. The laparoscopic IPAA had a longer operative time of on average 90 minutes. No reliable conclusions could be made regarding the benefit of laparoscopic IPAA on the postoperative recovery. Findings suggest that the laparoscopic approach may improve the postoperative recovery, but the importance of these advantages seems limited. The laparoscopic IPAA did result in better cosmesis than the open IPAA, but more studies will be needed to confirm these findings.<BR/>The most important limitation of this review is that we only found one randomised controlled trial (RCT) on this subject, and we therefore needed to include non-randomised controlled trials. Another important limitation is that most studies did not report on important long-term outcomes, like quality of life and functional outcome.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-11-04 13:52:11 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2008-06-27 13:53:06 +0200" MODIFIED_BY="Usama Ahmed Ali">
<P>Restorative proctocolectomy with ileo pouch anal anastomosis (IPAA) is the main surgical treatment for patients with ulcerative colitis (UC) and familial adenomatous polyposis (FAP). With the advancements of minimal-invasive surgery this demanding operation is increasingly being performed laparoscopically. Therefore, the presumed benefits of the laparoscopic approach need to be systematically evaluated.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To compare the beneficial and harmful effects of laparoscopic versus open IPAA for patients with UC and FAP.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-04-24 13:32:16 +0200" MODIFIED_BY="Usama Ahmed Ali">
<P>We searched The Cochrane IBD/FBD Group Specialized Trial Register (April 2007), The Cochrane Library (Issue 1, 2007), MEDLINE (1990 to April 2007), EMBASE (1990 to April 2007), ISI Web of Knowledge (1990 to April 2007) and the web casts of the American Society of Colon and Rectal Surgeons (ASCRS) (up to 2006) for all trials comparing open versus laparoscopic IPAA.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All trials in patients with UC or FAP comparing any kind of laparoscopic IPAA versus open IPAA. No language limitations were applied.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-11-04 13:36:32 +0100" MODIFIED_BY="[Empty name]">
<P>Two authors independently performed selection of trials and data extraction. The methodological quality of all included trials was evaluated to assess bias risk. Analysis of RCTs and non-RCTs was performed separately. Analyses were based on the intention-to-treat principle. Authors were requested additional information in case of missing data. Sensitivity and subgroup analyses were performed if appropriate.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-11-04 13:51:56 +0100" MODIFIED_BY="[Empty name]">
<P>Eleven trials included 607 patients of whom 253 (41%) in the laparoscopic IPAA group. Only one of the included trials was a randomised controlled trial. There were no significant differences in mortality or complications between the two groups. Reoperation and readmission rates were not significantly different. Operative time was significantly longer in the laparoscopic group both in the RCT and meta-analysis of non-RCTs (weighted mean difference (WMD) 91 minutes; 95% Confidence Interval (CI) 53 to 130). There were no significant differences between the two groups regarding postoperative recovery parameters. Total incision length was significantly shorter in the laparoscopic group, while two trials evaluating cosmesis found significantly higher cosmesis scores in the laparoscopic group. Other long-term outcomes were poorly reported.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-11-04 13:52:11 +0100" MODIFIED_BY="[Empty name]">
<P>The laparoscopic IPAA is a feasible and safe procedure. Short-term advantages of the laparoscopic approach seem to be limited and their clinical significance is arguable. Large high-quality trials focusing on differences regarding specific postoperative complications, cosmesis, quality of life and costs are needed.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-05 22:42:57 +0100" MODIFIED_BY="Usama Ahmed Ali">
<BACKGROUND MODIFIED="2008-11-04 13:53:18 +0100" MODIFIED_BY="[Empty name]">
<P>Ulcerative colitis (UC) is an inflammatory disease of the large intestine of uncertain aetiology characterized by recurring episodes of inflammation primarily involving the mucosal layer and occasionally the submucosa of the colon. The estimated incidence of UC is 8.7/100.000 in Europe (<LINK REF="REF-Shivananda-1996" TYPE="REFERENCE">Shivananda 1996</LINK>). Whereas medical treatment is the mainstream for the management of UC, several evidence-based indications for surgical treatment have been identified, including acute pan colitis, intractability to medical treatment and the presence of dysplasia or neoplasia (<LINK REF="REF-Cohen-2005" TYPE="REFERENCE">Cohen 2005</LINK>).</P>
<P>Familial adenomatous polyposis (FAP) is a rare autosomal dominant disease, characterized by the development of hundreds to thousands of adenomatous polyps in the colon and rectum of affected individuals leading to cancer at young age, if left untreated. The incidence is around 2 per million and the prevalence is around 40 per million (<LINK REF="REF-Bulow-2003" TYPE="REFERENCE">Bulow 2003</LINK>; <LINK REF="REF-Jarvinen-1992" TYPE="REFERENCE">Jarvinen 1992</LINK>). Because of the inevitable development of cancer in this disease, colectomy is warranted for all patients with FAP at a certain point of their disease.</P>
<P>Both UC and FAP are limited to the colon and rectum. Therefore, proctocolectomy provides relief of symptoms and eliminates the risk of developing colorectal cancer. Since its introduction in 1978 the restorative ileo pouch-anal anastomosis (IPAA) has gained wide acceptance in the surgical treatment of patients with UC and FAP (<LINK REF="REF-Parks-1978" TYPE="REFERENCE">Parks 1978</LINK>). The open IPAA has become the standard surgical approach for UC and FAP, due to its good functional results and high patient satisfaction (<LINK REF="REF-Cohen-1992" TYPE="REFERENCE">Cohen 1992</LINK>; <LINK REF="REF-Fazio-1995" TYPE="REFERENCE">Fazio 1995</LINK>; <LINK REF="REF-Hueting-2005" TYPE="REFERENCE">Hueting 2005</LINK>; <LINK REF="REF-Marcello-1993" TYPE="REFERENCE">Marcello 1993</LINK>).<BR/>
<BR/>Over the past decades laparoscopic techniques have evolved rapidly and large bowel resections were increasingly being performed laparoscopically. The first laparoscopic-assisted restorative proctocolectomy with IPAA (LA-IPAA) was described in 1992 (<LINK REF="REF-Peters-1992" TYPE="REFERENCE">Peters 1992</LINK>) and technical feasibility of this procedure has been shown repeatedly (<LINK REF="REF-Casillas-2005" TYPE="REFERENCE">Casillas 2005</LINK>; <LINK REF="STD-Ky-2002" TYPE="STUDY">Ky 2002</LINK>; <LINK REF="STD-Santoro-1999" TYPE="STUDY">Santoro 1999</LINK>; <LINK REF="STD-Wexner-1992" TYPE="STUDY">Wexner 1992</LINK>). Reduced post-operative pain, quicker recovery and superior cosmetic results are presumed advantages of the LA-IPAA over the open IPAA. However, reports have shown inconsistent results. Early reports tend to be sceptical with respect to the benefits of the LA-IPAA (<LINK REF="REF-Reissman-1996" TYPE="REFERENCE">Reissman 1996</LINK>; <LINK REF="REF-Sardinha-1998" TYPE="REFERENCE">Sardinha 1998</LINK>; <LINK REF="STD-Schmitt-1994" TYPE="STUDY">Schmitt 1994</LINK>), while recent studies tend to show more favourable results of the laparoscopic technique (<LINK REF="STD-Gill-2004" TYPE="STUDY">Gill 2004</LINK>; <LINK REF="STD-Larson-2005" TYPE="STUDY">Larson 2005</LINK>; <LINK REF="STD-Marcello-2000" TYPE="STUDY">Marcello 2000</LINK>).</P>
<P>As patients with UC and FAP requiring surgery generally are young, active and highly motivated individuals, minimal-invasive surgery may especially be appealing in this group of patients (<LINK REF="STD-Ky-2002" TYPE="STUDY">Ky 2002</LINK>). Cosmesis and patients' satisfaction could therefore play important role in the choice between these two approaches. However, possible benefits regarding these items is of secondary importance compared to primary outcomes of surgery, like postoperative morbidity and mortality.</P>
<P>To be able to compare both techniques in a satisfactory manner, a systematic evaluation of the benefits and harms of open versus LA-IPAA is needed.<BR/>
</P>
</BACKGROUND>
<OBJECTIVES>
<P>To study whether laparoscopic and open IPAA for UC and FAP are different in terms of primary (mortality and complications) and secondary outcomes (operative time, hospital stay, convalescence, cosmesis, functional outcome and quality of life). If data were present, differences in other secondary outcomes were compared as well. </P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-05 22:28:32 +0100" MODIFIED_BY="Usama Ahmed Ali">
<SELECTION_CRITERIA MODIFIED="2008-11-04 13:53:55 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2008-04-24 13:42:02 +0200" MODIFIED_BY="Usama Ahmed Ali">
<P>Due to the paucity of randomised clinical trials, non-randomised controlled clinical trials comparing open IPAA versus LA-IPAA were also included in this review. Trials were included if they performed a direct comparison of open IPAA versus LA-IPAA, irrespectively of randomisation, prospective data collection, number of patients or language of the article.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-04-24 13:42:31 +0200" MODIFIED_BY="Usama Ahmed Ali">
<P>Studies including patients with UC or FAP who underwent an IPAA procedure were included. If studies sporadically included patients with other diseases, they were included as long as the main population consisted of UC or FAP patients. Studies including mainly patients with other diseases were excluded, unless they presented the data for the UC and FAP patients separately. When multiple studies have overlapping patient populations, only the most recent publication was included in the review.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-04-24 13:45:34 +0200" MODIFIED_BY="Usama Ahmed Ali">
<P>Studies comparing any type of open IPAA to any type of LA-IPAA were included. The following classification of the surgical procedures (based on intention-to-treat) was used:</P>
<UL>
<LI>'Laparoscopic IPAA' included those procedures started as a laparoscopic procedure, with creation of any kind of pneumoperitoneum (by Veress needle or open introduction) or mechanical abdominal wall lift, irrespective of the number of trocars used. 'Laparoscopic-assisted IPAA' included those procedures in which an additional small incision laparotomy was used (e.g. Pfannenstiel or subumbilical midline incision) to facilitate the laparoscopic IPAA procedure.</LI>
</UL>
<UL>
<LI>In all other cases the surgical intervention was classified as 'open IPAA'.</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-11-04 13:53:55 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome measures were mortality and complications (except minor complications). Secondary outcome measures were all other outcomes assessed in the comparison of the two operative techniques. These included minor complications, operative time, operative blood loss, time to bowel movement, time to regular diet, hospital stay, readmission rate, reoperation rate, incision length, cosmesis, functional outcome (faecal and sexual function) and costs.</P>
<P>Complications were classified into the following categories:</P>
<UL>
<LI>Intraoperative complications: all complications occurring and detected intraoperatively, like small bowel perforation and severe intraoperative bleeding.</LI>
<LI>Procedure specific complications: pouch failure, pelvic sepsis, pouch fistula, anastomotic leakage and strictures.</LI>
<LI>Severe postoperative complications: e.g. intra-abdominal abscesses, bleeding, sepsis, burst abdomen (Platzbauch) and myocardial infarction.</LI>
<LI>Mild postoperative complications: e.g. including prolonged ileus, wound infections, urinary tract infections, urinary retention, pleural effusion, late incisional hernia, and deep venous thrombosis. Other postoperative complications were categorized appropriately at first encounter.</LI>
<LI>Total complications: the total number of all complications per study.</LI>
</UL>
<P>The following definitions were used for the procedure specific complications:<BR/>
</P>
<UL>
<LI>Pouch failure: pouch excision or a non-functioning pouch at 12 months after IPAA procedure.</LI>
<LI>Pelvic sepsis: pelvic abscess, anastomotic leakage or dehiscence or pelvic/perineal wound infection.</LI>
<LI>Pouch fistula: any pouch related fistula.</LI>
<LI>Stricture: anastomotic fibrosis necessitating dilatation.</LI>
</UL>
<P>Functional outcome was assessed using the following items:</P>
<UL>
<LI>Defecation frequency: times of defecation per day, night or per 24 hours.</LI>
<LI>Mild faecal incontinence: soiling or spotting in underwear.</LI>
<LI>Severe faecal incontinence: regularly severe leakage or faecal loss or passive faecal incontinence.Urge faecal incontinence: inability to defer defecation more than 15 minutes after first urge.</LI>
<LI>Sexual dysfunction: retrograde ejaculation, erection disorder or dyspareunia.</LI>
</UL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-04-24 13:51:31 +0200" MODIFIED_BY="Usama Ahmed Ali">
<P>We have searched the following databases:</P>
<UL>
<LI>The Cochrane IBD/FBD Group Specialized Trial Register (Non MEDLINE Records)</LI>
<LI>The Cochrane Library (including The Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects (DARE), The Cochrane Central Register of Controlled Trials (CENTRAL), Health Technology Assessment (HTA) Database, NHS Economic Evaluation Database) (Issue 1, 2007)</LI>
<LI>MEDLINE (1990 to April 2007)</LI>
<LI>EMBASE (1990 to April 2007)</LI>
<LI>ISI Web of Knowledge (Web of Science) (1990 to April 2007)</LI>
<LI>Web casts of the annual meetings of the American Society of Colon and Rectal Surgeons (ASCRS)</LI>
</UL>
<P>For each database a specific search strategy was devised and adapted to the syntax requirements of the respective database. The used search strategies are listed in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. Since the LA-IPAA was not described before 1992 the search was started from the year 1990. As a fall-safe strategy we pre-specified that if any eligible article published before 1992 was to be found, the search would have been expanded to start from 1985. During the search no eligible articles prior to 1992 were found, thus the search remained unchanged.<BR/>References of included trials and relevant reviews encountered during the search were searched manually. Finally, all authors of included trials were requested for additional information on any published, unpublished or ongoing trials.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-05 22:28:32 +0100" MODIFIED_BY="Usama Ahmed Ali">
<P>The review was conducted according to the prespecified protocol (<LINK REF="REF-Ahmed-Ali-2007" TYPE="REFERENCE">Ahmed Ali 2007</LINK>) and the recommendations from the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
<P>
<B>Selection of studies</B>
<BR/>Titles of all retrieved articles were first screened by UAA or FK and all obviously irrelevant reports were excluded. Subsequently, abstracts of selected articles were reviewed by both UAA and FK independently and differences were resolved by discussion with CVL, if necessary. In case of any uncertainty, articles were always selected for the subsequent step. Finally, the full-text of all selected articles was reviewed by UAA and FK independently to determine the eligibility of the article for this review. All included trials are listed in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table. Excluded studies are listed in the '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table along with the reason for their exclusion.</P>
<P>
<B>Extraction of data </B>
<BR/>Two reviewers (UAA and FK or JH) independently extracted all relevant data. For each study patient characteristics, study characteristics, data needed for the methodological quality assessment of the study and the primary and secondary outcomes were extracted according to availability. Data regarding patient characteristics included number of patients in each group, age, gender, BMI and diagnoses of included patients. Data regarding study characteristics included study design, sample size information, inclusion and exclusion criteria of the study, follow-up period, loss to follow-up, surgical experience and information regarding surgical techniques. Individual authors were contacted if any essential data were missing.</P>
<P>
<B>Assessment of methodological quality of included studies<BR/>
</B>In this review both randomised controlled trials (RCTs) and non-randomised controlled trials (non-RCTs) were included. For both types a different assessment method was chosen. <B>
<BR/>
<I>
<BR/>Assessment of methodological quality of randomised clinical trials</I>
</B>
<BR/>Based on the available empirical evidence (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>; <LINK REF="REF-Kjaergard-2001" TYPE="REFERENCE">Kjaergard 2001</LINK>; <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>; <LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>) we assessed the methodological quality of RCTs using the following items.</P>
<P>
<I>Generation of the allocation sequence</I>
<BR/>Adequate, if the allocation sequence was generated by a computer or random number table. Drawing of lots, tossing of a coin, shuffling of cards, or throwing dice was considered as adequate if a person who was not otherwise involved in the recruitment of participants performed the procedure.<BR/>Unclear, if the trial was described as randomised, but the method used for generation of the allocation sequence was not described.<BR/>Inadequate, if a system involving dates, names, or admittance numbers was used for the allocation of patients.</P>
<P>
<I>Allocation concealment </I>
<BR/>Adequate, if the allocation of patients involved a central independent unit, on-site locked computer, or sealed envelopes.<BR/>Unclear, if the trial was described as randomised, but the method used to conceal the allocation was not described.<BR/>Inadequate, if the allocation sequence was known to the investigators who assigned participants or if the study was quasi-randomised.</P>
<P>
<I>Blinding</I>
<BR/>Adequate, if the trial was described (at least) as blind to participants or assessors and the method of blinding was described. We are well aware that it is very difficult to properly blind trials comparing surgical treatments, therefore one level of blinding was considered adequate.<BR/>Unclear, if the trial was described as (double) blind, but the method of blinding was not described.<BR/>Not performed, if the trial was not blinded.</P>
<P>
<I>Follow-up</I>
<BR/>Adequate, if the numbers and reasons for dropouts and withdrawals in all intervention groups were described or if it was specified that there were no dropouts or withdrawals.<BR/>Unclear, if the report gave the impression that there had been no dropouts or withdrawals, but this was not specifically stated.<BR/>Inadequate, if the number or reasons for dropouts and withdrawals were not described.</P>
<P>
<B>
<I>Assessment of methodological quality of non-randomised clinical trials</I>
</B>
<BR/>Quality assessment for non-randomised clinical trials is a complex topic and is generally considered to be an area of ongoing research (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>, section 6.8). In an extensive review of this topic (<LINK REF="REF-Deeks-2003" TYPE="REFERENCE">Deeks 2003</LINK>, chapter 4) investigators reviewed 193 tools for quality assessment in literature, and concluded that based on quality and design of these tools only 6 tools were suitable for use in systematic reviews. They also concluded that all 6 tools needed some type of modification before being fully suitable for that purpose.</P>
<P>In this review we used a modification of the Methodological Index for Non-Randomised Studies (MINORS) (<LINK REF="REF-Slim-2003" TYPE="REFERENCE">Slim 2003</LINK>). This tool is one of the few validated and tested methods specifically developed for the assessment of quality of non-randomised trials. To adhere to the guidelines of the Cochrane Handbook the following modifications were applied:<BR/>
</P>
<UL>
<LI>Four of the 12 items of the MINORS were disregarded in the quality assessment, because these items related to the applicability, reporting quality, and precision of the results, rather than the validity of the assessed trials (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>, section 6.7.2).</LI>
<LI>Every item was used independently to distinguish between high and low quality trials, rather than using the sum score of this list. The draw-backs of using summary scores are the decreased transparency to readers of the review and the evidence showing that different scales could results in contradicting results when applied in the same review (<LINK REF="REF-Juni-1999" TYPE="REFERENCE">Juni 1999</LINK>).</LI>
</UL>
<P>The modified MINORS list is outlined in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>. Every study was assessed using this method by UAA and JH independently. Discrepancies were solved by consensus discussion with a third reviewer, CVL, if necessary.<BR/>
<B>
<BR/>Statistical analysis</B>
<BR/>Data from RCTs and non-RCT were analysed separately. With adequate data available statistical analysis of binary data was conducted using relative risks (RR) as the summary statistic. Trials with zero events in both arms were excluded from meta-analyses. However, a sensitivity analysis using risk differences (RD) was performed with inclusion of these trials, and in case of inconsistency the results of this sensitivity analysis were reported.</P>
<P>For continuous outcomes weighted mean differences (WMD) were used as the summary statistic. Authors, however, often presented their results in medians with ranges due to suspicion of skewed data, while means with their standard deviations (SD) are needed for meta-analysis. Authors were contacted for additional data if necessary. Additionally, sensitivity analyses imputing data for missing means and standard deviations (calculated from available medians and ranges) were performed (<LINK REF="REF-Hozo-2005" TYPE="REFERENCE">Hozo 2005</LINK>).</P>
<P>Heterogeneity was calculated using Higgins &#967;<SUP>2</SUP>-test and quantified by measuring I<SUP>2</SUP> (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>). A &#967;<SUP>2</SUP>-test with a P-value of &lt; 0.10 was considered to indicate the presence of heterogeneity, while an I<SUP>2</SUP> &gt; 50% was considered to suggest a marked inconsistency in effect between studies. The fixed-effect model was only used if no heterogeneity was present. In all other cases the random-effects model was used. If excessive heterogeneity was present, data were re-checked first. If heterogeneity persisted, subgroup or sensitivity analyses were used to explore its causes. When adequate reasons were present extreme outliers were excluded in sensitivity analyses. In situations of excessive heterogeneity that could not be explained, we refrained from reporting a pooled estimate.</P>
<P>
<B>
<I>Bias detection</I>
</B>
<BR/>Funnel plots were used to provide a visual assessment of whether treatment estimates were associated with study size. This may help identify the presence of publication or other type of biases (<LINK REF="REF-Begg-1994" TYPE="REFERENCE">Begg 1994</LINK>; <LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>; <LINK REF="REF-Macaskill-2001" TYPE="REFERENCE">Macaskill 2001</LINK>).</P>
<P>
<B>
<I>Subgroup and sensitivity analyses</I>
</B>
<BR/>Subgroup analyses were performed according to the methodological quality of the included trials:<BR/>
</P>
<UL>
<LI>For RCTs: adequate compared to unclear/inadequate regarding the four quality criteria used to assess the methodological quality of RCTs.</LI>
<LI>For non-RCTs: adequate compared to unclear/inadequate regarding each item of the modified MINORS list on which the studies differed.</LI>
</UL>
<P>Furthermore, causes of heterogeneity were explored by performing sensitivity analysis based on surgical technique and other factors that may explain heterogeneity.</P>
<P>Statistical analysis was conducted using the statistical package (RevMan Analyses v. 5.0.16) provided by The Cochrane Collaboration and was performed by UAA, FK and CVL.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-05 22:42:57 +0100" MODIFIED_BY="Usama Ahmed Ali">
<STUDY_DESCRIPTION MODIFIED="2008-11-04 13:49:58 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>
<BR/>Search and trial identification<BR/>
</B>The systematic search was conducted in The Cochrane IBD/FBD Group Specialized Trial Register (Non MEDLINE Records) (931 records, 0 selected), The Cochrane Library, Issue 1, 2007 (649 hits, 5 selected), The National Library of Medicine (MEDLINE) via PubMed (4455 hits, 117 selected), Exerpta Medica via EMBASE (6830 hits, 503 selected), ISI Web of Knowledge (1573 hits, 54 selected), and web casts of the annual meetings of the American Society of Colon and Rectal Surgeons (ASCRS) (all published web cast until 2006, 2 selected). For detailed information about the search strategies and the numbers of hits we refer to additional <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<P>Altogether, the search resulted in 14,438 hits. The first selection was performed based on the titles of publications and all clearly irrelevant publications were excluded. A total of 679 hits were considered possibly relevant based on their titles. After correction for duplicates, 590 publications remained. The abstracts of these 590 publications were reviewed independently by two reviewers (UAA and FK). Differences between UAA and FK were discussed with CVL. A total of 552 publications could be rejected based on their abstracts. Eventually, 37 publications were selected for further evaluation and these are listed in this review with reasons for in- and exclusion. Studies that described series of LA-IPAA operations, without comparison to an open IPAA group were excluded and are listed in the '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table as well.</P>
<P>From the selected 37, a total of 25 publications were excluded (see '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table). Eleven publications were included (see '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table), and one protocol of an ongoing RCT was identified (see '<LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>' table). A cross-reference search was performed of all included publications as well as five reviews considered relevant to our review (<LINK REF="REF-Ballantyne-2004" TYPE="REFERENCE">Ballantyne 2004</LINK>; <LINK REF="REF-Bemelman-1998" TYPE="REFERENCE">Bemelman 1998</LINK>; <LINK REF="REF-Chung-2003" TYPE="REFERENCE">Chung 2003</LINK>; <LINK REF="REF-Schwenk-2005" TYPE="REFERENCE">Schwenk 2005</LINK>; <LINK REF="REF-Tan-2006" TYPE="REFERENCE">Tan 2006</LINK>). This resulted in the identification of one additional publication (<LINK REF="STD-Araki-2001" TYPE="STUDY">Araki 2001</LINK>). Consequently, 12 publications were finally included in this review. A flow-chart of the selection process is provided in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>Of these 12 publications, two described the short- and long-term outcomes of a partially overlapping patient population (<LINK REF="STD-Larson-2005" TYPE="STUDY">Larson 2005</LINK>; <LINK REF="STD-Larson-2006" TYPE="STUDY">Larson 2006</LINK>). These publications were considered to be two distinct trials, but data of only one of these two publications was used in any single meta-analysis to prevent double reporting of patients. Two other publications (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>; <LINK REF="REF-Polle-2007" TYPE="REFERENCE">Polle 2007</LINK>) described the short- and long-term outcomes of the same trial. These two publications were considered one trial and data was handled accordingly. In summary, 12 publications, describing 11 trials were included in this review.</P>
<P>Finally, two publications (<LINK REF="STD-Berdah-2004" TYPE="STUDY">Berdah 2004</LINK>; <LINK REF="STD-Otani-2001" TYPE="STUDY">Otani 2001</LINK>) were translated from French and Japanese, respectively (see acknowledgement). Additional information on methodology was obtained regarding seven out of 11 trials and additional data (i.e. individual patient data) was obtained from two trials (<LINK REF="STD-Berdah-2004" TYPE="STUDY">Berdah 2004</LINK>; <LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>).<BR/>
<BR/>
<B>Patient characteristics</B>
<BR/>The 11 trials included 607 patients, of whom 253 (41%) in the laparoscopic and 354 (59%) in the open IPAA group. A total of 516 (85%) patients suffered from UC and 89 (14,7%) from FAP. Two studies exclusively included patients with UC (<LINK REF="STD-Araki-2001" TYPE="STUDY">Araki 2001</LINK>; <LINK REF="STD-Otani-2001" TYPE="STUDY">Otani 2001</LINK>), whereas all other studies included both UC and FAP patients. None of these studies presented the results of the UC and FAP patients separately.</P>
<P>
<B>Trial designs </B>
<BR/>Of the 11 included trials, only one was a randomised controlled trial (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>). Four of the 10 non-randomised trials collected their data prospectively. The other 6 had retrospectively data-collection or did not clearly specify this aspect. Ten trials had a mono-centre design, and one trial was conducted in two centres (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>). All trials, except one (<LINK REF="STD-Otani-2001" TYPE="STUDY">Otani 2001</LINK>), specified that they performed their analysis according to the intention-to-treat principle.</P>
<P>
<B>Surgical interventions</B>
<BR/>The types of performed surgical interventions varied between the included trials. Eight trials compared the laparoscopic-assisted IPAA (LA-IPAA) with the conventional open IPAA. The other three trials compared slightly different types of procedures: one trial (<LINK REF="STD-Brown-2001" TYPE="STUDY">Brown 2001</LINK>) compared the LA-IPAA with a mini-open IPAA, another trial (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>) compared the laparoscopic hand-assisted IPAA (HA-IPAA) with the conventional open IPAA, and yet another trial (<LINK REF="STD-Larson-2006" TYPE="STUDY">Larson 2006</LINK>) compared a combined group of LA-IPAA and HA-IPAA with the conventional open IPAA. We considered all trials comparing procedures using a laparoscopic technique versus open IPAA.</P>
<P>The HA-IPAA differs from the LA-IPAA in that the accessory incision is performed at the start of the operation and covered with an air sealed hand-port. Through this hand-port manual assistance could be provided during the different stages of the operation. In general, HA-IPAA and LA-IPAA were performed using a small Pfannenstiel incision, facilitating open rectum resection and open creation of a J-pouch by means of a double-stapling technique to construct the ileo pouch anal anastomosis. Details of the operative techniques used by the included trials are listed in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table.</P>
<P>
<B>Outcome measures</B>
<BR/>Primary outcome measures, mortality and complications, were well reported. Due to the brief follow-up period in most trials mainly short-term complications were reported. Long-term outcomes were reported by 4 trials only (<LINK REF="STD-Berdah-2004" TYPE="STUDY">Berdah 2004</LINK>; <LINK REF="STD-Dunker-2001" TYPE="STUDY">Dunker 2001</LINK>; <LINK REF="STD-Larson-2005" TYPE="STUDY">Larson 2005</LINK>; <LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK> ).</P>
<P>Secondary outcomes were reported variably . Based on availability of data, meta-analysis was performed for complications, operative time, blood loss, time to bowel movement, time to regular diet, hospital stay, re-operation rate and incision length. Cosmesis, functional outcome and costs were reviewed without meta-analysis.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-11-04 13:56:38 +0100" MODIFIED_BY="[Empty name]">
<P>Since only one RCT was identified all trials, including the RCT, were assessed using the modified MINORS. Differences were identified regarding three items only:</P>
<UL>
<LI>Prospective collection of data: five trials (45%) scored 'adequate' and six trials (55%) scored 'unclear / inadequate'.</LI>
<LI>Contemporary groups of cases and controls: seven trials (64%) scored 'adequate' and four trials (36%) scored 'unclear / inadequate'.</LI>
<LI>Baseline equivalence of groups: seven trials (64%) scored 'adequate' and the four trials (36%) scored 'inadequate'.</LI>
</UL>
<P>Only three trials, including the RCT, scored adequate for these three items. Detailed methodological assessment of trials is listed in <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-05 22:42:57 +0100" MODIFIED_BY="Usama Ahmed Ali">
<P>Characteristics of the included trials are shown in <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>. Baseline characteristics of included patients are shown in <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>.</P>
<P>Meta-analysis of RCTs was not feasible, since only one RCT (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>) was identified. An overview of the results of this RCT are presented in <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>. When adequate data was available, a meta-analysis of the non-randomised trials was performed. In this meta-analysis five comparisons were conducted. In three comparisons trials were subdivided into subgroups of high- and low-quality trials based on the three methodological quality criteria. In the fourth comparison trials meeting all three methodological criteria (highest-quality trials) were set against all other trials. The fifth comparison contained additional sensitivity analyses.The findings of the RCTs as well as the results of the meta-analysis of non-RCTs are presented below.</P>
<P>No significant differences were observed regarding mortality, intra-operative complications, procedure specific complications, severe complications, minor complications, readmission and reoperation rate in any of the performed comparisons.</P>
<P>
<B>Mortality<BR/>
</B>Mortality was not reported in two trials (<LINK REF="STD-Hashimoto-2001" TYPE="STUDY">Hashimoto 2001</LINK>; <LINK REF="STD-Otani-2001" TYPE="STUDY">Otani 2001</LINK>). In the nine trials reporting mortality a total of 232 patients and 323 patients were included in the laparoscopic and the open group, respectively. Eight trials reported zero mortality in both groups. With one death in the open group (<LINK REF="STD-Araki-2001" TYPE="STUDY">Araki 2001</LINK>), there was no statistically significant difference.<BR/>
<B>
<BR/>Intraoperative complications<BR/>
</B>Intraoperative complications were reported by 5 trials including 130 and 230 patients in the laparoscopic and open groups, respectively. The RCT by Maartense (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>) and the study by Larson (<LINK REF="STD-Larson-2006" TYPE="STUDY">Larson 2006</LINK>) reported one intraoperative complication in each group, while three trials reported zero intraoperative complications. No significant differences were observed between the two groups .</P>
<P>
<B>Procedure specific complications<BR/>
</B>Procedure specific complications were reported in 8 trials, with 2 trials reporting zero complications. The RCT reported 4/30 (13%) and 6/30 (20%) complications in the laparoscopic and open group, respectively (not statistically significant). Five non-RCTs were pooled showing 6/132 (4.5%) procedure specific complications in the laparoscopic group and 6/224 (2.7%) in the open group. Differences were not statistically significant (Relative risk (RR) 0.81; 95% confidence interval (CI) 0.32 to 2.02). Heterogeneity was not present.</P>
<P>
<B>Severe complications<BR/>
</B>Severe complications were reported in 9 trials, with 3 trials reporting zero complications.The RCT reported 0/30 (0%) and 2/30 (7%) severe complications in the laparoscopic and open group, respectively (not statistically significant). Five non-RCTs were pooled showing 8/157 (5.1%) severe complications in the laparoscopic group and 20/258 (7,8%) in the open group. Differences were not statistically significant (RR 0.65; 95% CI 0.29 to 1.48). Heterogeneity was not present.</P>
<P>
<B>Minor complications<BR/>
</B>Minor complications were reported in 9 trials. The RCT reported 9/30 (30%) and 7/30 (23%) minor complications in the laparoscopic and open group, respectively (not statistically significant). Eight non-RCTs were pooled. There were 59/213 (27.7%) minor complications in the laparoscopic group and 83/306 (27.1%) in the open group. Differences were not statistically significant (RR 1.05; 95% CI 0.78 to 1.41). No significant heterogeneity was present.</P>
<P>
<B>Total complications<BR/>
</B>Total complications consisted of the sum of all complications in the aforementioned categories. The RCT showed 14/30 (47%) and 16/30 (53%) total complications in the laparoscopic and open group, respectively (not statistically significant). Eight non-RCTs with 213 patients in the laparoscopic group and 306 patients in the open group were pooled. A total of 80 (37.6%) complications in the laparoscopic group and 127 (41.5%) in the open group were observed. There were no significant differences between the two groups (RR 0.91; 95% CI 0.73 to 1.14). No heterogeneity was observed between the studies. In a funnel plot on total complications we did not find arguments for bias (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
<P>
<B>Operative time<BR/>
</B>Operative time was reported in 10 trials, but only five provided data in means with their standard-deviations. Both the RCT and the pooled non-RCTs showed a significantly longer operative time for the laparoscopic procedure. The RCT showed an increase in the median operative time from 133 (range 97 to 260) for the open IPAA to 214 (range 149 to 400) for the laparoscopic approach (p=&lt;0.001). The meta-analysis of four non-RCTs included 58 patients in each group and showed a significantly longer operative time in the laparoscopic group (weighted mean difference (WMD) 92 minutes; 95% CI 53 to 130). The random-effects model was used, since substantial heterogeneity was present (&#967;<SUP>2</SUP>=11.02 (p=0.01), I<SUP>2</SUP>=73%).<BR/>Sensitivity analysis imputing data for missing values included 223 and 324 patients in the laparoscopic and open groups, respectively, and confirmed the findings of the primary meta-analysis (WMD 82 minutes; 95% CI 60 to 105). Heterogeneity remained significant (&#967;<SUP>2</SUP>=36.30 (p&lt;0.0001), I<SUP>2</SUP>=75.2%). Further exploring of data in subgroup analyses did not identify clear causes for the observed heterogeneity.</P>
<P>
<B>Blood loss<BR/>
</B>Operative blood loss was reported by five trials. The RCT reported no difference between the two groups with a median blood loss of 263 mL (range 75 to 1200) in the laparoscopic and 300 mL (range 50 to 800) in the open group (p=0.98). Two non-RCTs provided data in means and SDs and were pooled. The meta-analysis included 31 and 29 patients in the laparoscopic and open groups, respectively. There was no significant difference in blood loss between the two techniques (WMD -99 mL; 95% CI -261 to 64). As heterogeneity was present, the random-effects model was applied (&#967;<SUP>2 </SUP>=2.70 (p&lt;0.10), I<SUP>2</SUP>=63.0%).<BR/>A sensitivity analysis imputing data for two more trials included 62 patients in each group and did show a significant reduction in blood loss using the laparoscopic technique (WMD -138 mL; 95% CI -235 to -41). Adding these two extra trials reduced heterogeneity significantly (&#967;<SUP>2</SUP>=4.57 (p&lt;0.21), I<SUP>2</SUP>=34.4%).</P>
<P>
<B>Time to bowel movement<BR/>
</B>Time to bowel movement was reported by three non-RCTs. All trials found a significant shorter time to bowel movement in the laparoscopic group. Data of only one trial was provided in means and standard-deviations (<LINK REF="STD-Araki-2001" TYPE="STUDY">Araki 2001</LINK>). Therefore, only pooled data from a sensitivity analyses imputing data for means and SD from the two other trials was available. This analysis included 141 and 231 patients in the laparoscopic and open group, respectively, and showed a significant shorter time to bowel movement in the laparoscopic group (WMD -1.96 days; 95% CI -3.45 to -0.46). The random-effects model was used, since heterogeneity was present (&#967;<SUP>2</SUP>=6.74 (p=0.03), I<SUP>2</SUP>=70%).</P>
<P>
<B>Time to regular diet<BR/>
</B>Time to regular diet was reported by six trials. The RCT showed a median of 6 days (range 4 to 19) in the laparoscopic and 7 days (range 4-15) in the open group (p=0.6). Only two non-RCTs including 25 and 35 patients in the laparoscopic and open groups, respectively, provided data in means and standard-deviations. No significant difference between both groups was found when pooling these trials (WMD -2.72 days, 95% CI -8.33 to 2.88).<BR/>A sensitivity analysis with imputed data including three additional trials, with a total of 148 patients in the laparoscopic and 261 patients in the open group, did result in a significant difference in favour of the laparoscopic group (WMD -1.47 days; 95% CI -2.25 to -0.69). No significant heterogeneity was present.</P>
<P>
<B>Hospital stay</B>
<BR/>Hospital stay was reported by 9 trials. The RCT showed no significant difference between the two groups, with a median stay of 10 days (range 5 to 13) in the laparoscopic and 11 days (range 6-28) in the open group. Four non-RCTs, including 48 patients in the laparoscopic and 40 in the open group, presented data in means with SD. Pooling these trials showed a significantly shorter hospital stay for the laparoscopic procedure compared to the open technique (WMD -2.66 days; 95% CI -4.28, -1.04). No heterogeneity was present.<BR/>A sensitivity analysis using imputed data included five additional trials, with a total of 213 patients in the laparoscopic and 306 in the open group. This sensitivity analysis showed a significant shorter hospital stay for the laparoscopic group as well (WMD -2.12 days; 95% CI -3.12 to -1.12). The random-effects model was used, since heterogeneity was present (&#967;<SUP>2 </SUP>=12.33 (p=0.09), I<SUP>2</SUP>=43%).</P>
<P>
<B>Readmission rate<BR/>
</B>Readmission rate was reported by two trials. The RCT reported 5/23 (22%) and 3/23 (13%) readmissions in the laparoscopic and open group, respectively. <LINK REF="STD-Larson-2006" TYPE="STUDY">Larson 2006</LINK> found 21/100 (21%) readmissions in the laparoscopic and 44/200 (22%) in the open group. Both studies showed no significant difference between the two groups.</P>
<P>
<B>Reoperation rate<BR/>
</B>Re-operation rate was reported by seven trials. The RCT reported 5/30 (17%) reoperations in both groups (not statistically significant). Six non-RCTs were pooled. There were 7/172 (4,0%) reoperations in the laparoscopic and 16/275 (5,8%) in the open group. Differences were not statistically significant (RR 0.74; 95% CI 0.32 to 1.71). No significant heterogeneity was present.</P>
<P>
<B>Incision length<BR/>
</B>Incision length was reported by two studies (<LINK REF="STD-Brown-2001" TYPE="STUDY">Brown 2001</LINK>, <LINK REF="STD-Dunker-2001" TYPE="STUDY">Dunker 2001</LINK>). Both studies showed a significant smaller incision length for the laparoscopic group. Since only one trial provided means and SDs, no meta-analysis was performed. Sensitivity analysis with imputed data, including 27 patients in the laparoscopic and 30 patients in the open group, showed a significantly shorter incision in the laparoscopic group as well (WMD -7.79 cm; 95% CI -9.68 to -5.9). There was no heterogeneity present.</P>
<P>
<B>Cosmesis</B>
<BR/>Cosmesis scores were reported by two trials (<LINK REF="STD-Dunker-2001" TYPE="STUDY">Dunker 2001</LINK>; <LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>). Both studies used the same cosmesis scale and both showed significantly higher cosmesis scores in the laparoscopic group. The RCT showed a significant increase from a mean of 14.7 points in the open group to 18.5 in the laparoscopic groups (SD not reported, p=0.01). The study by <LINK REF="STD-Dunker-2001" TYPE="STUDY">Dunker 2001</LINK> reported an increase from a mean of 16 (4.6) points in the open to 19.8 (4.6) in the laparoscopic group (p=0.03).</P>
<P>
<B>Functional outcome<BR/>
</B>
<I>Defecation frequency<BR/>
</I>Defecation frequency was reported by four trials. However, pooling data was not possible due to inconsistencies in reporting of results. All available data of these four trials are presented in <LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>. The defecation frequency was reported by three trials (1 RCT and 2 non-RCTs) per day and night separately, all with a follow-up period of at least 12 months. One trial (<LINK REF="STD-Otani-2001" TYPE="STUDY">Otani 2001</LINK>) reported the defecation frequency per 24 hours at discharge. No significant differences were reported between the two groups by any of the four trials. Two sensitivity analyses imputing missing data for non-RCTs reporting the defecation frequency per day and night separately, showed no significant differences as well.</P>
<P>
<I>Faecal incontinence<BR/>
</I>Four trials (<LINK REF="STD-Berdah-2004" TYPE="STUDY">Berdah 2004</LINK>; <LINK REF="STD-Dunker-2001" TYPE="STUDY">Dunker 2001</LINK>; <LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>) reported on this outcome. Every study used its own classification for faecal incontinence and pooling results was not possible. None of the four trials found any significant difference between the two groups regarding daytime continence, overnight continence, soiling, urge incontinence, or any of the used measure of faecal continence.</P>
<P>
<I>Sexual function</I>
<B>
<BR/>
</B>Sexual function was reported by three trials (<LINK REF="STD-Dunker-2001" TYPE="STUDY">Dunker 2001</LINK>; <LINK REF="STD-Larson-2005" TYPE="STUDY">Larson 2005</LINK>; <LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>). All trials measured and reported sexual function differently. None of these trials identified a significant difference between the laparoscopic and open group regarding this outcome as well.</P>
<P>
<B>Costs<BR/>
</B>Only one trial (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>) reported on differences in costs between the laparoscopic and open IPAA (<LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>). Operative costs were significantly higher in the laparoscopic group. However, when the overall total costs (including costs for hospital stay, relaparotomies and readmission, etc) were analysed no significant difference was found.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-05 22:34:46 +0100" MODIFIED_BY="Usama Ahmed Ali">
<P>This systematic review evaluating differences between laparoscopic and open IPAA procedures shows several important findings. First, only one randomised trial has been conducted so far on LA-IPAA versus open IPAA. Therefore, lower level evidence had to be included in this review with consequently an increased risk for introducing bias. Second, no significant differences were found in the primary outcome measures: mortality and complications. Also readmission and reoperation rates were not significantly different. Third, laparoscopic IPAA is associated with a significantly longer operative time. Fourth, presumed short-term benefits of the LA-IPAA regarding convalescence could not be confirmed reliably. Fifth, follow-up periods of most studies were inappropriate for evaluation of long-term outcomes.<BR/>
<BR/>This review has encountered several methodological problems. First, by including non-randomised studies the risk for bias and its influence on false conclusions is considerable (<LINK REF="REF-Deeks-2003" TYPE="REFERENCE">Deeks 2003</LINK>). Non-randomised trials have a higher risk of bias, due to lack of standardized protocols, unclear methodology, high risk of selection bias and inability to match for all confounders. Moreover, the methodological quality of most included trials was moderate or poor. For example, only 3 out of the 10 non-randomised trials collected their data prospectively and had a sufficient level of base-line equivalence between the two groups. However, these lower level evidence studies are the best we have so far. While future research is obviously needed, we hope that by reviewing this evidence systematically we can provide clinicians with a balanced understanding of the present evidence and its possible implications.</P>
<P>Methodological quality assessment of non-randomised trials has proved to be problematic as well. Contrary to RCTs, little evidence exists regarding important items in the methodological assessment of non-randomised trials. Moreover, few validated scales and lists exist for this purpose and there is no consensus regarding the tool of choice. The MINORS index, chosen for its validation and simplicity, proved to have its own shortcomings as well. It was liable to confuse the validity of trials with other items like quality of reporting and precision of results, and it used a summary score to indicate the overall quality of trials. Both properties have important drawback and their use is discouraged by the Cochrane guidelines (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>, 6.7.2). The applied modifications did solve these problems, but they also may have undermined the validity of the scale. Empirical evidence regarding methodological criteria influencing reliability of the results of non-randomised trials is needed for better assessment of this type of trials.</P>
<P>Another problem that faced this review was the paucity of data regarding several outcomes. This was caused by the relatively small number of available trials, but also by the small numbers of patiens in every trial and the limited amount of data suitable for meta-analysis. Especially the latter point was of considerable importance. For several continuous outcomes less then half of the available trials could be included in the meta-analysis. This could undermine the reliability of results, as illustrated by the inconsistent results of the meta-analysis and the sensitivity analysis with imputed data, seen in several outcomes. Additionally, most trials had a short follow-up period, usually until discharge, which made it difficult to evaluate important long-term outcomes, like functional outcome and quality of life.</P>
<P>During the conduct of this review another meta-analysis comparing open versus laparoscopic IPAA was published (<LINK REF="REF-Tilney-2007" TYPE="REFERENCE">Tilney 2007</LINK>). General conclusions of this meta-analysis were quite similar to ours, although there were some important differences. First, the search strategy performed was less extensive and limits were applied for the study type in PUBMED. This resulted in failure to identify two relevant trials (<LINK REF="STD-Berdah-2004" TYPE="STUDY">Berdah 2004</LINK>; <LINK REF="STD-Otani-2001" TYPE="STUDY">Otani 2001</LINK>). Secondly, this meta-analysis included just over half the numbers of patients included in our meta-analysis (329 compared to 607), mainly due to a large trial (<LINK REF="STD-Larson-2006" TYPE="STUDY">Larson 2006</LINK>) which was published recently. Also, two trials were included in this meta-analysis that were excluded by us for having partial overlap in patients with other included trials (<LINK REF="STD-Wexner-1992" TYPE="STUDY">Wexner 1992</LINK>; <LINK REF="STD-Young_x002d_Fadok-2001" TYPE="STUDY">Young-Fadok 2001</LINK>). The last important difference is that the authors imputed means and standard deviations using medians and ranges in their meta-analyses without specification in the methods section. Some of their findings were therefore partly based on imputed data and may very well be biased.</P>
<P>The absence in this review of differences between the open and laparoscopic IPAA considering the primary outcomes, mortality and complications, suggests that the LA-IPAA is a feasible and safe procedure. This is in accordance to the results of several relative large series of LA-IPAA published recently (<LINK REF="STD-Kienle-2005" TYPE="STUDY">Kienle 2005</LINK>; <LINK REF="STD-Ky-2002" TYPE="STUDY">Ky 2002</LINK>). However we have to emphasize that the number of included patients is rather low to be able to detect all clinically relevant differences. Especially detailed evaluation of individual complications, like wound infections or late incisional hernia that may benefit from a minimal invasive approach, is not possible based on the available data.</P>
<P>Regarding postoperative recovery, this review could not reliable identify clinically significant benefits of the laparoscopic approach. Hospital stay was shorter for the laparoscopic approach in both the meta-analysis of non-RCTs (WMD -2.7 days) and the sensitivity analysis with imputed data (WMD -2.1 days). However, this was not supported by the result of the RCT. One explanation could be that the RCT used a hand-assisted approach for the laparoscopic IPAA, while most other trials used a laparoscopic-assisted approach (see <LINK TAG="STUDY_DESCRIPTION" TYPE="SECTION">Description of studies</LINK> - Surgical interventions). Sensitivity analyses imputing missing data also suggested that the laparoscopic technique was associated with less blood loss, time to bowel movement and time to regular diet. As proved by these inconsistent findings, more data is needed before a final word could be said regarding this matter.</P>
<P>A point worth considering is that the clinical relevance of such relatively small benefits regarding the postoperative recovery remains questionable. With a complex operation like the IPAA a one or a two day reduction of hospital stay is not likely to be decisive in the choice of operative technique. Neither will be a slightly faster normalization of bowel function or return to normal diet. Especially with the increased implementation of 'fast-track' perioperative care programs, the differences between open and laparoscopic techniques could diminish even further. 'Fast-track' programmes have already been applied in a wide variety of colonic operations and results seem to confirm there ability to accelerate recovery, reduce morbidity and shorten hospital stay (<LINK REF="REF-Wind-2006" TYPE="REFERENCE">Wind 2006</LINK>). In time, implementation of such programs even in complex procedures, like the IPAA, seems likely. Therefore, future studies comparing open and laparoscopic IPAA should probably focus on other clinically more relevant outcomes, like specific complications, costs and long-term outcomes.</P>
<P>One of the most relevant long-term outcomes is maybe the cosmetic result of surgery and its impact in this predominately young group of patients. In this review, two trials showed a significantly shorter incision in the laparoscopic IPAA. Also, two trials reported results of cosmesis and body image. Both trials observed significantly higher scores regarding cosmesis in the laparoscopic group. Additionally, in the long-term follow-up of the only RCT (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>) body image scores in female patients were found to be significantly higher in the laparoscopic group. These results suggest that the shorter incision of the laparoscopic approach is associated with long-lasting benefits in the perception of patients of their own body, which could be an interesting argument in favour of the laparoscopic technique. While these results need conformation from other trials, the social and psychological impact could be significant. With an ever increasing patient's awareness a smaller scar and improved cosmesis could be important factor in guiding the choice of operative technique in clinical practice.</P>
<P>Costs also play an important role when evaluating new operative techniques, since fear of increased costs could be a strong motive against their implementation. In this review only one trial (<LINK REF="STD-Maartense-2004a" TYPE="STUDY">Maartense 2004a</LINK>) reported on costs and found no significant differences when the overall costs, including admission, complications and readmission, were evaluated. The costs of the laparoscopic procedure was, however, significantly higher than the open technique. Trials comparing costs of other types of colonic surgery give contradicting results: some trials show no differences in costs between laparoscopic and open approaches (<LINK REF="REF-Pokala-2005" TYPE="REFERENCE">Pokala 2005</LINK>), while others show results favouring the laparoscopic approach (<LINK REF="STD-Senagore-1993" TYPE="STUDY">Senagore 1993</LINK>). It is therefore not possible to draw reliable conclusion from these studies and future research is required to resolve this issue as well.</P>
<P>In this context the ongoing LapCon-Pouch Trial (<LINK REF="STD-Antolovic-2006" TYPE="STUDY">Antolovic 2006</LINK>) is an important step in the right direction. This single-centre, patient blinded trial will randomise 160 patients into two groups: a totally laparoscopic IPAA group and a conventional open IPAA group. This trial will be the largest randomised clinical trial and will have the largest number of total laparoscopic IPAA patients included in any report so far. It will have the power to answer several interesting question and with a follow-up period of 12 month more light could be shed on important long-term outcomes. While the sample-size is not large enough to resolve all issues, it should be noted that for a relatively infrequent operation as the IPAA a sample of this size is substantial. It is therefore to be hoped that other high-volume centres will follow the example of this trial and that in the near future a meta-analysis based solely on RCTs would become feasible.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-11-04 13:38:36 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2008-11-04 13:38:36 +0100" MODIFIED_BY="[Empty name]">
<P>The laparoscopic IPAA is a safe procedure, that could be performed successfully in centres experienced in laparoscopic and restorative pouch surgery. The laparoscopic approach seems to be associated with some short-term advantages regarding postoperative recovery, but these advantages seem to be limited and their clinical significance is arguable. For a complex operation like the IPAA other outcomes, like specific complications, long-term functional outcome, cosmesis and costs are more likely to influence the choice of the operative technique. This review have shown that for cosmesis there are some data favouring the laparoscopic approach, but that the evidence is still inconclusive and more research is needed before a general recommendation can be made. There is also some evidence that costs, a crucial item in today's health care, may not become a decisive item in the decision between open and laparoscopic IPAA.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>High volume colorectal surgical centres should include patients scheduled for laparoscopic IPAA in high-quality RCTs with sufficiently long follow-up to be able to reliable assess differences in relevant long-term outcomes. The focus of these trials should be specific postoperative complications, cosmesis, quality of life and costs.Trials should provide data suitable for meta-analysis in there published publications, or at least make it readily available upon request. There is need for empirical evidence to guide the process of methodological quality assessment of non-randomised controlled trials. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We thank the Cochrane Colorectal Cancer Group in Copenhagen for their support and guidance. All workers of the Library of the St. Elisabeth Hospital in Tilburg for assistance in the search for full text articles. Dr. Yoshitaka Hitomi (University Medical Centre Groningen) for his tremendous effort in translation from Japanese. We wish to thank all authors for their willingness to help in improving the review by responding to our request for additional information, especially professor Berdah, who was admirably generous and swift in provide us with all the needed information, and professor Bemelman, who open heartedly shared with us the results of years of continued work and research.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P> <BR/>None.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-11-04 13:38:36 +0100" MODIFIED_BY="[Empty name]">
<P>U Ahmed Ali, F Keus, JT Heikens, HG Gooszen and CJHM van Laarhoven participated in the design of the review and drafting of the protocol.<BR/>U Ahmed Ali, F Keus and JT Heikens participated in the literature search, extraction of data and methodological quality assessement of studies.<BR/>U Ahmed Ali, F Keus and CJHM van Laarhoven participated in the statistical analysis and interpretation of results.<BR/>SV Berdah and WA Bemelman provided individual patient data and reviewed the protocol and final manuscript.<BR/>U Ahmed Ali and F Keus drafted the review.<BR/>CJHM van Laarhoven conceived the idea for the review and supervised the review.<BR/>All authors co-authored the writing of the review, read and approved the final manuscript.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-04-24 15:05:46 +0200" MODIFIED_BY="Usama Ahmed Ali">
<UL>
<LI>Relative Risks (RR) are used as a summary statistic for dichotomous data in stead of Odds Ratios (OR). The RR were chosen over OR, because the were considered easier to understand and interpret.</LI>
<LI>We used a modified version of the MINORS index in this review. Motivation and detailed information about the modifications can be found in the "Assessment of methodological quality of non-randomised clinical trials" section.</LI>
</UL>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-04 13:46:47 +0100" MODIFIED_BY="[Empty name]">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Araki-2001" NAME="Araki 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Araki Y, Ishibashi N, Ogata Y, Shirouzo K, Isomoto H</AU>
<TI>The Usefulness of Restorative Laparoscopic-Assisted Total Colectomy for Ulcerative Colitis</TI>
<SO>Kurume Medical Journal</SO>
<YR>2001</YR>
<VL>48</VL>
<NO>2</NO>
<PG>99-103</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11501505"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Berdah-2004" NAME="Berdah 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berdah SV, Barthet M, Emungania O, Orsoni P, Alliot P, Grimaud JC, Brunet C</AU>
<TI>Two stage videoassisted restorative proctocolectomy. Early experience of 12 cases</TI>
<TO>Coloproctectomie totale avec anastomose iléoanale en deux temps vidéoassistée. Expérience initiale de 12 cas</TO>
<SO>Annales de Chirurgie</SO>
<YR>2004 Jul-Aug</YR>
<VL>129</VL>
<NO>6-7</NO>
<PG>332-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-2001" NAME="Brown 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown SR, Eu KW, Seow-Choen F</AU>
<TI>Consecutive series of laparoscopic-assisted vs. minilaparotomy restorative proctocolectomies</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2001 Mar</YR>
<VL>44</VL>
<NO>3</NO>
<PG>397-400</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunker-2001" NAME="Dunker 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunker MS, Bemelman WA, Slors JFM, van Duijvendijk P, Gouma DJ</AU>
<TI>Functional outcome, quality of life, body image, and cosmesis in patients after laparoscopic assisted and conventional restorative proctocolectomy - A comparative study</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2001</YR>
<VL>44</VL>
<NO>12</NO>
<PG>1800-07</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hashimoto-2001" NAME="Hashimoto 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hashimoto A, Funayama Y, Naito H, Fukushima K, Shibata C, Naitoh T, Shibuya K, Koyama K, Takahashi K, Ogawa H, Satoh S, Ueno T, Kitayama T, Matsuno S, Sasaki I</AU>
<TI>Laparascope-assisted versus conventional restorative proctocolectomy with rectal mucosectomy</TI>
<SO>Surgery Today</SO>
<YR>2001</YR>
<VL>31</VL>
<NO>3</NO>
<PG>210-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Larson-2005" NAME="Larson 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larson DW, Dozois EJ, Piotrowicz K, Cima RR, Wolff BG, Young-Fadok TM</AU>
<TI>Laparoscopic-assisted vs. open ileal pouch-anal anastomosis: Functional outcome in a casematched series</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2005</YR>
<VL>48</VL>
<NO>10</NO>
<PG>1845-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Larson-2006" NAME="Larson 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larson DW, Cima RR, Dozois EJ, Davies M, Piotrowicz K, Barnes SA, Wolff B, Pemberton J</AU>
<TI>Safety, feasibility, and short-term outcomes of laparoscopic illeal-pouch-anal anastomosis - A single institutional case-matched experience</TI>
<SO>Annals of Surgery</SO>
<YR>2006</YR>
<VL>243</VL>
<NO>5</NO>
<PG>667-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Maartense-2004a" NAME="Maartense 2004a" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maartense S, Dunker MS, Slors JF, Cuesta MA, Gouma DJ, van Deventer SJ, van Bodegraven AA, Bemelman WA</AU>
<TI>Hand-assisted laparoscopic versus open restorative proctocolectomy with ileal pouch anal anastomosis: a randomized trial</TI>
<SO>Annals of Surgery</SO>
<YR>2004 Dec</YR>
<VL>240</VL>
<NO>6</NO>
<PG>984-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Polle SW, Dunker MS, Slors JFM, Sprangers MA, Cuesta MA, Gouma DJ, Bemelman WA.</AU>
<TI>Body image, cosmesis, quality of life, and functional outcome of hand-assisted laparoscopic versus open restorative proctocolectomy: long-term results of a randomized trial.</TI>
<SO>Surgical Endoscopy and Other Interventional Techniques</SO>
<YR>2007</YR>
<VL>21</VL>
<NO>8</NO>
<PG>1301-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Marcello-2000" NAME="Marcello 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marcello PW, Milsom JW, Wong SK, Hammerhofer KA, Goormastic M, Church JM, Fazio VW</AU>
<TI>Laparoscopic restorative proctocolectomy: case-matched comparative study with open restorative proctocolectomy</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2000 May</YR>
<VL>43</VL>
<NO>5</NO>
<PG>604-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Otani-2001" NAME="Otani 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Otani Y, Nakamura T, Kanazawa H, Aihara N, Kokuba Y, Ihara A, Kakita A</AU>
<TI>Article in Japanese</TI>
<TO>Laparoscoy-assisted ileal-pouch anal-canal anastomosis for ulcerative colitis</TO>
<SO>Japanese Journal of Gastroenterological Surgery</SO>
<YR>2001</YR>
<VL>34</VL>
<NO>4</NO>
<PG>351-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmitt-1994" NAME="Schmitt 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmitt SL, Cohen SM, Wexner SD, Nogueras JJ, Jagelman DG</AU>
<TI>Does laparoscopic-assisted ileal pouch anal anastomosis reduce the length of hospitalization?</TI>
<SO>International Journal of Colorectal Disease</SO>
<YR>1994 Aug</YR>
<VL>9</VL>
<NO>3</NO>
<PG>134-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Araki-2000" NAME="Araki 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Araki Y, Matsumoto A, Isomoto H</AU>
<TI>Total colectomy combined laparoscopy</TI>
<SO>Minimally Invasive Therapy &amp; Allied Technologies</SO>
<YR>2000</YR>
<VL>9</VL>
<NO>1</NO>
<PG>3-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Araujo-2005" NAME="Araujo 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Araujo SE, Nahas SC, Seid VE, Marchini GS, Torricelli FC</AU>
<TI>Laparoscopy-assisted ileal pouch-anal anastomosis: surgical outcomes after 10 cases</TI>
<SO>Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques</SO>
<YR>2005</YR>
<VL>15</VL>
<NO>6</NO>
<PG>321-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baccari-2000" NAME="Baccari 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baccari P, Di Palo S, Redaelli A, Carlucci M, Staudacher C</AU>
<TI>Laparoscopic versus conventional surgery in the treatment of colorectal diseases</TI>
<TO>Chirurgia laparoscopica versus chirurgia tradizionale nel trattamento della patologia colo-rettale</TO>
<SO>Chirurgia Italiana</SO>
<YR>2000</YR>
<VL>52</VL>
<NO>1</NO>
<PG>17-27</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10832523"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delaney-2003" NAME="Delaney 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Delaney CP, Kiran RP, Senagore AJ, Brady K, Fazio VW</AU>
<TI>Case-matched comparison of clinical and financial outcome after laparoscopic or open colorectal surgery</TI>
<SO>Annals of Surgery</SO>
<YR>2003</YR>
<VL>238</VL>
<NO>1</NO>
<PG>67-72</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12832967"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunker-2000" NAME="Dunker 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunker MS, Bemelman WA, Slors JFM, Van Hogezand RA, Ringers J, Gouma DJ</AU>
<TI>Laparoscopic-assisted vs open colectomy for severe acute colitis in patients with inflammatory bowel disease (IBD): A retrospective study in 42 patients</TI>
<SO>Surgical Endoscopy and Other Interventional Techniques</SO>
<YR>2000</YR>
<VL>14</VL>
<NO>10</NO>
<PG>911-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Etienne-1993" NAME="Etienne 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Etienne J, Jehaes C, Kartheuser A, de Neve de Roden A</AU>
<TI>Laparoscopic surgery for benign colorectal disease: a multicentre prospective study</TI>
<SO>The British Journal of Surgery</SO>
<YR>1993</YR>
<VL>80</VL>
<NO>Supplement</NO>
<PG>S45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Georgeson-2002" NAME="Georgeson 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Georgeson KE</AU>
<TI>Laparoscopic-assisted total colectomy with pouch reconstruction</TI>
<SO>Seminars in pediatric surgery</SO>
<YR>2002</YR>
<VL>11</VL>
<PG>233-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12407505"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gill-2004" NAME="Gill 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gill TS, Karantana A, Rees J, Pandey S, Dixon AR</AU>
<TI>Laparoscopic proctocolectomy with restorative ileal-anal pouch</TI>
<SO>Colorectal Disease</SO>
<YR>2004</YR>
<VL>6</VL>
<NO>6</NO>
<PG>458-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hahnloser-2004" NAME="Hahnloser 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hahnloser D, Young-Fadok TM</AU>
<TI>Laparoscopic proctocolectomy and ileal pouch-anal anastomosis (IPAA) offers benefits compared with open IPAA</TI>
<SO>Surgical Endoscopy and Other Interventional Techniques</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>Suppl</NO>
<PG>163</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hasegawa-2002" NAME="Hasegawa 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hasegawa H, Watanabe M, Baba H, Nishibori H, Kitajima M</AU>
<TI>Laparoscopic restorative proctocolectomy for patients with ulcerative colitis</TI>
<SO>Journal of Laparoendoscopic &amp; Advanced Surgical Techniques-Part A</SO>
<YR>2002</YR>
<VL>12</VL>
<NO>6</NO>
<PG>403-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hildebrandt-1998" NAME="Hildebrandt 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hildebrandt U, Lindemann W, Kreissler-Haag D, Feifel G, Ecker KW</AU>
<TI>Laparoscopically-assisted proctocolectomy with ileoanal pouch in ulcerative colitis</TI>
<TO>Die laparoskopisch assistierte Proktokolektomie mit ileoanalem Pouch bei Colitis ulcerosa</TO>
<SO>Zentralblatt fur Chirurgie</SO>
<YR>1998</YR>
<VL>123</VL>
<NO>4</NO>
<PG>403-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9622901"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hong-2002" NAME="Hong 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hong D, Lewis M, Tabet J, Anvari M</AU>
<TI>Prospective comparison of laparoscopic versus openresection for benign colorectal disease</TI>
<SO>Surgical Laparoscopy Endoscopy &amp; Percutaneous Techniques</SO>
<YR>2002</YR>
<VL>12</VL>
<NO>4</NO>
<PG>238-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ishida-2003" NAME="Ishida 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ishida H, Hashimoto D, Inokuma S, Nakada H, Ohsawa T, Hoshino T</AU>
<TI>Gasless laparoscopic surgery for ulcerative colitis and familial adenomatous polyposis - Initial experience of 7 cases</TI>
<SO>Surgical Endoscopy and Other Interventional Techniques</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>6</NO>
<PG>899-902</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kessler-2001" NAME="Kessler 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kessler H, Milsom JW, Marcello PW, Hohenberger W</AU>
<TI>Laparoscopic restorative proctocolectomy in ulcerative colitis and colonicpolyps</TI>
<TO>Laparoskopische restaurative Proktokolektomie bei Colitis ulcerosa und Polyposis coli</TO>
<SO>Kongressband / Deutsche Gesellschaft fur Chirurgie Kongress</SO>
<YR>2001</YR>
<VL>118</VL>
<PG>109-13</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11824230"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kienle-2003" NAME="Kienle 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kienle P, Weitz J, Benner A, Herfarth C, Schmidt J</AU>
<TI>Laparoscopically assisted colectomy and ileoanal pouch procedure with and without protective ileostomy</TI>
<SO>Surgical Endoscopy and Other Interventional Techniques</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>5</NO>
<PG>716-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kienle-2005" NAME="Kienle 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kienle P, Z'graggen K, Schmidt J, Benner A, Weitz J, Buchler MW</AU>
<TI>Laparoscopic restorative proctocolectomy</TI>
<SO>British Journal of Surgery</SO>
<YR>2005</YR>
<VL>92</VL>
<NO>1</NO>
<PG>88-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ky-2002" NAME="Ky 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ky AJ, Sonoda T, Milsom JW</AU>
<TI>One-stage laparoscopic restorative proctocolectomy: an alternative to the conventional approach?</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2002 Feb</YR>
<VL>45</VL>
<NO>2</NO>
<PG>207-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Larach-1993" NAME="Larach 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larach SW, Salomon MC, Williamson PR, Goldstein E</AU>
<TI>Laparoscopic assisted colectomy: experience during the learning curve</TI>
<TO>Laparoskopie-unterstutzte Kolektomie: Erfahrungen wahrend der Lernperiode</TO>
<SO>Coloproctology</SO>
<YR>1993</YR>
<VL>1</VL>
<PG>38-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindemann-1995" NAME="Lindemann 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindemann W, Hildebrandt U, Schuder G, Kreissler-Haag D, Pistorius G</AU>
<TI>Laparoscopic surgery of benign small and large intestinal diseases</TI>
<TO>Laparoskopische Chirurgie benigner Dunn- und Dickdarmerkrankungen</TO>
<SO>Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie</SO>
<YR>1995</YR>
<VL>30</VL>
<NO>7</NO>
<PG>444-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-1995" NAME="Liu 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu CD, Rolandelli R, Ashley SW, Evans B, Shin M, Mcfadden DW</AU>
<TI>Laparoscopic Surgery For Inflammatory Bowel-Disease</TI>
<SO>American Surgeon</SO>
<YR>1995</YR>
<VL>61</VL>
<NO>12</NO>
<PG>1054-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maartense-2004b" NAME="Maartense 2004b" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maartense S, Dunker MS, Slors JF, Gouma DJ, Bemelman WA</AU>
<TI>Restorative proctectomy after emergency laparoscopic colectomy for ulcerative colitis: a case-matched study</TI>
<SO>Colorectal Disease</SO>
<YR>2004</YR>
<VL>6</VL>
<NO>4</NO>
<PG>254-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15206968"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marcello-2001" NAME="Marcello 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marcello PW, Milsom JW, Wong SK, Brady K, Goormastic M, Fazio VW</AU>
<TI>Laparoscopic total colectomy for acute colitis: a case-control study</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2001</YR>
<VL>44</VL>
<NO>10</NO>
<PG>1441-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nogueras-1992" NAME="Nogueras 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nogueras JJ, Wexner SD</AU>
<TI>Laparoscopic Colon Resection</TI>
<SO>Perspectives in Colon and Rectal Surgery</SO>
<YR>1992</YR>
<VL>5</VL>
<NO>1</NO>
<PG>79-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ouaissi-2006" NAME="Ouaissi 2006" YEAR="2006">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ouaissi M, Alves A, Bouhnik Y, Valleur P, Panis Y</AU>
<TI>Three-step ileal pouch-anal anastomosis under total laparoscopic approach for acute or severe colitis complicating inflammatory bowel disease</TI>
<SO>Journal of the American College of Surgeons</SO>
<YR>2006</YR>
<VL>202</VL>
<PG>637-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pace-2002" NAME="Pace 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pace DE, Seshadri PA, Chiasson PM, Poulin EC, Schlachta CM, Mamazza J</AU>
<TI>Early experience with laparoscopic ileal pouch-anal anastomosis for ulcerative colitis</TI>
<SO>Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques</SO>
<YR>2002</YR>
<VL>12</VL>
<NO>5</NO>
<PG>337-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Panis-2005" NAME="Panis 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Panis YH, Marceau C, Alves A, Bouhnik Y, Lavergne-Slove A, Valleur P</AU>
<TI>Laparoscopic vs conventional subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: a case-control study in 82 patients</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2005</YR>
<VL>48</VL>
<NO>3</NO>
<PG>678-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pfeifer-1995" NAME="Pfeifer 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pfeifer J, Wexner SD, Reissman P, Bernstein M, Nogueras JJ, Singh S, Weiss E</AU>
<TI>Laparoscopic vs open colon surgery. Costs and outcome</TI>
<SO>Surgical Endoscopy and Other Interventional Techniques</SO>
<YR>1995</YR>
<VL>9</VL>
<PG>1322-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8629220"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santoro-1999" NAME="Santoro 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santoro E, Carlini M, Carboni F, Feroce A</AU>
<TI>Laparoscopic total proctocolectomy with ileal J pouch-anal anastomosis</TI>
<SO>Hepatogastroenterology</SO>
<YR>1999</YR>
<VL>46</VL>
<NO>26</NO>
<PG>894-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Senagore-1993" NAME="Senagore 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Senagore AJ, Luchtefeld MA, Mackeigan JM, Mazier WP</AU>
<TI>Open colectomy versus laparoscopic colectomy: are there differences?</TI>
<SO>American Surgeon</SO>
<YR>1993</YR>
<VL>59</VL>
<NO>8</NO>
<PG>549-53</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8338287"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seow-1999" NAME="Seow 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seow-Choen F, Eu KW, Leong AFPK, Ho YH, Wexner SD</AU>
<TI>A consecutive series of open compared to laparoscopic restorative proctocolectomy with ileo-pouch anal anastomosis for familial adenomatous polyposis</TI>
<SO>Techniques in Coloproctology</SO>
<YR>1999</YR>
<VL>3</VL>
<NO>2</NO>
<PG>83-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seshadri-2001" NAME="Seshadri 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seshadri PA, Poulin EC, Schlachta CM, Cadeddu MO, Mamazza J</AU>
<TI>Does a laparoscopic approach to total abdominal colectomy and proctocolectomy offer advantages?</TI>
<SO>Surgical Endoscopy-Ultrasound and Interventional Techniques</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>8</NO>
<PG>837-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stocchi-2000" NAME="Stocchi 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stocchi L, Nelson H, Young-Fadok TM, Larson DR, Ilstrup DM</AU>
<TI>Safety and advantages of laparoscopic vs. open colectomy in the elderly: matched-control study</TI>
<SO>Diseaes of the Colon &amp; Rectum</SO>
<YR>2000</YR>
<VL>43</VL>
<PG>326-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vignali-2004" NAME="Vignali 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vignali A, Braga M, Zuliani W, Frasson M, Radaelli G, Di Carlo V</AU>
<TI>Laparoscopic colorectal surgery modifies risk factors for postoperative morbidity</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2004</YR>
<VL>47</VL>
<NO>10</NO>
<PG>1686-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wexner-1992" NAME="Wexner 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wexner SD, Johansen OB, Nogueras JJ, Jagelman DG</AU>
<TI>Laparoscopic total abdominal colectomy - a prospective trial</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>1992</YR>
<VL>35</VL>
<NO>7</NO>
<PG>651-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wexner-1996" NAME="Wexner 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wexner SD, Reissman P, Pfeifer J, Bernstein M, Gron N</AU>
<TI>Laparoscopic colorectal surgery - Analysis of 140 cases</TI>
<SO>Surgical Endoscopy-Ultrasound and Interventional Techniques</SO>
<YR>1996</YR>
<VL>10</VL>
<NO>2</NO>
<PG>133-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Young_x002d_Fadok-2001" NAME="Young-Fadok 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Young-Fadok TM, Dozois E, Sandborn WJ, Tremaine WJ</AU>
<TI>A case matched study of laparoscopic proctocolectomy and ileal pouch-anal anastomosis (PC-IPAA) versus open PC-IPAA for ulcerative colitis</TI>
<SO>Gastroenterology</SO>
<YR>2001</YR>
<VL>Suppl</VL>
<PG>2302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Antolovic-2006" NAME="Antolovic 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Antolovic D, Kienle P, Knaebel HP, Schmidt J, Gutt CN, Weitz J, Koch M, Buchler MW, Seiler CM</AU>
<TI>Totally laparoscopic versus conventional ileoanal pouch procedure--design of a single-centre, expertise based randomised controlled trial to compare the laparoscopic and conventional surgical approach in patients undergoing primary elective restorative proctocolectomy--LapConPouch-Trial</TI>
<SO>BMC Surgery</SO>
<YR>2006</YR>
<VL>6</VL>
<PG>13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-04 13:46:47 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-04 13:46:47 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Ahmed-Ali-2007" NAME="Ahmed Ali 2007" TYPE="COCHRANE_REVIEW">
<AU>Ahmed Ali U, Keus E, Heikens JT, Gooszen HG, van Laarhoven CJHM</AU>
<TI>Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis or familial adenomatous polyposis (Protocol)</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="Art. No.: CD006267. DOI: 10.1002/14651858.CD006267."/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ballantyne-2004" NAME="Ballantyne 2004" TYPE="JOURNAL_ARTICLE">
<AU>Ballantyne GH, Leahy PF</AU>
<TI>Hand-Assisted Laparoscopic Colectomy: Evolution to a Clinically Useful Technique</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2004</YR>
<VL>47</VL>
<NO>5</NO>
<PG>753-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Begg-1994" NAME="Begg 1994" TYPE="JOURNAL_ARTICLE">
<AU>Begg CB, Mazumdar M</AU>
<TI>Operating characteristics of a rank correlation test for publication bias</TI>
<SO>Biometrics</SO>
<YR>1994</YR>
<VL>50</VL>
<NO>4</NO>
<PG>1088-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bemelman-1998" NAME="Bemelman 1998" TYPE="JOURNAL_ARTICLE">
<AU>Bemelman WA, Hogezand van RA, Meijerink WJHJ , Griffioen G, Ringers J</AU>
<TI>Laparoscopic-assisted bowel resections in inflammatory bowel disease: state of the art</TI>
<SO>Netherlands Journal of Medicine</SO>
<YR>1998</YR>
<VL>53</VL>
<PG>S39&#8211;S46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bulow-2003" NAME="Bulow 2003" TYPE="JOURNAL_ARTICLE">
<AU>Bulow S</AU>
<TI>Results of national registration of familial adenomatous polyposis</TI>
<SO>Gut</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>5</NO>
<PG>742-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Casillas-2005" NAME="Casillas 2005" TYPE="JOURNAL_ARTICLE">
<AU>Casillas S, Delaney CP</AU>
<TI>Laparoscopic surgery for inflammatory bowel disease</TI>
<SO>Digestive Surgery</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>3</NO>
<PG>135-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chung-2003" NAME="Chung 2003" TYPE="JOURNAL_ARTICLE">
<AU>Chung CC, Tsang WWC, Kwok SY, Li MKW</AU>
<TI>Laparoscopy and its current role in the management of colorectal disease</TI>
<SO>Colorectal Disease</SO>
<YR>2003</YR>
<VL>5</VL>
<PG>528&#8211;43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1992" NAME="Cohen 1992" TYPE="JOURNAL_ARTICLE">
<AU>Cohen Z, McLeod RS, Stephen W, Stern HS, O'Connor B, Reznick R</AU>
<TI>Continuing evolution of the pelvic pouch procedure</TI>
<SO>Annals of Surgery</SO>
<YR>1992</YR>
<VL>216</VL>
<NO>4</NO>
<PG>506-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-2005" NAME="Cohen 2005" TYPE="JOURNAL_ARTICLE">
<AU>Cohen JL, Strong SA, Hyman NH, Buie WD, Dunn GD, Ko CY, Fleshner PR, Stahl TJ, Kim DG, Bastawrous AL, Perry WB, Cataldo PA, Rafferty JF, Ellis CN, Rakinic J, Gregorcyk S, Shellito PC, Kilkenny JW 3rd, Ternent CA, Koltun W, Tjandra JJ, Orsay CP, Whiteford MH, Penzer JR</AU>
<TI>Standards Practice Task Force American Society of Colon and Rectal Surgeons. Practice parameters for the surgical treatment of ulcerative colitis</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2005</YR>
<VL>48</VL>
<NO>11</NO>
<PG>1997-2009</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2003" MODIFIED="2008-11-04 13:46:47 +0100" MODIFIED_BY="[Empty name]" NAME="Deeks 2003" TYPE="JOURNAL_ARTICLE">
<AU>Deeks JJ, Dinnes J, D'Amico R, Sakarovitch C, Song F, Petticrew M, Altman DG, for the International Stroke Trial Collaborative Group</AU>
<TI>Evaluating non-randomised intervention studies</TI>
<SO>Health Technology Assessment</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>27</NO>
<PG>iii-x, 1-173</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fazio-1995" NAME="Fazio 1995" TYPE="JOURNAL_ARTICLE">
<AU>Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK</AU>
<TI>Ileal pouch-anal anastomoses complications and function in 1005 patients</TI>
<SO>Annals of Surgery</SO>
<YR>1995 Aug</YR>
<VL>222</VL>
<NO>2</NO>
<PG>120-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2008-11-04 12:09:13 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions version 5.0.0 [updated February 2008].</TI>
<SO>The Cochrane Collaboration 2008 available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hozo-2005" NAME="Hozo 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hozo SP, Djulbegovic B, Hozo I</AU>
<TI>Estimating the mean and variance from the median, range, and the size of a sample</TI>
<SO>BMC Medical Research Methodology</SO>
<YR>2005</YR>
<VL>5</VL>
<NO>1</NO>
<PG>13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hueting-2005" NAME="Hueting 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hueting WE, Buskens E, van der Tweel I, Gooszen HG, van Laarhoven CJ</AU>
<TI>Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients</TI>
<SO>Digestive Surgery</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>1-2</NO>
<PG>69-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jarvinen-1992" NAME="Jarvinen 1992" TYPE="JOURNAL_ARTICLE">
<AU>Jarvinen HJ</AU>
<TI>Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival</TI>
<SO>Gut</SO>
<YR>1992</YR>
<VL>33</VL>
<NO>3</NO>
<PG>357-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Juni-1999" NAME="Juni 1999" TYPE="JOURNAL_ARTICLE">
<AU>Juni P, Witschi A, Block R, Egger M</AU>
<TI>The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis</TI>
<SO>JAMA</SO>
<YR>1999</YR>
<VL>282</VL>
<NO>11</NO>
<PG>1054-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-2001" NAME="Kjaergard 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard LL, Villumsen J, Gluud C</AU>
<TI>Reported methodological quality and discrepancies between large and small randomised trials in meta-analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2001</YR>
<VL>135</VL>
<NO>11</NO>
<PG>982-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Macaskill-2001" NAME="Macaskill 2001" TYPE="JOURNAL_ARTICLE">
<AU>Macaskill P, Walter SD, Irwig L</AU>
<TI>A comparison of methods to detect publication bias in meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2001</YR>
<VL>20</VL>
<PG>641-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marcello-1993" NAME="Marcello 1993" TYPE="JOURNAL_ARTICLE">
<AU>Marcello PW, Roberts PL, Schoetz DJ Jr, Coller JA, Murray JJ, Veidenheimer MC</AU>
<TI>Long-term results of the ileoanal pouch procedure</TI>
<SO>Archives of Surgery</SO>
<YR>1993 May</YR>
<VL>128</VL>
<NO>5</NO>
<PG>500-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9128</NO>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parks-1978" NAME="Parks 1978" TYPE="JOURNAL_ARTICLE">
<AU>Parks AG, Nicholls RJ</AU>
<TI>Proctocolectomy without ileostomy for ulcerative colitis</TI>
<SO>British Medical Journal</SO>
<YR>1978 Jul 8</YR>
<VL>2</VL>
<NO>6130</NO>
<PG>85-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peters-1992" NAME="Peters 1992" TYPE="JOURNAL_ARTICLE">
<AU>Peters WR</AU>
<TI>Laparoscopic total proctocolectomy with creation of ileostomy for ulcerative colitis: report of two cases</TI>
<SO>Journal of Laparoendoscopic Surgery</SO>
<YR>1992 Jun</YR>
<VL>2</VL>
<NO>3</NO>
<PG>175-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pokala-2005" NAME="Pokala 2005" TYPE="JOURNAL_ARTICLE">
<AU>Pokala N, Delaney CP, Senagore AJ, Brady KM, Fazio VW</AU>
<TI>Laparoscopic vs open total colectomy: a case-matched comparative study</TI>
<SO>Surgical Endoscopy and Other Interventional Techniques</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>4</NO>
<PG>531-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Polle-2007" NAME="Polle 2007" TYPE="JOURNAL_ARTICLE">
<AU>Polle SW, Dunker MS, Slors JFM, Sprangers MA, Cuesta MA, Gouma DJ, Bemelman WA.</AU>
<TI>Body image, cosmesis, quality of life, and functional outcome of hand-assisted laparoscopic versus open restorative proctocolectomy: long-term results of a randomized trial.</TI>
<SO>Surgical Endoscopy and Other Interventional Techniques</SO>
<YR>2007</YR>
<VL>21</VL>
<NO>8</NO>
<PG>1301-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reissman-1996" NAME="Reissman 1996" TYPE="JOURNAL_ARTICLE">
<AU>Reissman P, Salky BA, Pfeifer J, Edye M, Jagelman DG, Wexner SD</AU>
<TI>Laparoscopic surgery in the management of inflammatory bowel disease</TI>
<SO>American Journal of Surgery</SO>
<YR>1996</YR>
<VL>171</VL>
<NO>1</NO>
<PG>47-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sardinha-1998" NAME="Sardinha 1998" TYPE="JOURNAL_ARTICLE">
<AU>Sardinha TC, Wexner SD</AU>
<TI>Laparoscopy for inflammatory bowel disease: pros and cons</TI>
<SO>World Journal of Surgery</SO>
<YR>1998 Apr</YR>
<VL>22</VL>
<NO>4</NO>
<PG>370-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayer R, Altman D</AU>
<TI>Empirical evidence of bias</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schwenk-2005" NAME="Schwenk 2005" TYPE="COCHRANE_REVIEW">
<AU>Schwenk W, Haase O, Neudecker J, Müller JM</AU>
<TI>Short term benefits for laparoscopic colorectal resection</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>2</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="Art. No.: CD003145. DOI: 10.1002/14651858.CD003145.pub2."/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Shivananda-1996" NAME="Shivananda 1996" TYPE="JOURNAL_ARTICLE">
<AU>Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M</AU>
<TI>Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)</TI>
<SO>Gut</SO>
<YR>1996</YR>
<VL>39</VL>
<NO>5</NO>
<PG>690-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Slim-2003" NAME="Slim 2003" TYPE="JOURNAL_ARTICLE">
<AU>Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J</AU>
<TI>Methodological index for non-randomized studies (minors): development and validation of a new instrument</TI>
<SO>ANZ Journal of Surgery</SO>
<YR>2003 Sep</YR>
<VL>73</VL>
<NO>9</NO>
<PG>712-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tan-2006" NAME="Tan 2006" TYPE="JOURNAL_ARTICLE">
<AU>Tan JJY, Tjandra JJ</AU>
<TI>Laparoscopic surgery for ulcerative colitis &#8211; a meta-analysis</TI>
<SO>Colorectal Disease</SO>
<YR>2006</YR>
<VL>8</VL>
<PG>626&#8211;36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tilney-2007" NAME="Tilney 2007" TYPE="JOURNAL_ARTICLE">
<AU>HS Tilney, RE Lovegrove, AG Heriot, S Purkayastha, V Constantinides, RJ Nicholls, PP Tekkis</AU>
<TI>Comparison of short-term outcomes of laparoscopic vs open approaches to ileal pouch surgery</TI>
<SO>International Journal of Colorectal Disease</SO>
<YR>2007</YR>
<VL>22</VL>
<PG>531-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wind-2006" NAME="Wind 2006" TYPE="JOURNAL_ARTICLE">
<AU>Wind J, Polle SW, Fung Kon Jin PH, Dejong CH, von Meyenfeldt MF, Ubbink DT, Gouma DJ, Bemelman WA; Laparoscopy and/or Fast Track Multimodal Management Versus Standard Care (LAFA) Study Group; Enhanced Recovery after Surgery (ERAS) Group</AU>
<TI>Systematic review of enhanced recovery programmes in colonic surgery</TI>
<SO>British Journal of Surgery</SO>
<YR>2006</YR>
<VL>93</VL>
<NO>7</NO>
<PG>800-9</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-11-04 14:05:41 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-11-04 14:05:41 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Araki-2001">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 32 (21 cases, 11 controls)<BR/>- Collection of data: retrospective.<BR/>- Matching: no (base-line equal) <BR/>- Contemporary groups: no (controls from 1990 to 1994 and cases from 1994 to 1999)<BR/>- Loss to follow-up: 0<BR/>- Intention to treat: yes<BR/>- Sample size calculation: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diangosis: UC only<BR/>In- and exclusion criteria: all patients undergoing IPAA procedures in the period of study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs Open IPAA.<BR/>- LA-IPAA: 7 cm incision along the lower abdomen, J-pouch, double-stapled, without diverting loop ileostomy. <BR/>- Open IPAA: not specified.</P>
<P>Surgical experience: not described.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: not stated. <BR/>Measured outcomes: mortality, postoprative complications, operative time, time to removal of nasogastric tube, to stool passage, to fluid diet and to stool solidification, and length of hospital stay. </P>
<P>Follow-up: till discharge.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Berdah-2004">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 24 (12 cases, 12 controls)<BR/>- Collection of data: prospective<BR/>- Matching: matched for age, gender, BMI and diagnosis.<BR/>- Contemporary groups: yes<BR/>- Loss to follow-up: 0<BR/>- Intention to treat: yes<BR/>- Sample size calculation: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC and FAP. <BR/>In- and exclusion criteria: first 6 patients on basis of favorable morphology. After that all IPAA patients.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs Open IPAA.<BR/>- LA-IPAA: through Pfannenstiel incision with unspecified length, J-pouch, double-stapled, with diverting loop ileostomy for all. <BR/>- Open IPAA: midline incision from xephoid till symphesis, J-pouch, double-stabled, with diverting loop ileostomy for all. </P>
<P>Surgical experience: not described.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: not stated. <BR/>Measured outcomes: mortality, postoprative complications, conversion, operative time, length of incision, start of ileostomy function, commencement of diet, length of hospital stay. </P>
<P>Follow-up: &gt; 3 years</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Brown-2001">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 25 (cases 12, controls 13)<BR/>- Collection of data: retrospective<BR/>- Matching: not matched<BR/>- Contemporary groups: no<BR/>- Loss to follow-up: 0<BR/>- Intention to treat: yes<BR/>- Sample size calculation: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC, FAP and 1 rectal cancer (LA group)<BR/>In- and exclusion criteria: all LA-IPAA and subsequently all mini-open IPAA.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs Mini-Open IPAA.<BR/>- LA-IPAA: through short suprapubic incision of unspecified length, J-pouch, double-stapled anastomosis, with diverting loop ileostomy.<BR/>- Mini-Open IPAA: suprapubic incision of variable length, using an illuminated St. Mark's retractor to facilitate the mobilization, J-pouch, double-stapled anastomosis, with diverting loop ileostomy.</P>
<P>Surgical experience: claim to have large experience in laparoscopic colonic surgery. No specific data is presented.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: not very well descriped. <BR/>Measured outcomes: mortality, postoprative complications, conversion, operative time, length of incision, start of ileostomy function, commencement of diet, length of hospital stay. </P>
<P>Follow-up: till discharge</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>- Performed a mini-open IPAA technique.<BR/>- Included one patient with juvenile polyposis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dunker-2001">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 32 (cases 15, controls 17)<BR/>- Collection of data: retrospective<BR/>- Matching: matched for follow-up duration, type of disease and type of operation (1- or 2-stages).<BR/>- Contemporary groups: yes<BR/>- Loss to follow-up: 2/35 (5.7%)<BR/>- Intention to treat: yes<BR/>- Sample size calculation: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC and FAP<BR/>In- and exclusion criteria: all LAP-IPAA in periode of study, who agreed to participate and fill out the necessary forms.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs Open IPAA.<BR/>- LA-IPAA: through Pfannenstiel incision with unspecified length, J-pouch, type of anastomosis not specified, no diverting loop ileostomy for all. Some patients had the operation in 2-stages (an emergency LA-total collectomy and ileostomy followed by a proctectomy with IPAA later on).<BR/>- Open IPAA: midline incision from xephoid till symphesis, J-pouch, anastomosis type not specified, no diverting loop ileostomy for all. Some had a 2-stage operation.<BR/> <BR/>Surgical experience: not described.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: not very well descriped. <BR/>Measured outcomes: functional outcome: questenaire focusing on feacal function and sexual activity; quality of life using the SF-36 and GIQLI; Body image and cosmesis: body image questionnaire; Other outcomes: mortality, postoperative complications, conversion, length of operation, length of incision, time to intake &gt; 1000 ml, time to regular diet, time to pouch drain &gt; 100ml, length of hospital stay, relaparotomy.</P>
<P>Follow-up: variable, mean 16 month.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hashimoto-2001">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 24 (cases 11, controls 13)<BR/>- Collection of data: retrospective<BR/>- Matching: not matched<BR/>- Contemporary groups: no<BR/>- Loss to follow-up: 0<BR/>- Intention to treat: yes<BR/>- Sample size calculation: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC and FAP<BR/>In- and exclusion criteria: all LAP-IPAA in periode of study (indication for LAP-IPAA are well described).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs Open IPAA.<BR/>- LA-IPAA: through Pfannenstiel of 6 to 8 cm, J-pouch, with mucosectomy and hand-sewn, with diverting loop ileostomy for all. <BR/>- Open IPAA: incision type and length not specified, J-pouch, mucosectomy and hand-sewn, with diverting loop ileostomy for all.</P>
<P>Surgical experience: not described.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: not very well descriped.<BR/>Measured outcomes: mortality, intra- and postoperative complications, conversion, operative time, intraoperative blood loss, time to solid intake, length of hospital stay, relaparotomy, frequency of use of analgesic drugs.</P>
<P>Follow-up: till discharge.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-04 14:05:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Larson-2005">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 66 (cases 33, controls 33)<BR/>- Collection of data: prospective<BR/>- Matching: matched for age, gender, date of surgery, BMI and indication.<BR/>- Contemporary groups: yes<BR/>- Loss to follow-up: 0 (4 of eligible 37 didn't return the standard annual survey, therefore not included in study)<BR/>- Intention to treat: yes<BR/>- Sample size calculation: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC and FAP<BR/>In- and exclusion criteria: all LAP-IPAA in periode of study, with a follow-up &gt; 12 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs open IPAA.<BR/>- LA-IPAA: through periumbilical of 4 to 5 cm, J-pouch, either mucosectomy and handsewn or double-stapled, with diverting loop ileostomy in majority (30/33)<BR/>- Open IPAA: type en length of incision: not mentioned, J-pouch, either mucosectomy and handsewn or double-stapled, with diverting loop ileostomy in all.</P>
<P>Surgical experience: not specified.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-04 14:05:41 +0100" MODIFIED_BY="[Empty name]">
<P>Primary and secondary outcomes: not well described.<BR/>Measured outcomes: mortality, posoperative complications, reoperation, rate of use of diverting ileostomy, faecal function and sexual activity.</P>
<P>Follow-up: &gt; 12 months.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>- Focus on longterm outcomes (shortterm outcomes published separately)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Larson-2006">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 300 (cases 100, controls 200)<BR/>- Collection of data: cases prospective, controls retrospective<BR/>- Matching: matched for age, gender, date of surgery, BMI and procedure.<BR/>- Contemporary groups: yes<BR/>- Loss to follow-up: 0<BR/>- Intention to treat: yes<BR/>- Sample size calculation: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC and FAP<BR/>In- and exclusion criteria: all LAP-IPAA in periode of study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA and HA-IPAA vs open IPAA.<BR/>- LA-IPAA: through periumbilical, low midline or Pfannenstiel incision of 4 to 5 cm, J-pouch, either handsewn or double-stapled, with diverting loop ileostomy. <BR/>- HA-IPAA: through lower midline or Pfannenstiel incision of 6 to 8 cm, J-Pouch, either handsewn mucosectomy or double-Stapled, with diverting loop ileostomy .<BR/>- Open IPAA: type en length of incision: not mentioned, J-pouch, either mucosectomy or double-stapled, with diverting loop ileostomy.</P>
<P>Surgical experience: LAP-IPAA: large experience in laparoscopic surgery, but most surgeons are new to LAP-IPAA. Open-IPAA: collective large experience in open IPAA.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: not stated.<BR/>Measured outcomes: intraoperative complications, postoperative complications (bowel obstruction, wound infection, intra-abdominal abscesses, pulmonary infections, ileus, UTI, urinary retention, anastomotic leak, readmission and cause of readmission, surgical reintervention), mortality, duration of operation, conversion rate to open, time to bowel movement, time to regular diet, postoperative use of analgesic, length of hospital stay.<BR/>Follow-up: 90 days</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>- Both LA-IPAA and HA-IPAA.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Maartense-2004a">
<CHAR_METHODS>
<P>- Two-centre trial.<BR/>- N = 60 (30 cases, 30 controls)<BR/>- Generation of allocation: unclear<BR/>- Allocation concealment: adequate (sealed envelope). <BR/>- Blinding: not performed. <BR/>- Follow-up: adequate. <BR/>- Loss to follow up: <BR/>-- Maartense 2004: 2 in HA-IPAA, 3 in open group.<BR/>-- Polle 2007: 7 in HA-IPAA, 7 in open group.</P>
<P>- Intention-to-treat: yes<BR/>- Sample size calculations: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC and FAP<BR/>In- and exclusion criteria: well described.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>HA-IPAA vs open IPAA.<BR/>- HA-IPAA: through Pfannenstiel incision of 8 cm, J-Pouch, double-Stapled, with diverting loop ileostomy on surgeon's discretion.<BR/>- Open IPAA: median incision of unspecified length, J-pouch, double-stapled, with diverting loop ileostomy on surgeon's discretion.</P>
<P>Surgical experience: good experience in both laparoscopic colorectal surgery and open IPAA.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: well described.</P>
<P>Measured outcomes: postoperative recovery, operating time, blood loss, conversion rate, morphine requirement, mortality, early complications, early readmissions and reoperations, costs and short-term quality of life (SF-36 &amp; GIQLI).</P>
<P>Follow-up: <BR/>- Maartense 2004: 3 months.<BR/>- Polle 2007: 2.7 years.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>- Long-term outcomes published separately (Polle 2007)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-04 13:28:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marcello-2000">
<CHAR_METHODS MODIFIED="2008-11-04 13:28:14 +0100" MODIFIED_BY="[Empty name]">
<P>- Mono-center trial<BR/>- N = 40 (20 cases, 20 control)<BR/>- Collection of data: prospective<BR/>- Matching: matched for age, gender, diagnosis, BMI and severity of MUC (albumine, Hb, WCC, steroid requirements and indication for surgery)<BR/>- Contemporary groups: yes<BR/>- Loss to follow-up: 0<BR/>- Intention to treat: yes<BR/>- Sample size calculations: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC and FAP<BR/>In- and exclusion criteria: all LAP-IPAA in periode of study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs Open IPAA.<BR/>- LA-IPAA: through Pfannenstiel incision of 6 to 8 cm, pouch-configuration: not mentioned, double-stapled, with diverting loop ileostomy for all but one patient with MUC and without ileostomy for all FAP. - Open IPAA: type and length of incision and pouch-configuration not mentioned, double-stapled anastomosis, with diverting loop ileostomy for all MUC and without for all FAP. </P>
<P>Surgical experience: good experience in laparoscopic colorectal surgery (&gt;700 cases), including total abdominal colectomies (&gt;100). However, new in LAP-IPAA.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: not stated. </P>
<P>Measured outcomes: intraoperative complications, postoperative complications, conversion rate, estimated blood loss, operative time, time to bowel function, length of hospital stay, rate of use of diverting ileostomy.</P>
<P>Follow-up: till discharge.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Otani-2001">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 28 (10 cases, 18 control)<BR/>- Collection of data: not specified<BR/>- Matching: not matched<BR/>- Contemporary groups: yes<BR/>- Loss to follow-up: 0<BR/>- Intention to treat: ns<BR/>- Sample size calculations: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC only<BR/>In- and exclusion criteria: all LAP-IPAA and Open IPAA performed till that time.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs Open IPAA.<BR/>- LA-IPAA: through midline incision of 6 to 7 cm, J-pouch, double-stapled, without a diverting loop ileostomy. <BR/>- Open IPAA: type and length of incision, pouch-configuration and type of anastomosis not specified. A diverting ileostomy is used when the patient uses &gt; 30 mg/day corticosteroids.</P>
<P>Surgical experience: new in LAP-IPAA.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary and secondary outcomes: not stated. </P>
<P>Measured outcomes: estimated blood loss, time to oral feeding, operative time, length of hospital stay, frequency of defecation at discharge.</P>
<P>Follow-up: till discharge.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-04 13:28:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schmitt-1994">
<CHAR_METHODS>
<P>- Mono-center trial<BR/>- N = 42 (22 cases, 20 control)<BR/>- Collection of data: prospective<BR/>- Matching: matched for age, gender and diagnosis<BR/>- Contemporary groups: yes<BR/>- Loss to follow-up: 0<BR/>- Intention to treat: yes<BR/>- Sample size calculations: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis: UC, FAP and 1 juvenile polyposis (LA-group)<BR/>In- and exclusion criteria: all LAP-IPAA in periode of study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>LA-IPAA vs Open IPAA.<BR/>- LA-IPAA: through Pfannenstiel incision of unspecified length, J-Pouch, double-stapled anastomosis, with diverting loop ileostomy .<BR/>- Open IPAA: type and length of incision not mentioned, J-pouch, double-stapled anastomosis, with diverting loop ileostomy. </P>
<P>Surgical experience: not specified.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-04 13:28:18 +0100" MODIFIED_BY="[Empty name]">
<P>Primary and secondary outcomes: not stated.</P>
<P>Measured outcomes: mortality, postoperative complications, operative time, blood transfusion requirement, time clearance of ileus, time to first oral intake, length of hospital stay, reoperation rate.</P>
<P>Follow-up: till discharge.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>- Included one patient with juvenile polyposis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>IPAA=restorative proctocolectomy with ileal-pouch anal anastomosis. LA-IPAA= laparoscopic-assisted IPAA. HA-IPAA= hand-assisted IPAA. N=number of patients.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-11-04 13:30:54 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:28:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Araki-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:28:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Araujo-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:28:37 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Baccari-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Delaney-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dunker-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:28:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Etienne-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:28:41 +0100" MODIFIED_BY="[Empty name]">
<P>No abstract was found in the electronic databases, therefore the full publications was obtained. This showed that no IPAA were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Georgeson-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>The full article showed that this was mainly a theoretical review, with a brief description of clinical experience without presentation of outcomes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:28:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gill-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:28:46 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:28:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hahnloser-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:28:51 +0100" MODIFIED_BY="[Empty name]">
<P>This study had an overlapping patient population with a subsequent study from the same institution (Larson 2006).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:28:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hasegawa-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:28:56 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hildebrandt-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:01 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract did not specify wether the laparoscopic group was compared to an open group . Reviewing the full article revealed that there was no control group in this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hong-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that only 2 out of the 279 patients included in this study had an IPAA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ishida-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:11 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that 4 of the 7 patients in this study did not underwent an IPAA procedure.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kessler-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract did not specify wether the laparoscopic group was compared to an open group . Reviewing the full article revealed that there was no control group in this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kienle-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:19 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kienle-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:22 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ky-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:26 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Larach-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:29 +0100" MODIFIED_BY="[Empty name]">
<P>No abstract was found in the electronic databases, therefore the full article has been retrieved. This showed that there were no IPAA's performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindemann-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:35 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract did not specify wether the laparoscopic group was compared to an open group . Reviewing the full article revealed that there was no control group in this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:38 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maartense-2004b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:42 +0100" MODIFIED_BY="[Empty name]">
<P>While the emergency colectomy was performed laparoscopically, the IPAA that has been done after a multiple month recovery periode was performed open in both groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Marcello-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify types of operations performed. Reviewing the full article revealed that no IPAAs were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nogueras-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>No abstract was available. Reviewing the full article revealed that there was no control group in this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ouaissi-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:45 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract did not specify wether the laparoscopic group was compared to an open group . Reviewing the full article revealed that there was no control group in this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pace-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:50 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Panis-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pfeifer-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that out of the 106 patients included in this study, only 2 had undergone a laparoscopic-assisted IPAA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:29:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santoro-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:29:53 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:30:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Senagore-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:30:32 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract did not specify type of operations performed. Reviewing the full article didn't reveal any explicit mention of IPAA. Furthermore this study included patients with a large variety of diseases and the final analyses was made for all patients together.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:30:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seow-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:30:39 +0100" MODIFIED_BY="[Empty name]">
<P>This study had an overlapping patient population with a subsequent study from the same institution (Brown 2001).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Seshadri-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Stocchi-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vignali-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were performed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:30:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wexner-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:30:47 +0100" MODIFIED_BY="[Empty name]">
<P>A preliminary study with partially overlapping patients with a subsequent trial of the same institution (Schmitt 1994).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:30:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wexner-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:30:51 +0100" MODIFIED_BY="[Empty name]">
<P>Descriptive series, with no control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 13:30:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Young_x002d_Fadok-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 13:30:54 +0100" MODIFIED_BY="[Empty name]">
<P>This study had an overlapping patient population with a subsequent study from the same institution (Larson 2006).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR STUDY_ID="STD-Antolovic-2006">
<CHAR_STUDY_NAME>
<P>LapConPouch-Trial: Totally Lparoscopic versus Conventional Ileoanal Pouch Procedure.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS>
<P>160 patients (80 per intervention arm) with ulcerative colitis or familial adenomatous polyposis, requiring restorative proctocolectomy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Totally laparoscopic versus conventional<BR/>open restorative proctocolectomy.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Blood loss, operative time, early and late onset complications, postoperative pain and analgesic drug use, length of hospital stay, lung function, quality of life (SF-36), body image and cosmesis.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>September 2004,with a duration of 4 years.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION>
<P>Corresponding author: Seiler - christoph_seiler@med.uni-heidelberg.de.<BR/>Department of Surgery, University of Heidelberg, Heidelberg, Germany. <BR/>Christoph M</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Araki-2001">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Berdah-2004">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Brown-2001">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dunker-2001">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hashimoto-2001">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Larson-2005">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Larson-2006">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Maartense-2004a">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Marcello-2000">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Otani-2001">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schmitt-1994">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-11-05 22:30:53 +0100" MODIFIED_BY="Usama Ahmed Ali">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-11-04 13:33:18 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE>Search strategies</TITLE>
<TABLE COLS="4" ROWS="7">
<TR>
<TH>
<P>Database</P>
</TH>
<TH>
<P>Search strategy</P>
</TH>
<TH>
<P>Time span of search</P>
</TH>
<TH>
<P>Hits</P>
</TH>
</TR>
<TR>
<TD>
<P>The Cochrane Library</P>
</TD>
<TD>
<P>((ulcerative colitis OR colitis ulcerosa OR "uc" OR "ibd" OR inflammatory bowel disease)<BR/>OR<BR/>(familial adenomatous polyposis OR familial polyposis OR adenomatous polyposis coli OR polyposis coli OR FAP))<BR/>AND<BR/>(surgery OR surgical OR surgically OR laparoscopy OR laparoscopic OR laparoscopically OR ileo pouch OR ileal pouch OR pouch-anal anastomosis OR pelvic pouch OR "IPAA" OR restorative proctocolectomy OR "RPC" OR "RP" OR colorectal surgery OR colonic pouch)</P>
</TD>
<TD>
<P>Issue 1, 2007</P>
</TD>
<TD>
<P>649</P>
</TD>
</TR>
<TR>
<TD>
<P>Pubmed</P>
</TD>
<TD>
<P>((ulcerative colitis [TIAB] OR colitis ulcerosa [TIAB] OR "uc" [TIAB] OR "ibd" [TIAB] OR inflammatory bowel disease [TIAB] OR Colitis, Ulcerative [MH] OR Inflammatory Bowel Diseases [MH])<BR/>OR<BR/>(familial adenomatous polyposis [TIAB] OR familial polyposis [TIAB] OR "FAP"[TIAB] OR adenomatous polyposis coli [TIAB] OR polyposis coli [TIAB] OR adenomatous polyposis coli [MH]))<BR/>AND<BR/>(surgery[TIAB] OR surgery [MH] OR surgery [Subheading] OR surgical[TIAB] OR surgically[TIAB] OR laparoscopy[TIAB] OR laparoscopy [MH] OR laparoscopic [TIAB] OR laparoscopically [TIAB] OR ileo pouch[TIAB] OR ileal pouch [TIAB] OR pelvic pouch[TIAB] OR pouch-anal anastomosis [TIAB] OR "IPAA" OR restorative proctocolectomy[TIAB] OR colorectal surgery [MH] OR surgical procedures, operative [MH] OR Surgical Procedures, Minor [MeSH] OR proctocolectomy, restorative [MH] OR Colonic Pouches [MH])<BR/>AND<BR/>(Randomized Controlled Trial [pt] OR Controlled Clinical Trial [pt] OR Randomized Controlled Trials [mh] OR Random Allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR ("clinical trial" [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR ( placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:no exp] OR comparative study [publication type] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective studies [mh] OR control* [tw] OR prospectiv* [tw] OR volunteer* [tw]) NOT (animals [mh] NOT human [mh]))</P>
</TD>
<TD>
<P>1990 - 19 April 2007</P>
</TD>
<TD>
<P>4455</P>
</TD>
</TR>
<TR>
<TD>
<P>Embase</P>
</TD>
<TD>
<P>Search strategy will be conducted through the advanced search feature of EMBASE, with the next options tagged on:<BR/>-Map to preferred terminology<BR/>-Also search as keyword<BR/>-Include sub-terms/derivatives (explosion search)<BR/>-1990 - 2006<BR/>-EMBASE Only<BR/>
<BR/>('colitis ulcerosa':ti,ab OR 'ulcerative colitis':ti,ab OR 'uc':ti,ab OR 'ibd':ti,ab OR 'inflammatory bowel disease':ti,ab OR 'colitis, ulcerative'/exp OR 'inflammatory bowel diseases'/exp OR<BR/>'familial adenomatous polyposis':ti,ab OR 'familial polyposis':ti,ab OR 'FAP':ti,ab OR 'polyposis coli':ti,ab OR 'adenomatous polyposis coli'/exp OR 'familial adenomatous polyposis'/exp )<BR/>AND<BR/>("surgery":ti,ab OR "surgical":ti,ab OR "surgically":ti,ab OR "surgery"/exp OR<BR/>"laparoscopy":ti,ab OR "laparoscopic":ti,ab OR "laparoscopically":ti,ab OR "laparoscopy"/exp OR "ileo pouch":ti,ab OR "ileal pouch":ti,ab OR "pelvic pouch":ti,ab OR "pouch-anal anastomosis":ti,ab OR "IPAA":ti,ab OR "restorative proctocolectomy":ti,ab OR "colorectal surgery"/exp OR "surgical procedures, operative"/exp OR "proctocolectomy, restorative"/exp OR "Colonic Pouches"/exp)<BR/>AND<BR/>("randomisation"/exp OR "controlled clinical trial"/exp OR "randomised controlled trials"/exp OR "random allocation"/exp OR "double-blind method"/exp OR "single-blind method"/exp OR "clinical trials"/exp OR "clinical trial":ti,ab OR Random* :ti,ab OR "comparative studies"/exp OR "evaluation studies"/exp OR "follow-up studies"/exp OR "prospective studies"/exp OR control* :ti,ab OR prospectiv* :ti,ab OR volunteer* :ti,ab)</P>
</TD>
<TD>
<P>1990 - 19 April 2007</P>
</TD>
<TD>
<P>6890</P>
</TD>
</TR>
<TR>
<TD>
<P>ISI Web of Knowledge</P>
</TD>
<TD>
<P>#1 (ulcerative colitis OR colitis ulcerosa OR uc OR ibd OR inflammatory bowel disease)<BR/>#2 (familial adenomatous polyposis OR familial polyposis OR adenomatous polyposis coli OR polyposis coli OR FAP)<BR/>#3 (surgery OR surgical OR surgically OR laparoscopy OR laparoscopic OR laparoscopically OR ileo pouch OR ileal pouch OR pouch-anal anastomosis OR pelvic pouch OR IPAA OR restorative proctocolectomy OR RPC OR colorectal surgery OR colonic pouch)<BR/>#4 (randomised controlled trial OR controlled clinical trial OR randomised controlled trials OR random allocation OR double-blind method OR single-blind method OR clinical trial OR clinical trials OR clinical trial OR ((singl* OR doubl* OR trebl* OR tripl* ) AND (mask* OR blind* )) OR placebos OR placebo* OR random* OR comparative study OR evaluation stud* OR follow-up stud* OR prospective stud* OR control* OR prospectiv* OR volunteer*)<BR/>#5 ((#1 OR #2) AND #3 AND #4)</P>
</TD>
<TD>
<P>1990 - 19 April 2007</P>
</TD>
<TD>
<P>1573</P>
</TD>
</TR>
<TR>
<TD>
<P>The Cochrane IBD/FBD Group Specialized Trial Register (Non Medline Records)</P>
</TD>
<TD>
<P>Full manual search.</P>
</TD>
<TD>
<P>April 2007</P>
</TD>
<TD>
<P>930</P>
</TD>
</TR>
<TR>
<TD>
<P>Webcasts of the Annual Meetings of the ASCRS</P>
</TD>
<TD>
<P>Full manual search.</P>
</TD>
<TD>
<P>All online available web casts (1997 - 2006)</P>
</TD>
<TD>
<P>Not applicable.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2008-04-24 15:11:46 +0200" MODIFIED_BY="Usama Ahmed Ali" NO="2">
<TITLE>Modified Methodological Index for Non-Randomised Studies (MINORS)</TITLE>
<TABLE COLS="1" ROWS="9">
<TR>
<TH>
<P>Item*</P>
</TH>
</TR>
<TR>
<TD>
<P>1. Inclusion of consecutive patients: all patients potentially fit for inclusion (satisfying the criteria for inclusion) have been included in the study during the study period (no exclusion or details about the reasons for exclusion).</P>
</TD>
</TR>
<TR>
<TD>
<P>2. Prospective collection of data: data were collected according to a protocol established before the beginning of the study.</P>
</TD>
</TR>
<TR>
<TD>
<P>3. Unbiased assessment of the study endpoint: blind evaluation of objective endpoints and double-blind evaluation of subjective endpoints. Otherwise the reasons for not blinding should be stated.</P>
</TD>
</TR>
<TR>
<TD>
<P>4. Follow-up period appropriate to the aim of the study: the follow-up should be sufficiently long to allow the assessment of the main endpoint and possible adverse events.</P>
</TD>
</TR>
<TR>
<TD>
<P>5. Loss to follow up less then 5%^: all patients should be included in the follow up. Otherwise, the proportion lost to follow up should not exceed the proportion experiencing the major endpoint; or if the numbers and reasons for dropouts and withdrawals in all intervention groups were described.</P>
</TD>
</TR>
<TR>
<TD>
<P>6. An adequate control group: having a gold standard diagnostic test or therapeutic intervention recognized as the optimal intervention according to the available published data</P>
</TD>
</TR>
<TR>
<TD>
<P>7. Contemporary groups: control and studied group should be managed during the same time period (no historical comparison).</P>
</TD>
</TR>
<TR>
<TD>
<P>8. Baseline equivalence of groups **: the groups should be similar regarding the criteria other than the studied endpoints, i.e. absence of confounding factors that could bias the interpretation of the results.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Items were scored 'adequate' if condition was satisfied, 'inadequate' if condition was not satisfied and 'unclear' if information regarding item was not reported. </P>
<P>^ Measured at time of discharge, since most trials only followed patients until discharge. </P>
<P>** In this review baselines of the two groups should be equivalent regarding age, gender, BMI and distribution of diagnoses (UC/FAP).</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2008-04-24 15:11:56 +0200" MODIFIED_BY="Usama Ahmed Ali" NO="3">
<TITLE>Methodological assessment of included studies</TITLE>
<TABLE COLS="9" ROWS="13">
<TR>
<TH>
<P>Trial</P>
</TH>
<TH>
<P>Item 1</P>
</TH>
<TH>
<P>Item 2</P>
</TH>
<TH>
<P>Item 3</P>
</TH>
<TH>
<P>Item 4</P>
</TH>
<TH>
<P>Item 5</P>
</TH>
<TH>
<P>Item 6</P>
</TH>
<TH>
<P>Item 7</P>
</TH>
<TH>
<P>Item 8</P>
</TH>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Consecutive patients</P>
</TD>
<TD>
<P>Prospective design</P>
</TD>
<TD>
<P>Assessment of outcomes</P>
</TD>
<TD>
<P>FU-period</P>
</TD>
<TD>
<P>Loss to FU &lt; 5%</P>
</TD>
<TD>
<P>Adequate control group</P>
</TD>
<TD>
<P>Contemporary control group</P>
</TD>
<TD>
<P>Baseline equivalence</P>
</TD>
</TR>
<TR>
<TD>
<P>Araki 2001</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>U</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
</TR>
<TR>
<TD>
<P>Berdah 2004</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
</TR>
<TR>
<TD>
<P>Brown 2001</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
</TR>
<TR>
<TD>
<P>Dunker 2001</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
</TR>
<TR>
<TD>
<P>Hashimoto 2001</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>I</P>
</TD>
</TR>
<TR>
<TD>
<P>Larson 2005</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
</TR>
<TR>
<TD>
<P>Larson 2006</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
</TR>
<TR>
<TD>
<P>Maartense 2004a</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
</TR>
<TR>
<TD>
<P>Marcello 2000</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
</TR>
<TR>
<TD>
<P>Otani 2001</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>U</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>U</P>
</TD>
<TD>
<P>I</P>
</TD>
</TR>
<TR>
<TD>
<P>Schmitt 1994</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>I</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>A: Adequate; I: Inadequate; U: Unclear</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2008-11-04 13:33:23 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE>Characteristics of studies included in the meta-analysis</TITLE>
<TABLE COLS="8" ROWS="14">
<TR>
<TH>
<P>Trial</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Design</P>
</TH>
<TH>
<P>Matching^</P>
</TH>
<TH>
<P>Follow-up period</P>
</TH>
<TH>
<P>Loss to Follow-up</P>
</TH>
<TH>
<P>Loss to Follow-up</P>
</TH>
<TH>
<P>Conversion rate (%)</P>
</TH>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Cases/Controls</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>LA-IPAA</P>
</TD>
<TD>
<P>Open IPAA</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Araki 2001</P>
</TD>
<TD>
<P>21/11</P>
</TD>
<TD>
<P>R, NR</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>D/C</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Berdah 2004</P>
</TD>
<TD>
<P>12/12</P>
</TD>
<TD>
<P>P, NR</P>
</TD>
<TD>
<P>1,2,3,4</P>
</TD>
<TD>
<P>&gt; 3 years</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>3/12 (25%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Brown 2001</P>
</TD>
<TD>
<P>12/13</P>
</TD>
<TD>
<P>R, NR</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>D/C</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0/12 (0%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Dunker 2001</P>
</TD>
<TD>
<P>15/17</P>
</TD>
<TD>
<P>R, NR</P>
</TD>
<TD>
<P>4,5,8</P>
</TD>
<TD>
<P>Mean 16 month</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0/15 (0%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hashimoto 2001</P>
</TD>
<TD>
<P>11/13</P>
</TD>
<TD>
<P>R, NR</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>D/C</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0/11 (0%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Larson 2005</P>
</TD>
<TD>
<P>33/33</P>
</TD>
<TD>
<P>P, NR</P>
</TD>
<TD>
<P>1,2,3,4,6</P>
</TD>
<TD>
<P>&gt; 12 months</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>N/A</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Larson 2006</P>
</TD>
<TD>
<P>100/200</P>
</TD>
<TD>
<P>P+R, NR</P>
</TD>
<TD>
<P>1,2,3,5,6</P>
</TD>
<TD>
<P>90 days</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>6/100 (6%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Maartense 2004a</P>
</TD>
<TD>
<P>30/30</P>
</TD>
<TD>
<P>RCT</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>30 days</P>
</TD>
<TD>
<P>2/30 (6,6%)</P>
</TD>
<TD>
<P>3/30 (10%)</P>
</TD>
<TD>
<P>0/30 (0%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Marcello 2000</P>
</TD>
<TD>
<P>20/20</P>
</TD>
<TD>
<P>P, NR</P>
</TD>
<TD>
<P>1,2,3,4,7</P>
</TD>
<TD>
<P>D/C</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0/20 (%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Otani 2001</P>
</TD>
<TD>
<P>10/18</P>
</TD>
<TD>
<P>NS, NR</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>D/C</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Schmitt 1994</P>
</TD>
<TD>
<P>22/20</P>
</TD>
<TD>
<P>P, NR</P>
</TD>
<TD>
<P>1,2,4</P>
</TD>
<TD>
<P>D/C</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Totals</P>
</TD>
<TD>
<P>253/354*</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>9/200 (4,5%)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Larson 2005 was not added up to the total of patients to avoid duplication patient duplication.</P>
<P>^ 1: age; 2: gender; 3: BMI; 4: diagnosis; 5: operative technique; 6: date of operation; 7: severity of disease; 8: Duration of follow-up. Each number indicates that the study had actively matched between the two groups regarding that item.</P>
<P>IPAA: ileo pouch anal anastomosis; LA-IPAA: laparoscopic (assisted) IPAA; R: retrospective; P: prospective; P+R: prospective for the LA-IPAA group, and retrospective for the open-IPAA group; NS: not specified; NR: non-randomised trial; RCT: randomised controlled trial; N/A: not applicable; D/C: until discharge</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2008-04-24 14:32:14 +0200" MODIFIED_BY="Usama Ahmed Ali" NO="5">
<TITLE>Patients characteristics of included studies</TITLE>
<TABLE COLS="10" ROWS="13">
<TR>
<TH>
<P>Trial</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Age</P>
</TH>
<TH>
<P>Age</P>
</TH>
<TH>
<P>Gender (M:F)</P>
</TH>
<TH>
<P>Gender (M:F)</P>
</TH>
<TH>
<P>BMI</P>
</TH>
<TH>
<P>BMI</P>
</TH>
<TH>
<P>Diagnosis (UC:FAP)</P>
</TH>
<TH>
<P>Diagnosis (UC:FAP)</P>
</TH>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>LA-IPAA / Open IPAA</P>
</TD>
<TD>
<P>LA-IPAA</P>
</TD>
<TD>
<P>Open IPAA</P>
</TD>
<TD>
<P>LA-IPAA</P>
</TD>
<TD>
<P>Open IPAA</P>
</TD>
<TD>
<P>LA-IPAA</P>
</TD>
<TD>
<P>Open IPAA</P>
</TD>
<TD>
<P>LA-IPAA</P>
</TD>
<TD>
<P>Open IPAA</P>
</TD>
</TR>
<TR>
<TD>
<P>Araki 2001</P>
</TD>
<TD>
<P>21/11</P>
</TD>
<TD>
<P>27.2(8.1)^</P>
</TD>
<TD>
<P>31.1(11.2)^</P>
</TD>
<TD>
<P>8:13</P>
</TD>
<TD>
<P>2:9</P>
</TD>
<TD>
<P>31.2(4.5)^</P>
</TD>
<TD>
<P>33.1(4.8)^</P>
</TD>
<TD>
<P>21:0</P>
</TD>
<TD>
<P>11:0</P>
</TD>
</TR>
<TR>
<TD>
<P>Berdah 2004</P>
</TD>
<TD>
<P>12/12</P>
</TD>
<TD>
<P>32 (16-60)</P>
</TD>
<TD>
<P>31 (21-58)</P>
</TD>
<TD>
<P>6:6</P>
</TD>
<TD>
<P>6:6</P>
</TD>
<TD>
<P>24 (17-29)</P>
</TD>
<TD>
<P>22 (20-26)</P>
</TD>
<TD>
<P>11:1</P>
</TD>
<TD>
<P>11:1</P>
</TD>
</TR>
<TR>
<TD>
<P>Brown 2001</P>
</TD>
<TD>
<P>12/13</P>
</TD>
<TD>
<P>32 (16-69)</P>
</TD>
<TD>
<P>29 (15-59)</P>
</TD>
<TD>
<P>4:8</P>
</TD>
<TD>
<P>5:8</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>2:9 + 1 other</P>
</TD>
<TD>
<P>6:7</P>
</TD>
</TR>
<TR>
<TD>
<P>Dunker 2001</P>
</TD>
<TD>
<P>15/17</P>
</TD>
<TD>
<P>30.6 (7.1) ^*</P>
</TD>
<TD>
<P>39.2 (8.4) ^*</P>
</TD>
<TD>
<P>4:11</P>
</TD>
<TD>
<P>9:8</P>
</TD>
<TD>
<P>23.6(4.6) ^</P>
</TD>
<TD>
<P>24.5 (3.2)</P>
</TD>
<TD>
<P>14:1</P>
</TD>
<TD>
<P>14:3</P>
</TD>
</TR>
<TR>
<TD>
<P>Hashimoto 2001</P>
</TD>
<TD>
<P>11/13</P>
</TD>
<TD>
<P>30.0 (19-47)</P>
</TD>
<TD>
<P>30.0 (18-49)</P>
</TD>
<TD>
<P>4:7</P>
</TD>
<TD>
<P>7:6</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>6:5</P>
</TD>
<TD>
<P>6:7</P>
</TD>
</TR>
<TR>
<TD>
<P>Larson 2005</P>
</TD>
<TD>
<P>33/33</P>
</TD>
<TD>
<P>28 (18-56)</P>
</TD>
<TD>
<P>27 (17-56)</P>
</TD>
<TD>
<P>6:27</P>
</TD>
<TD>
<P>6:27</P>
</TD>
<TD>
<P>21.7 (17-31)</P>
</TD>
<TD>
<P>22.3 (18-33)</P>
</TD>
<TD>
<P>31:2</P>
</TD>
<TD>
<P>31:2</P>
</TD>
</TR>
<TR>
<TD>
<P>Larson 2006</P>
</TD>
<TD>
<P>100/200</P>
</TD>
<TD>
<P>32 (17-66)</P>
</TD>
<TD>
<P>32 (17-64)</P>
</TD>
<TD>
<P>40:60</P>
</TD>
<TD>
<P>80:120</P>
</TD>
<TD>
<P>22.4 (17-34)</P>
</TD>
<TD>
<P>23 (16-32)</P>
</TD>
<TD>
<P>98:2</P>
</TD>
<TD>
<P>191:9</P>
</TD>
</TR>
<TR>
<TD>
<P>Maartense 2004a</P>
</TD>
<TD>
<P>30/30</P>
</TD>
<TD>
<P>29 (16-57)*</P>
</TD>
<TD>
<P>35 (16-57)*</P>
</TD>
<TD>
<P>9:21</P>
</TD>
<TD>
<P>15:15</P>
</TD>
<TD>
<P>22.6 (18.1-34.7)</P>
</TD>
<TD>
<P>23.3 (17.2-34.2)</P>
</TD>
<TD>
<P>20:10</P>
</TD>
<TD>
<P>20:10</P>
</TD>
</TR>
<TR>
<TD>
<P>Marcello 2000</P>
</TD>
<TD>
<P>20/20</P>
</TD>
<TD>
<P>25 (12-61)</P>
</TD>
<TD>
<P>26 (9-61)</P>
</TD>
<TD>
<P>15:5</P>
</TD>
<TD>
<P>15 :5</P>
</TD>
<TD>
<P>24 (18-32)</P>
</TD>
<TD>
<P>24 (18-30)</P>
</TD>
<TD>
<P>13:7</P>
</TD>
<TD>
<P>13:7</P>
</TD>
</TR>
<TR>
<TD>
<P>Otani 2001</P>
</TD>
<TD>
<P>10/18</P>
</TD>
<TD>
<P>30.2(11.8)^</P>
</TD>
<TD>
<P>39.6(17.7)^</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>10:0</P>
</TD>
<TD>
<P>18:0</P>
</TD>
</TR>
<TR>
<TD>
<P>Schmitt 1994</P>
</TD>
<TD>
<P>22/20</P>
</TD>
<TD>
<P>31 (12-59)</P>
</TD>
<TD>
<P>34 (17-64)</P>
</TD>
<TD>
<P>11:11</P>
</TD>
<TD>
<P>11:9</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>16:5 + 1 other</P>
</TD>
<TD>
<P>15:5</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* significant difference; ^ mean (SD).</P>
<P>IPAA: ileo pouch anal anastomosis; LA-IPAA: laparoscopic (assisted) IPAA; M: male; F: female; UC: ulcerative colitis; FAP: familial adenomatous polyposis.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2008-11-01 13:07:58 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="6">
<TITLE MODIFIED="2008-11-01 11:41:48 +0100" MODIFIED_BY="Usama Ahmed Ali">Reported outcomes by Maartense 2004 (RCT)</TITLE>
<TABLE COLS="4" ROWS="14">
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>LA-IPAA</P>
<P>(N=30)</P>
</TH>
<TH>
<P>Open IPAA</P>
<P>(N=30)</P>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TH>
<P/>
</TH>
<TH>
<P>N (%) /</P>
<P>Median (range)</P>
</TH>
<TH>
<P>N (%) /</P>
<P>Median (range)</P>
</TH>
<TH>
<P>P-value*</P>
</TH>
</TR>
<TR>
<TD>
<P>Mortality</P>
</TD>
<TD>
<P>0 (0%)</P>
</TD>
<TD>
<P>0 (0%)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Intraoperative complications</P>
</TD>
<TD>
<P>1 (3%)</P>
</TD>
<TD>
<P>1 (3%)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Procedure specific complications</P>
</TD>
<TD>
<P>4 (13%)</P>
</TD>
<TD>
<P>6 (20%)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Severe postoperative complications</P>
</TD>
<TD>
<P>0 (0%)</P>
</TD>
<TD>
<P>2 (7%)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Mild postoperative complications</P>
</TD>
<TD>
<P>9 (30%)</P>
</TD>
<TD>
<P>7 (23%)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Total complications</P>
</TD>
<TD>
<P>14 (47%)</P>
</TD>
<TD>
<P>16 (53%)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Operative time</P>
</TD>
<TD>
<P>214 (149 - 400)</P>
</TD>
<TD>
<P>133 ( 97 - 260)</P>
</TD>
<TD>
<P>p=&lt;0.001</P>
</TD>
</TR>
<TR>
<TD>
<P>Blood loss</P>
</TD>
<TD>
<P>263 (75&#8211;1200)</P>
</TD>
<TD>
<P>300 (50&#8211;800)</P>
</TD>
<TD>
<P>p=0.98</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to regulat diet</P>
</TD>
<TD>
<P>6 (4 - 19)</P>
</TD>
<TD>
<P>7 (4 - 15)</P>
</TD>
<TD>
<P>0.6</P>
</TD>
</TR>
<TR>
<TD>
<P>Hospital stay</P>
</TD>
<TD>
<P>10 (5 - 13)</P>
</TD>
<TD>
<P>11 (6 - 28)</P>
</TD>
<TD>
<P>0.767</P>
</TD>
</TR>
<TR>
<TD>
<P>Readmission</P>
</TD>
<TD>
<P>5/23* (22%)</P>
</TD>
<TD>
<P>3/23* (13%)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Reoperation</P>
</TD>
<TD>
<P>5 (17%)</P>
</TD>
<TD>
<P>5 (17%)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Only reported in a sub-group of patients (N=23).</P>
<P>IPAA: ileo pouch anal anastomosis; LA-IPAA: laparoscopic (assisted) IPAA. NS = not statistically significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-07" MODIFIED="2008-11-05 22:30:53 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="7">
<TITLE MODIFIED="2008-11-01 11:23:51 +0100" MODIFIED_BY="Usama Ahmed Ali">Available data for defecation frequency and costs.</TITLE>
<TABLE COLS="6" ROWS="12">
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P/>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>LA-IPAA</P>
</TH>
<TH>
<P>Open IPAA</P>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TH>
<P>DEFECATION FREQUENCY</P>
</TH>
<TH>
<P>Trial</P>
</TH>
<TH>
<P>LA-IPAA / Open-IPAA</P>
</TH>
<TH>
<P>Mean/Median (SD/Range)</P>
</TH>
<TH>
<P>Mean/Median (SD/Range)</P>
</TH>
<TH>
<P>P-value*</P>
</TH>
</TR>
<TR>
<TD>
<P>- during the day</P>
</TD>
<TD>
<P>Dunker 2001</P>
</TD>
<TD>
<P>15/17</P>
</TD>
<TD>
<P>5.70 (1.30)</P>
</TD>
<TD>
<P>6.30 (2.00)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Larson 2005</P>
</TD>
<TD>
<P>33/33</P>
</TD>
<TD>
<P>7 (3-14)</P>
</TD>
<TD>
<P>6 (3-12)</P>
</TD>
<TD>
<P>p=0.23*</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Maartense 2004</P>
</TD>
<TD>
<P>22/23</P>
</TD>
<TD>
<P>6.09 (2.29)</P>
</TD>
<TD>
<P>5.35 (1.82)</P>
</TD>
<TD>
<P>p=0.161</P>
</TD>
</TR>
<TR>
<TD>
<P>- during the night</P>
</TD>
<TD>
<P>Dunker 2001</P>
</TD>
<TD>
<P>15/17</P>
</TD>
<TD>
<P>1.0 (0.7)</P>
</TD>
<TD>
<P>1.3 (0.7)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Larson 2005</P>
</TD>
<TD>
<P>33/33</P>
</TD>
<TD>
<P>1 (1-5)</P>
</TD>
<TD>
<P>2 (1-4)</P>
</TD>
<TD>
<P>p=0.86*</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Maartense 2004</P>
</TD>
<TD>
<P>22/23</P>
</TD>
<TD>
<P>2.14 (1.91)</P>
</TD>
<TD>
<P>1.78 (1.41)</P>
</TD>
<TD>
<P>p=0.371</P>
</TD>
</TR>
<TR>
<TD>
<P>- per 24 hours</P>
</TD>
<TD>
<P>Otani 2001</P>
</TD>
<TD>
<P>10/18</P>
</TD>
<TD>
<P>8.00 (2.3)</P>
</TD>
<TD>
<P>11.00 (1.0)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TH>
<P>COSTS (Euros)</P>
</TH>
<TH>
<P>Trial</P>
</TH>
<TH>
<P>LA-IPAA / Open-IPAA</P>
</TH>
<TH>
<P>Mean (SD)</P>
</TH>
<TH>
<P>Mean (SD)</P>
</TH>
<TH>
<P>P-value*</P>
</TH>
</TR>
<TR>
<TD>
<P>- operative costs</P>
</TD>
<TD>
<P>Maartense 2004a</P>
</TD>
<TD>
<P>30/30</P>
</TD>
<TD>
<P>3467.35 (290.73)</P>
</TD>
<TD>
<P>1755.65 (170.89)</P>
</TD>
<TD>
<P>p&lt; 0.001</P>
</TD>
</TR>
<TR>
<TD>
<P>- overall costs</P>
</TD>
<TD>
<P>Maartense 2004a</P>
</TD>
<TD>
<P>30/30</P>
</TD>
<TD>
<P>18,733.23 (8666.69)</P>
</TD>
<TD>
<P>16,830.29 (8625.96)</P>
</TD>
<TD>
<P>p=0.095</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* As provided by author.</P>
<P>IPAA: ileo pouch anal anastomosis; LA-IPAA: laparoscopic (assisted) IPAA</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-11-05 22:36:37 +0100" MODIFIED_BY="Usama Ahmed Ali">
<COMPARISON ID="CMP-001" MODIFIED="2008-11-05 22:35:23 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1">
<NAME>LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection</NAME>
<DICH_OUTCOME CHI2="1.2675524971016372" CI_END="2.0215394156875357" CI_START="0.32369943000917417" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8089321087700341" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.3056822135641842" LOG_CI_START="-0.48985806533047704" LOG_EFFECT_SIZE="-0.09208792588314646" METHOD="MH" MODIFIED="2008-10-31 14:32:40 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.8668562075067828" P_Q="0.0" P_Z="0.6500072971028082" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="256" WEIGHT="100.00000000000001" Z="0.4537520548745458">
<NAME>Procedure specific complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.27483050249443153" CI_END="4.298059186507185" CI_START="0.08375873490298624" DF="1.0" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.6332723916571675" LOG_CI_START="-1.0769698908898802" LOG_EFFECT_SIZE="-0.22184874961635637" MODIFIED="2008-10-30 22:00:37 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.6001097389993743" P_Z="0.6111138435125529" STUDIES="2" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="28.092922744462452" Z="0.5084841647298487">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="7.450631558527997" CI_START="0.014912978884848133" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="281" O_E="0.0" SE="1.585187847802434" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="2.5128205128205123" WEIGHT="16.85575364667747"/>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528004" LOG_EFFECT_SIZE="0.0" ORDER="280" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="11.237169097784982"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9421445360813178" CI_END="2.511582547789353" CI_START="0.3157747700755047" DF="2.0" EFFECT_SIZE="0.8905584773353367" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.3999474566187073" LOG_CI_START="-0.5006225724110305" LOG_EFFECT_SIZE="-0.05033755789616156" MODIFIED="2008-10-30 21:56:26 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.6243324971084383" P_Z="0.8265680789066436" STUDIES="3" TAU2="0.0" TOTAL_1="132" TOTAL_2="224" WEIGHT="71.90707725553756" Z="0.21910522750234376">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="2.5811311926517133" CI_START="0.18897927338710277" EFFECT_SIZE="0.6984126984126984" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.4118100792423185" LOG_CI_START="-0.7235858251771071" LOG_EFFECT_SIZE="-0.1558878729673943" ORDER="7" O_E="0.0" SE="0.6669371745563405" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.44480519480519465" WEIGHT="44.246353322528364"/>
<DICH_DATA CI_END="78.18735073936817" CI_START="0.15667495936567133" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="8" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="5.186385737439222"/>
<DICH_DATA CI_END="6.327720202056128" CI_START="0.07023768912854692" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.8012472673623147" LOG_CI_START="-1.1534297854736772" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="9" O_E="0.0" SE="1.1481869766433224" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="1.3183333333333334" WEIGHT="22.474338195569963"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.7196666567090144" CI_END="1.4835031306540982" CI_START="0.2870476291966434" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6525611515866212" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.17128846715057885" LOG_CI_START="-0.5420460357361543" LOG_EFFECT_SIZE="-0.18537878429278773" METHOD="MH" MODIFIED="2008-10-31 19:55:37 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.44527207637915067" P_Q="0.0" P_Z="0.3083470089229847" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="157" TOTAL_2="258" WEIGHT="100.0" Z="1.0186966682288063">
<NAME>Severe postoperative complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.895607142313974" CI_END="17.499883923321175" CI_START="0.46438903959986216" DF="1.0" EFFECT_SIZE="2.8507462686567164" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="1.2430351680218212" LOG_CI_START="-0.3331180389280192" LOG_EFFECT_SIZE="0.4549585645469011" MODIFIED="2008-10-31 19:54:41 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.34396245116087043" P_Z="0.25784807204038895" STUDIES="2" TAU2="0.0" TOTAL_1="34" TOTAL_2="32" WEIGHT="10.017497074875518" Z="1.1314920364823966">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="14.207980025005401" CI_START="0.07038298183415555" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.152532337860481" LOG_CI_START="-1.152532337860481" LOG_EFFECT_SIZE="0.0" ORDER="283" O_E="0.0" SE="1.3540064007726602" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="1.8333333333333335" WEIGHT="6.578654795440639"/>
<DICH_DATA CI_END="116.5681402396685" CI_START="0.35042826609873" EFFECT_SIZE="6.391304347826087" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.066579867671753" LOG_CI_START="-0.45540087021058673" LOG_EFFECT_SIZE="0.8055894987305832" ORDER="285" O_E="0.0" SE="1.4814239694380784" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="2.1946169772256727" WEIGHT="3.4388422794348794"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5750740713828479" CI_END="1.1349975224437576" CI_START="0.14655209476371836" DF="2.0" EFFECT_SIZE="0.4078434313137373" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="19" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.05499491352017321" LOG_CI_START="-0.8340079695297288" LOG_EFFECT_SIZE="-0.38950652800477775" MODIFIED="2008-10-31 19:55:37 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.7501088105421146" P_Z="0.08589297154887855" STUDIES="3" TAU2="0.0" TOTAL_1="123" TOTAL_2="226" WEIGHT="89.98250292512448" Z="1.717471970424991">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="15.463493017511325" CI_START="0.07589560196923674" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.189307602575942" LOG_CI_START="-1.119783390057518" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="15" O_E="0.0" SE="1.3563714792576516" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="1.8397435897435899" WEIGHT="6.315508603623013"/>
<DICH_DATA CI_END="8.687483415485351" CI_START="0.01740832881840793" EFFECT_SIZE="0.3888888888888889" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9388939885253562" LOG_CI_START="-1.7592429187034546" LOG_EFFECT_SIZE="-0.4101744650890492" MODIFIED="2008-10-31 19:55:37 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="279" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="9.108906639840884"/>
<DICH_DATA CI_END="1.176119819000932" CI_START="0.10591393158756404" EFFECT_SIZE="0.35294117647058826" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="0.0704515684069405" LOG_CI_START="-0.9750469103962011" LOG_EFFECT_SIZE="-0.45229767099463025" MODIFIED="2008-10-30 19:53:51 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="18" O_E="0.0" SE="0.6141309817499017" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.377156862745098" WEIGHT="74.55808768166058"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.201042568189608" CI_END="1.4120952263024533" CI_START="0.7773276354279662" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0476930100276536" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="83" I2="31.379562890675217" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.14986398486252875" LOG_CI_START="-0.1093958920519768" LOG_EFFECT_SIZE="0.02023404640527599" METHOD="MH" MODIFIED="2008-10-31 14:32:40 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="3" P_CHI2="0.17746401739547413" P_Q="0.0" P_Z="0.7596560930403821" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" WEIGHT="100.00000000000001" Z="0.30593243110217816">
<NAME>Minor complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.2474446954313922" CI_END="4.535740714212539" CI_START="1.0100008281218753" DF="2.0" EFFECT_SIZE="2.140350877192983" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="8" I2="38.413115924232265" ID="CMP-001.03.01" LOG_CI_END="0.6566482201341353" LOG_CI_START="0.004321729870378561" LOG_EFFECT_SIZE="0.33048497500225693" MODIFIED="2008-10-30 22:00:45 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.1971635783920661" P_Z="0.04704066293965287" STUDIES="3" TAU2="0.0" TOTAL_1="54" TOTAL_2="52" WEIGHT="12.921032885036183" Z="1.9859339091814041">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="24.91862084290609" CI_START="0.3611756869185698" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3965240019963447" LOG_CI_START="-0.4422814925570199" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="288" O_E="0.0" SE="1.0801234497346435" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="1.1666666666666667" WEIGHT="1.586793512197426"/>
<DICH_DATA CI_END="2.9297807522256587" CI_START="0.19199388881665874" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4668351214936105" LOG_CI_START="-0.7167125947102104" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="289" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="6.347174048789704"/>
<DICH_DATA CI_END="11.043092400132222" CI_START="1.1974128275617295" EFFECT_SIZE="3.6363636363636362" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="1.043090706024852" LOG_CI_START="0.07824390631462287" LOG_EFFECT_SIZE="0.5606673061697374" ORDER="286" O_E="0.0" SE="0.5667557862184746" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="0.32121212121212117" WEIGHT="4.987065324049053"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.3962720847017493" CI_END="1.23195602692671" CI_START="0.6365638618513744" DF="4.0" EFFECT_SIZE="0.8855612266419202" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="75" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.09059520652653641" LOG_CI_START="-0.19615802019824255" LOG_EFFECT_SIZE="-0.05278140683585307" MODIFIED="2008-10-30 21:56:47 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.4938248637548389" P_Z="0.47058723301108785" STUDIES="5" TAU2="0.0" TOTAL_1="159" TOTAL_2="254" WEIGHT="87.07896711496383" Z="0.7215239223858326">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="2.4630954998868235" CI_START="0.3411470557338875" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.39148125076310536" LOG_CI_START="-0.467058372541905" LOG_EFFECT_SIZE="-0.0377885608893998" MODIFIED="2008-10-30 20:03:07 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="23" O_E="0.0" SE="0.504310424569039" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.2543290043290043" WEIGHT="8.330665939036486"/>
<DICH_DATA CI_END="72.45938986445702" CI_START="0.14405130711161593" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.86009467278967" LOG_CI_START="-0.8414827966075424" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="24" O_E="0.0" SE="1.5869199785480734" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="2.518315018315018" WEIGHT="0.7640116910580198"/>
<DICH_DATA CI_END="3.256291095371462" CI_START="0.04382779217299543" EFFECT_SIZE="0.37777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5127232216049622" LOG_CI_START="-1.3582504063991017" LOG_EFFECT_SIZE="-0.42276359239706973" MODIFIED="2008-10-30 20:02:53 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="25" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.2078431372549019" WEIGHT="4.46285675305526"/>
<DICH_DATA CI_END="4.712479375003825" CI_START="0.6668595729330961" EFFECT_SIZE="1.7727272727272727" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6732494624516998" LOG_CI_START="-0.1759656100431138" LOG_EFFECT_SIZE="0.24864192620429296" MODIFIED="2008-10-30 20:06:53 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="26" O_E="0.0" SE="0.49883313726585843" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="0.24883449883449876" WEIGHT="5.818242878057228"/>
<DICH_DATA CI_END="1.1970398330607592" CI_START="0.5514906286050816" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="64" LOG_CI_END="0.07810860236184411" LOG_CI_START="-0.2584618630600201" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2008-10-30 20:07:14 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="27" O_E="0.0" SE="0.19770315743947658" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.039086538461538464" WEIGHT="67.70318985375684"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.731846923657038" CI_END="1.1427064248133" CI_START="0.7271330887923901" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9115369725125821" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="127" I2="28.071207295875375" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.05793466918783665" LOG_CI_START="-0.13838609197698853" LOG_EFFECT_SIZE="-0.04022571139457597" METHOD="MH" MODIFIED="2008-10-31 14:32:40 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="4" P_CHI2="0.20428565321474745" P_Q="0.0" P_Z="0.42186781953484065" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" WEIGHT="99.99999999999997" Z="0.8031850031355454">
<NAME>Total Complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.788522450969686" CI_END="2.441959491639428" CI_START="0.8650505913815981" DF="2.0" EFFECT_SIZE="1.453416149068323" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="15" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.387738455389624" LOG_CI_START="-0.06295849263303767" LOG_EFFECT_SIZE="0.16238998137829314" MODIFIED="2008-10-30 22:00:49 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.408909619147364" P_Z="0.15783700878492654" STUDIES="3" TAU2="0.0" TOTAL_1="54" TOTAL_2="52" WEIGHT="15.77990463448938" Z="1.412383715256848">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="4.7248385182665125" CI_START="0.3762621242831433" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6743869701311649" LOG_CI_START="-0.4245094969145651" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="293" O_E="0.0" SE="0.6454972243679028" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="0.41666666666666663" WEIGHT="3.0873726458783572"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="292" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="5.145621076463929"/>
<DICH_DATA CI_END="3.776474428962186" CI_START="1.004880732994098" EFFECT_SIZE="1.948051948051948" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" LOG_CI_END="0.5770865483743177" LOG_CI_START="0.002114519392080945" LOG_EFFECT_SIZE="0.28960053388319934" ORDER="291" O_E="0.0" SE="0.3377414159816116" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="0.11406926406926403" WEIGHT="7.546910912147095"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.689445348899717" CI_END="1.0433646746559238" CI_START="0.628842966572345" DF="4.0" EFFECT_SIZE="0.8100077389923016" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="112" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.018436128666102974" LOG_CI_START="-0.20145779217893642" LOG_EFFECT_SIZE="-0.09151083175641672" MODIFIED="2008-10-30 21:57:00 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.4496629828288178" P_Z="0.10282423685157208" STUDIES="5" TAU2="0.0" TOTAL_1="159" TOTAL_2="254" WEIGHT="84.22009536551059" Z="1.6313132600357396">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="1.5071432568227316" CI_START="0.449553658511318" EFFECT_SIZE="0.8231292517006803" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.17815453479018326" LOG_CI_START="-0.34721846365363523" LOG_EFFECT_SIZE="-0.084531964431726" ORDER="32" O_E="0.0" SE="0.3086066999241838" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.09523809523809523" WEIGHT="9.45507872800247"/>
<DICH_DATA CI_END="6.528029811075431" CI_START="0.17978029284118263" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.814782129011123" LOG_CI_START="-0.7452579164926991" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="33" O_E="0.0" SE="0.9163752450517144" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="0.8397435897435896" WEIGHT="1.9759184933621485"/>
<DICH_DATA CI_END="3.256291095371462" CI_START="0.04382779217299543" EFFECT_SIZE="0.37777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5127232216049622" LOG_CI_START="-1.3582504063991017" LOG_EFFECT_SIZE="-0.42276359239706973" ORDER="34" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.2078431372549019" WEIGHT="2.8944118555109597"/>
<DICH_DATA CI_END="3.7565334804988004" CI_START="0.7287358612317042" EFFECT_SIZE="1.6545454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5747872638881639" LOG_CI_START="-0.13742985823446446" LOG_EFFECT_SIZE="0.21867870282684976" ORDER="35" O_E="0.0" SE="0.41835986306644546" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="0.175024975024975" WEIGHT="4.716819320091934"/>
<DICH_DATA CI_END="1.02223461006909" CI_START="0.5619105697215061" EFFECT_SIZE="0.7578947368421053" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="95" LOG_CI_END="0.009550580891931466" LOG_CI_START="-0.25033279860709007" LOG_EFFECT_SIZE="-0.1203911088575793" ORDER="36" O_E="0.0" SE="0.1526567835612013" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.023304093567251456" WEIGHT="65.1778669685431"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="11.02102256950485" CI_END="129.67731119616823" CI_START="53.360719467169965" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="91.5190153316691" ESTIMABLE="YES" I2="72.77929537771755" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2008-11-05 22:35:23 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="5" P_CHI2="0.01161278668026311" P_Q="0.5306890117440086" P_Z="2.5916230212076174E-6" Q="0.39307277071598357" RANDOM="YES" SCALE="496.5914535280943" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="1008.1311163525743" TOTALS="YES" TOTAL_1="58" TOTAL_2="58" UNITS="" WEIGHT="100.0" Z="4.700785763274152">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="128.82639117014142" CI_START="66.17360882985857" DF="0.0" EFFECT_SIZE="97.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.01" MODIFIED="2008-10-30 22:00:57 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="1.0" P_Z="1.0595197306948122E-9" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="12" WEIGHT="29.996795602486944" Z="6.100175645983691">
<NAME>High-quality trials</NAME>
<CONT_DATA CI_END="128.82639117014142" CI_START="66.17360882985857" EFFECT_SIZE="97.5" ESTIMABLE="YES" MEAN_1="402.5" MEAN_2="305.0" ORDER="37" SD_1="35.96" SD_2="42.1" SE="15.983146331891813" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="29.996795602486944"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="10.627949798788867" CI_END="144.61200401179588" CI_START="21.449161555742116" DF="2.0" EFFECT_SIZE="83.03058278376899" ESTIMABLE="YES" I2="81.18169507887669" ID="CMP-001.05.02" NO="2" P_CHI2="0.004922333839794124" P_Z="0.008226471753323071" STUDIES="3" TAU2="2244.8759711301773" TOTAL_1="46" TOTAL_2="46" WEIGHT="70.00320439751306" Z="2.6426306607794565">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="106.54006864662435" CI_START="-72.54006864662435" EFFECT_SIZE="17.0" ESTIMABLE="YES" MEAN_1="215.0" MEAN_2="198.0" ORDER="39" SD_1="141.0" SD_2="112.0" SE="45.68454795746503" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="12.245930070839067"/>
<CONT_DATA CI_END="158.2134640773819" CI_START="106.58653592261813" EFFECT_SIZE="132.4" ESTIMABLE="YES" MEAN_1="292.3" MEAN_2="159.9" ORDER="40" SD_1="39.0" SD_2="35.0" SE="13.17037674212138" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="32.0785681731808"/>
<CONT_DATA CI_END="111.39799217574674" CI_START="26.602007824253263" EFFECT_SIZE="69.0" ESTIMABLE="YES" MEAN_1="377.0" MEAN_2="308.0" ORDER="41" SD_1="58.8" SD_2="46.9" SE="21.63202615465217" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="25.678706153493188"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.702637967612797" CI_END="63.856757454971955" CI_START="-261.03780024083403" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-98.59052139293104" ESTIMABLE="YES" I2="62.999113755391875" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2008-11-01 14:27:13 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="6" P_CHI2="0.10018242882741057" P_Q="1.0" P_Z="0.23423613399756438" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="8680.017893217893" TOTALS="YES" TOTAL_1="31" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.1895174392431196">
<NAME>Blood loss (mL)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.702637967612797" CI_END="63.856757454971955" CI_START="-261.03780024083403" DF="1.0" EFFECT_SIZE="-98.59052139293104" ESTIMABLE="YES" I2="62.999113755391875" ID="CMP-001.06.01" MODIFIED="2008-11-01 14:27:13 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.10018242882741057" P_Z="0.23423613399756438" STUDIES="2" TAU2="8680.017893217893" TOTAL_1="31" TOTAL_2="29" WEIGHT="100.0" Z="1.1895174392431196">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="109.50614838892508" CI_START="-149.50614838892508" EFFECT_SIZE="-20.0" ESTIMABLE="YES" MEAN_1="218.0" MEAN_2="238.0" ORDER="42" SD_1="268.0" SD_2="102.0" SE="66.07577966251067" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="52.65631241389697"/>
<CONT_DATA CI_END="-36.3486244862961" CI_START="-335.6513755137039" EFFECT_SIZE="-186.0" ESTIMABLE="YES" MEAN_1="177.0" MEAN_2="363.0" ORDER="43" SD_1="142.0" SD_2="262.0" SE="76.35414563437637" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="47.34368758610302"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5127910271563227" CI_END="-0.25125973195762397" CI_START="-2.7090447018010697" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4801522168793468" ESTIMABLE="YES" I2="33.897016702977446" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2008-11-01 14:27:18 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="7" P_CHI2="0.21871409197092662" P_Q="1.0" P_Z="0.018240537882031112" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="EFFECT_SIZE" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="35" UNITS="" WEIGHT="100.0" Z="2.3606988180950816">
<NAME>Time to regular diet (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.5127910271563227" CI_END="-0.25125973195762397" CI_START="-2.7090447018010697" DF="1.0" EFFECT_SIZE="-1.4801522168793468" ESTIMABLE="YES" I2="33.897016702977446" ID="CMP-001.07.01" MODIFIED="2008-11-01 14:27:18 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.21871409197092662" P_Z="0.018240537882031112" STUDIES="2" TAU2="0.0" TOTAL_1="25" TOTAL_2="35" WEIGHT="100.0" Z="2.3606988180950816">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="2.987396555302711" CI_START="-20.787396555302706" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="19.2" ORDER="46" SD_1="3.5" SD_2="25.3" SE="6.065109690315218" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="1.0686962250579541"/>
<CONT_DATA CI_END="-0.16448784565546215" CI_START="-2.6355121543445383" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="7.0" ORDER="45" SD_1="1.3" SD_2="2.2" SE="0.6303749273405533" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="98.93130377494205"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.029942122730977898" CI_END="-1.04210294941052" CI_START="-4.281761419163345" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.6619321842869326" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2008-10-31 14:32:40 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="8" P_CHI2="0.9851404498781581" P_Q="0.8695864255283021" P_Z="0.001277933450449857" Q="0.02695634205210047" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="40" UNITS="" WEIGHT="100.00000000000001" Z="3.2208896457462">
<NAME>Hospital stay (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1480551567568105" CI_START="-7.108055156756811" DF="0.0" EFFECT_SIZE="-2.9800000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.01" MODIFIED="2008-10-30 22:01:16 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="1.0" P_Z="0.15710439372492405" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="12" WEIGHT="15.39740321516575" Z="1.4148775760346375">
<NAME>High-quality trial</NAME>
<CONT_DATA CI_END="1.1480551567568105" CI_START="-7.108055156756811" EFFECT_SIZE="-2.9800000000000004" ESTIMABLE="YES" MEAN_1="11.92" MEAN_2="14.9" ORDER="47" SD_1="3.68" SD_2="6.3" SE="2.1061892919045366" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="15.39740321516575"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.002985780678877428" CI_END="-0.8429717432803723" CI_START="-4.365117966017809" DF="1.0" EFFECT_SIZE="-2.6040448546490906" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.02" NO="2" P_CHI2="0.9564234664079535" P_Z="0.0037538454538480546" STUDIES="2" TAU2="0.0" TOTAL_1="36" TOTAL_2="28" WEIGHT="84.60259678483426" Z="2.898138695259689">
<NAME>Low-quality trial</NAME>
<CONT_DATA CI_END="18.248728474244125" CI_START="-24.648728474244116" EFFECT_SIZE="-3.1999999999999957" ESTIMABLE="YES" MEAN_1="36.1" MEAN_2="39.3" ORDER="49" SD_1="31.4" SD_2="28.3" SE="10.94342990148235" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="0.5703420115505224"/>
<CONT_DATA CI_END="-0.8329606352074224" CI_START="-4.367039364792577" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="12.5" ORDER="50" SD_1="2.4" SD_2="2.7" SE="0.9015672628327654" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="84.03225477328374"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.6191683480032477" CI_END="1.7118857420694773" CI_START="0.31947466286459547" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.739529661548713" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.23347477480102227" LOG_CI_START="-0.49556357949127683" LOG_EFFECT_SIZE="-0.13104440234512732" METHOD="MH" MODIFIED="2008-10-31 14:32:41 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="9" P_CHI2="0.7584508102730714" P_Q="0.0" P_Z="0.4810556228918468" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="172" TOTAL_2="275" WEIGHT="100.00000000000001" Z="0.7046057521112201">
<NAME>Reoperation</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8719702755645493" CI_END="6.619011607333552" CI_START="0.137804911161714" DF="1.0" EFFECT_SIZE="0.955056179775281" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="0.8207931426830808" LOG_CI_START="-0.8607353045443207" LOG_EFFECT_SIZE="-0.01997108093062" MODIFIED="2008-10-30 22:01:07 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.35041052600509304" P_Z="0.9628671196946567" STUDIES="2" TAU2="0.0" TOTAL_1="34" TOTAL_2="32" WEIGHT="15.50168794668956" Z="0.04655597640455074">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="7.450631558527997" CI_START="0.014912978884848133" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="53" O_E="0.0" SE="1.585187847802434" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="2.5128205128205123" WEIGHT="11.495633758219224"/>
<DICH_DATA CI_END="63.6312363433901" CI_START="0.11791120163472589" EFFECT_SIZE="2.739130434782609" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8036703615812775" LOG_CI_START="-0.9284449347092995" LOG_EFFECT_SIZE="0.43761271343598884" ORDER="55" O_E="0.0" SE="1.6048580492299167" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="2.5755693581780537" WEIGHT="4.006054188470335"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.697647960917799" CI_END="1.7792945944968654" CI_START="0.2753822579376674" DF="3.0" EFFECT_SIZE="0.6999901163365331" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.2502478593668626" LOG_CI_START="-0.5600640434835158" LOG_EFFECT_SIZE="-0.15490809205832662" NO="2" P_CHI2="0.6374569208895422" P_Z="0.45363041728034725" STUDIES="4" TAU2="0.0" TOTAL_1="138" TOTAL_2="243" WEIGHT="84.49831205331046" Z="0.749376333434403">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="15.463493017511325" CI_START="0.07589560196923674" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.189307602575942" LOG_CI_START="-1.119783390057518" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="56" O_E="0.0" SE="1.3563714792576516" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="1.8397435897435899" WEIGHT="7.357205605260303"/>
<DICH_DATA CI_END="16.58673887610161" CI_START="0.07743803372313825" EFFECT_SIZE="1.1333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2197610076438197" LOG_CI_START="-1.1110456829986344" LOG_EFFECT_SIZE="0.054357662322592676" ORDER="57" O_E="0.0" SE="1.3691273877625736" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.8745098039215686" WEIGHT="7.184771098887015"/>
<DICH_DATA CI_END="78.18735073936817" CI_START="0.15667495936567133" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="58" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="3.537118079452069"/>
<DICH_DATA CI_END="1.5825352054872504" CI_START="0.1346053792299069" EFFECT_SIZE="0.46153846153846156" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" LOG_CI_END="0.19935338022416468" LOG_CI_START="-0.8709375840705509" LOG_EFFECT_SIZE="-0.3357921019231931" ORDER="59" O_E="0.0" SE="0.6286942104524347" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.39525641025641023" WEIGHT="66.41921726971107"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-11-05 22:35:40 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2">
<NAME>LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups</NAME>
<DICH_OUTCOME CHI2="1.2675524971016372" CI_END="2.0215394156875357" CI_START="0.32369943000917417" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8089321087700341" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.3056822135641842" LOG_CI_START="-0.48985806533047704" LOG_EFFECT_SIZE="-0.09208792588314646" METHOD="MH" MODIFIED="2008-10-31 14:33:23 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.8668562075067828" P_Q="0.0" P_Z="0.6500072971028082" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="256" WEIGHT="100.0" Z="0.4537520548745458">
<NAME>Procedure specific complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.27608778510929805" CI_END="2.7744129691666317" CI_START="0.14288913543632392" DF="2.0" EFFECT_SIZE="0.6296296296296295" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.44317110593753006" LOG_CI_START="-0.845000791498957" LOG_EFFECT_SIZE="-0.20091484278071345" MODIFIED="2008-10-30 22:20:27 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.8710604663777567" P_Z="0.5409433281626308" STUDIES="3" TAU2="0.0" TOTAL_1="132" TOTAL_2="232" WEIGHT="50.56726094003241" Z="0.6113871240218408">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="7.450631558527997" CI_START="0.014912978884848133" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="63" O_E="0.0" SE="1.585187847802434" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="2.5128205128205123" WEIGHT="16.85575364667747"/>
<DICH_DATA CI_END="6.327720202056128" CI_START="0.07023768912854692" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.8012472673623147" LOG_CI_START="-1.1534297854736772" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="64" O_E="0.0" SE="1.1481869766433224" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="1.3183333333333334" WEIGHT="22.474338195569963"/>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528004" LOG_EFFECT_SIZE="0.0" ORDER="66" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="11.237169097784982"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.909870948983435" CI_END="3.155301218052971" CI_START="0.3120963458569498" DF="1.0" EFFECT_SIZE="0.9923497267759561" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.49904082509960646" LOG_CI_START="-0.5057113161903328" LOG_EFFECT_SIZE="-0.003335245545363237" NO="2" P_CHI2="0.34014879196328973" P_Z="0.9896181496280055" STUDIES="2" TAU2="0.0" TOTAL_1="32" TOTAL_2="24" WEIGHT="49.43273905996759" Z="0.013012087021018328">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="2.5811311926517133" CI_START="0.18897927338710277" EFFECT_SIZE="0.6984126984126984" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.4118100792423185" LOG_CI_START="-0.7235858251771071" LOG_EFFECT_SIZE="-0.1558878729673943" ORDER="67" O_E="0.0" SE="0.6669371745563405" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.44480519480519465" WEIGHT="44.246353322528364"/>
<DICH_DATA CI_END="78.18735073936817" CI_START="0.15667495936567133" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="68" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="5.186385737439222"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.7196666567090135" CI_END="1.4835031306540984" CI_START="0.28704762919664345" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6525611515866213" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.17128846715057894" LOG_CI_START="-0.5420460357361543" LOG_EFFECT_SIZE="-0.18537878429278765" METHOD="MH" MODIFIED="2008-10-31 19:59:05 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.4452720763791508" P_Q="0.0" P_Z="0.30834700892298483" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="157" TOTAL_2="258" WEIGHT="100.0" Z="1.018696668228806">
<NAME>Severe postoperative complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.4693312325243673" CI_END="1.6006373399816323" CI_START="0.26297714691424917" DF="2.0" EFFECT_SIZE="0.6487919858573954" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" I2="42.352001986712786" ID="CMP-002.02.01" LOG_CI_END="0.20429294398292056" LOG_CI_START="-0.5800819906747687" LOG_EFFECT_SIZE="-0.18789452334592402" MODIFIED="2008-10-31 19:58:43 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.1764595105661354" P_Z="0.34772752622537073" STUDIES="3" TAU2="0.0" TOTAL_1="134" TOTAL_2="232" WEIGHT="84.5755847565361" Z="0.9390062899219173">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="14.207980025005401" CI_START="0.07038298183415555" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.152532337860481" LOG_CI_START="-1.152532337860481" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-10-31 19:57:51 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="69" O_E="0.0" SE="1.3540064007726602" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="1.8333333333333335" WEIGHT="6.578654795440639"/>
<DICH_DATA CI_END="1.176119819000932" CI_START="0.10591393158756404" EFFECT_SIZE="0.35294117647058826" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="0.0704515684069405" LOG_CI_START="-0.9750469103962011" LOG_EFFECT_SIZE="-0.45229767099463025" MODIFIED="2008-10-31 19:58:08 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="71" O_E="0.0" SE="0.6141309817499017" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.377156862745098" WEIGHT="74.55808768166058"/>
<DICH_DATA CI_END="116.5681402396685" CI_START="0.35042826609873" EFFECT_SIZE="6.391304347826087" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.066579867671753" LOG_CI_START="-0.45540087021058673" LOG_EFFECT_SIZE="0.8055894987305832" MODIFIED="2008-10-31 19:58:43 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="74" O_E="0.0" SE="1.4814239694380784" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="2.1946169772256727" WEIGHT="3.4388422794348794"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2429056806184009" CI_END="4.790307267351917" CI_START="0.0946153098699579" DF="1.0" EFFECT_SIZE="0.6732283464566929" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="0.680363371501309" LOG_CI_START="-1.0240385839568775" LOG_EFFECT_SIZE="-0.1718376062277842" MODIFIED="2008-10-31 19:59:05 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.6221153398156205" P_Z="0.6926903638818385" STUDIES="2" TAU2="0.0" TOTAL_1="23" TOTAL_2="26" WEIGHT="15.424415243463898" Z="0.3952066803461201">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="15.463493017511325" CI_START="0.07589560196923674" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.189307602575942" LOG_CI_START="-1.119783390057518" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="76" O_E="0.0" SE="1.3563714792576516" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="1.8397435897435899" WEIGHT="6.315508603623013"/>
<DICH_DATA CI_END="8.687483415485351" CI_START="0.01740832881840793" EFFECT_SIZE="0.3888888888888889" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9388939885253562" LOG_CI_START="-1.7592429187034546" LOG_EFFECT_SIZE="-0.4101744650890492" MODIFIED="2008-10-31 19:59:05 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="77" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="9.108906639840884"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.20104256818961" CI_END="1.412095226302453" CI_START="0.7773276354279661" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0476930100276534" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="83" I2="31.379562890675228" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.1498639848625287" LOG_CI_START="-0.10939589205197688" LOG_EFFECT_SIZE="0.020234046405275898" METHOD="MH" MODIFIED="2008-10-31 20:06:03 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="3" P_CHI2="0.1774640173954738" P_Q="0.0" P_Z="0.7596560930403831" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" WEIGHT="99.99999999999999" Z="0.3059324311021768">
<NAME>Minor complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.253908886006363" CI_END="1.3830077184390108" CI_START="0.710594726206776" DF="4.0" EFFECT_SIZE="0.9913415107953599" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="75" I2="51.53811296873435" ID="CMP-002.03.01" LOG_CI_END="0.14082460387367607" LOG_CI_START="-0.14837802002118436" LOG_EFFECT_SIZE="-0.003776708073754169" MODIFIED="2008-10-31 20:05:43 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.08270777775768301" P_Z="0.9591737309384362" STUDIES="5" TAU2="0.0" TOTAL_1="169" TOTAL_2="269" WEIGHT="85.08707949184826" Z="0.051190488557744815">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="24.91862084290609" CI_START="0.3611756869185698" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3965240019963447" LOG_CI_START="-0.4422814925570199" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2008-10-31 20:05:17 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="78" O_E="0.0" SE="1.0801234497346435" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="1.1666666666666667" WEIGHT="1.5867935121974255"/>
<DICH_DATA CI_END="3.256291095371462" CI_START="0.04382779217299543" EFFECT_SIZE="0.37777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5127232216049622" LOG_CI_START="-1.3582504063991017" LOG_EFFECT_SIZE="-0.42276359239706973" MODIFIED="2008-10-31 20:05:24 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="79" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.2078431372549019" WEIGHT="4.462856753055259"/>
<DICH_DATA CI_END="1.1970398330607592" CI_START="0.5514906286050816" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="64" LOG_CI_END="0.07810860236184411" LOG_CI_START="-0.2584618630600201" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2008-10-31 20:05:33 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="80" O_E="0.0" SE="0.19770315743947658" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.039086538461538464" WEIGHT="67.70318985375681"/>
<DICH_DATA CI_END="2.9297807522256587" CI_START="0.19199388881665874" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4668351214936105" LOG_CI_START="-0.7167125947102104" LOG_EFFECT_SIZE="-0.12493873660829993" MODIFIED="2008-10-31 20:05:38 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="82" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="6.347174048789702"/>
<DICH_DATA CI_END="11.043092400132222" CI_START="1.1974128275617295" EFFECT_SIZE="3.6363636363636362" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="1.043090706024852" LOG_CI_START="0.07824390631462287" LOG_EFFECT_SIZE="0.5606673061697374" MODIFIED="2008-10-31 20:05:43 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="83" O_E="0.0" SE="0.5667557862184746" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="0.32121212121212117" WEIGHT="4.987065324049051"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1937806466325205" CI_END="2.682757740663664" CI_START="0.6988111475352274" DF="2.0" EFFECT_SIZE="1.3692118226600984" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="8" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.42858145662898034" LOG_CI_START="-0.15564017570624858" LOG_EFFECT_SIZE="0.13647064046136584" MODIFIED="2008-10-31 20:06:03 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.5505211546281219" P_Z="0.35983924404677914" STUDIES="3" TAU2="0.0" TOTAL_1="44" TOTAL_2="37" WEIGHT="14.91292050815173" Z="0.9156714693437165">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="2.4630954998868235" CI_START="0.3411470557338875" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.39148125076310536" LOG_CI_START="-0.467058372541905" LOG_EFFECT_SIZE="-0.0377885608893998" MODIFIED="2008-10-31 20:05:53 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="84" O_E="0.0" SE="0.504310424569039" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.2543290043290043" WEIGHT="8.330665939036484"/>
<DICH_DATA CI_END="72.45938986445702" CI_START="0.14405130711161593" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.86009467278967" LOG_CI_START="-0.8414827966075424" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="85" O_E="0.0" SE="1.5869199785480734" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="2.518315018315018" WEIGHT="0.7640116910580196"/>
<DICH_DATA CI_END="4.712479375003825" CI_START="0.6668595729330961" EFFECT_SIZE="1.7727272727272727" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6732494624516998" LOG_CI_START="-0.1759656100431138" LOG_EFFECT_SIZE="0.24864192620429296" MODIFIED="2008-10-31 20:06:03 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="86" O_E="0.0" SE="0.49883313726585843" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="0.24883449883449876" WEIGHT="5.818242878057227"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.731846923657038" CI_END="1.1427064248133" CI_START="0.7271330887923901" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9115369725125821" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="127" I2="28.071207295875375" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.05793466918783665" LOG_CI_START="-0.13838609197698853" LOG_EFFECT_SIZE="-0.04022571139457597" METHOD="MH" MODIFIED="2008-10-31 14:33:23 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="4" P_CHI2="0.20428565321474745" P_Q="0.0" P_Z="0.42186781953484065" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" WEIGHT="99.99999999999999" Z="0.8031850031355454">
<NAME>Total Complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.533014296248724" CI_END="1.130007803457018" CI_START="0.678565251602964" DF="4.0" EFFECT_SIZE="0.8756620520875186" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="113" I2="46.90040609650891" ID="CMP-002.04.01" LOG_CI_END="0.053081442586624165" LOG_CI_START="-0.1684083837470119" LOG_EFFECT_SIZE="-0.05766347058019386" MODIFIED="2008-10-30 22:20:42 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.11026238702614155" P_Z="0.30747795629191976" STUDIES="5" TAU2="0.0" TOTAL_1="169" TOTAL_2="269" WEIGHT="83.85218345854344" Z="1.020528368562829">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="4.7248385182665125" CI_START="0.3762621242831433" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6743869701311649" LOG_CI_START="-0.4245094969145651" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="87" O_E="0.0" SE="0.6454972243679028" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="0.41666666666666663" WEIGHT="3.0873726458783572"/>
<DICH_DATA CI_END="3.256291095371462" CI_START="0.04382779217299543" EFFECT_SIZE="0.37777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5127232216049622" LOG_CI_START="-1.3582504063991017" LOG_EFFECT_SIZE="-0.42276359239706973" ORDER="88" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.2078431372549019" WEIGHT="2.8944118555109597"/>
<DICH_DATA CI_END="1.02223461006909" CI_START="0.5619105697215061" EFFECT_SIZE="0.7578947368421053" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="95" LOG_CI_END="0.009550580891931466" LOG_CI_START="-0.25033279860709007" LOG_EFFECT_SIZE="-0.1203911088575793" ORDER="89" O_E="0.0" SE="0.1526567835612013" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.023304093567251456" WEIGHT="65.1778669685431"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="91" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="5.145621076463929"/>
<DICH_DATA CI_END="3.776474428962186" CI_START="1.004880732994098" EFFECT_SIZE="1.948051948051948" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" LOG_CI_END="0.5770865483743177" LOG_CI_START="0.002114519392080945" LOG_EFFECT_SIZE="0.28960053388319934" ORDER="92" O_E="0.0" SE="0.3377414159816116" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="0.11406926406926403" WEIGHT="7.546910912147095"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.832312409182625" CI_END="1.7700429411564218" CI_START="0.6809020796535925" DF="2.0" EFFECT_SIZE="1.097827818790164" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.24798380245280408" LOG_CI_START="-0.16691533937034223" LOG_EFFECT_SIZE="0.04053423154123094" NO="2" P_CHI2="0.400053864596976" P_Z="0.7017467561197108" STUDIES="3" TAU2="0.0" TOTAL_1="44" TOTAL_2="37" WEIGHT="16.147816541456553" Z="0.38296359743103253">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="1.5071432568227316" CI_START="0.449553658511318" EFFECT_SIZE="0.8231292517006803" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.17815453479018326" LOG_CI_START="-0.34721846365363523" LOG_EFFECT_SIZE="-0.084531964431726" ORDER="93" O_E="0.0" SE="0.3086066999241838" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.09523809523809523" WEIGHT="9.45507872800247"/>
<DICH_DATA CI_END="6.528029811075431" CI_START="0.17978029284118263" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.814782129011123" LOG_CI_START="-0.7452579164926991" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="94" O_E="0.0" SE="0.9163752450517144" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="0.8397435897435896" WEIGHT="1.9759184933621485"/>
<DICH_DATA CI_END="3.7565334804988004" CI_START="0.7287358612317042" EFFECT_SIZE="1.6545454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5747872638881639" LOG_CI_START="-0.13742985823446446" LOG_EFFECT_SIZE="0.21867870282684976" ORDER="95" O_E="0.0" SE="0.41835986306644546" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="0.175024975024975" WEIGHT="4.716819320091934"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="11.02102256950485" CI_END="129.6773111961682" CI_START="53.36071946716995" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="91.51901533166908" ESTIMABLE="YES" I2="72.77929537771755" I2_Q="85.96097103953107" ID="CMP-002.05" MODIFIED="2008-11-05 22:35:40 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="5" P_CHI2="0.01161278668026311" P_Q="0.007610146922771954" P_Z="2.5916230212076174E-6" Q="7.12299976597953" RANDOM="YES" SCALE="496.5914535280943" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="1008.1311163525743" TOTALS="YES" TOTAL_1="58" TOTAL_2="58" UNITS="" WEIGHT="100.0" Z="4.700785763274152">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.839715088555819" CI_END="150.24858850230007" CI_START="82.00104310621728" DF="1.0" EFFECT_SIZE="116.12481580425867" ESTIMABLE="YES" I2="64.78519961280462" ID="CMP-002.05.01" MODIFIED="2008-10-30 22:20:48 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.09196063042218283" P_Z="2.5606442544584238E-11" STUDIES="2" TAU2="394.54510490196094" TOTAL_1="27" TOTAL_2="29" WEIGHT="62.07536377566774" Z="6.669850332837271">
<NAME>High-quality trials</NAME>
<CONT_DATA CI_END="128.82639117014142" CI_START="66.17360882985857" EFFECT_SIZE="97.5" ESTIMABLE="YES" MEAN_1="402.5" MEAN_2="305.0" ORDER="96" SD_1="35.96" SD_2="42.1" SE="15.983146331891813" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="29.996795602486944"/>
<CONT_DATA CI_END="158.2134640773819" CI_START="106.58653592261813" EFFECT_SIZE="132.4" ESTIMABLE="YES" MEAN_1="292.3" MEAN_2="159.9" ORDER="97" SD_1="39.0" SD_2="35.0" SE="13.17037674212138" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="32.0785681731808"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0583077149695017" CI_END="99.38194015381481" CI_START="17.755239971615325" DF="1.0" EFFECT_SIZE="58.56859006271507" ESTIMABLE="YES" I2="5.509523756158389" ID="CMP-002.05.02" NO="2" P_CHI2="0.30360185153678343" P_Z="0.0049140124570305165" STUDIES="2" TAU2="74.48876118326143" TOTAL_1="31" TOTAL_2="29" WEIGHT="37.924636224332254" Z="2.8126171189569917">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="106.54006864662435" CI_START="-72.54006864662435" EFFECT_SIZE="17.0" ESTIMABLE="YES" MEAN_1="215.0" MEAN_2="198.0" ORDER="99" SD_1="141.0" SD_2="112.0" SE="45.68454795746503" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="12.245930070839067"/>
<CONT_DATA CI_END="111.39799217574674" CI_START="26.602007824253263" EFFECT_SIZE="69.0" ESTIMABLE="YES" MEAN_1="377.0" MEAN_2="308.0" ORDER="100" SD_1="58.8" SD_2="46.9" SE="21.63202615465217" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="25.678706153493188"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.702637967612797" CI_END="63.856757454971955" CI_START="-261.03780024083403" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-98.59052139293104" ESTIMABLE="YES" I2="62.999113755391875" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2008-11-01 14:27:38 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="6" P_CHI2="0.10018242882741057" P_Q="1.0" P_Z="0.23423613399756438" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="8680.017893217893" TOTALS="YES" TOTAL_1="31" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.1895174392431196">
<NAME>Blood loss (mL)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.702637967612797" CI_END="63.856757454971955" CI_START="-261.03780024083403" DF="1.0" EFFECT_SIZE="-98.59052139293104" ESTIMABLE="YES" I2="62.999113755391875" ID="CMP-002.06.01" MODIFIED="2008-11-01 14:27:38 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.10018242882741057" P_Z="0.23423613399756438" STUDIES="2" TAU2="8680.017893217893" TOTAL_1="31" TOTAL_2="29" WEIGHT="100.0" Z="1.1895174392431196">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="109.50614838892508" CI_START="-149.50614838892508" EFFECT_SIZE="-20.0" ESTIMABLE="YES" MEAN_1="218.0" MEAN_2="238.0" ORDER="101" SD_1="268.0" SD_2="102.0" SE="66.07577966251067" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="52.65631241389697"/>
<CONT_DATA CI_END="-36.3486244862961" CI_START="-335.6513755137039" EFFECT_SIZE="-186.0" ESTIMABLE="YES" MEAN_1="177.0" MEAN_2="363.0" ORDER="102" SD_1="142.0" SD_2="262.0" SE="76.35414563437637" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="47.34368758610302"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5127910271563227" CI_END="-0.25125973195762397" CI_START="-2.7090447018010697" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4801522168793468" ESTIMABLE="YES" I2="33.897016702977446" I2_Q="33.897016702977446" ID="CMP-002.07" MODIFIED="2008-10-31 23:50:11 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="7" P_CHI2="0.21871409197092662" P_Q="0.21871409197092662" P_Z="0.018240537882031112" Q="1.5127910271563227" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="35" UNITS="" WEIGHT="100.0" Z="2.3606988180950816">
<NAME>Time to regular diet (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.16448784565546215" CI_START="-2.6355121543445383" DF="0.0" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.01" MODIFIED="2008-10-30 22:20:55 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="1.0" P_Z="0.026357700434728685" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="17" WEIGHT="98.93130377494205" Z="2.2209005137726">
<NAME>High-quality trials</NAME>
<CONT_DATA CI_END="-0.16448784565546215" CI_START="-2.6355121543445383" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="7.0" ORDER="103" SD_1="1.3" SD_2="2.2" SE="0.6303749273405533" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="98.93130377494205"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.987396555302711" CI_START="-20.787396555302706" DF="0.0" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.02" NO="2" P_CHI2="1.0" P_Z="0.14226467281800642" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="18" WEIGHT="1.0686962250579541" Z="1.4674095695600593">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="2.987396555302711" CI_START="-20.787396555302706" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="19.2" ORDER="105" SD_1="3.5" SD_2="25.3" SE="6.065109690315218" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="1.0686962250579541"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.029942122730977898" CI_END="-1.04210294941052" CI_START="-4.281761419163345" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.6619321842869326" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2008-10-31 14:33:23 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="8" P_CHI2="0.9851404498781581" P_Q="0.960673118189467" P_Z="0.001277933450449857" Q="0.002431370623235927" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="40" UNITS="" WEIGHT="100.00000000000001" Z="3.2208896457462">
<NAME>Hospital stay (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.02751075210774197" CI_END="-1.034377382409861" CI_START="-4.283314126142701" DF="1.0" EFFECT_SIZE="-2.658845754276281" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.01" MODIFIED="2008-10-30 22:21:00 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.868264276186439" P_Z="0.0013367655303455695" STUDIES="2" TAU2="0.0" TOTAL_1="27" TOTAL_2="29" WEIGHT="99.42965798844949" Z="3.2079676090223477">
<NAME>High-quality trial</NAME>
<CONT_DATA CI_END="1.1480551567568105" CI_START="-7.108055156756811" EFFECT_SIZE="-2.9800000000000004" ESTIMABLE="YES" MEAN_1="11.92" MEAN_2="14.9" ORDER="106" SD_1="3.68" SD_2="6.3" SE="2.1061892919045366" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="15.39740321516575"/>
<CONT_DATA CI_END="-0.8329606352074224" CI_START="-4.367039364792577" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="12.5" ORDER="107" SD_1="2.4" SD_2="2.7" SE="0.9015672628327654" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="84.03225477328374"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="18.248728474244125" CI_START="-24.648728474244116" DF="0.0" EFFECT_SIZE="-3.1999999999999957" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.02" NO="2" P_CHI2="1.0" P_Z="0.769970951777716" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="11" WEIGHT="0.5703420115505224" Z="0.2924128932891997">
<NAME>Low-quality trial</NAME>
<CONT_DATA CI_END="18.248728474244125" CI_START="-24.648728474244116" EFFECT_SIZE="-3.1999999999999957" ESTIMABLE="YES" MEAN_1="36.1" MEAN_2="39.3" ORDER="109" SD_1="31.4" SD_2="28.3" SE="10.94342990148235" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="0.5703420115505224"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.6191683480032473" CI_END="1.7118857420694762" CI_START="0.3194746628645953" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7395296615487127" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="0.23347477480102197" LOG_CI_START="-0.49556357949127705" LOG_EFFECT_SIZE="-0.13104440234512751" METHOD="MH" MODIFIED="2008-10-31 14:33:23 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="9" P_CHI2="0.7584508102730715" P_Q="0.0" P_Z="0.4810556228918461" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="172" TOTAL_2="275" WEIGHT="99.99999999999997" Z="0.7046057521112212">
<NAME>Reoperation</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.422523712528025" CI_END="1.5661460965658116" CI_START="0.23106335564730834" DF="3.0" EFFECT_SIZE="0.6015637726014008" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" I2="0.0" ID="CMP-002.09.01" LOG_CI_END="0.1948322723917049" LOG_CI_START="-0.6362689238503422" LOG_EFFECT_SIZE="-0.22071832572931865" MODIFIED="2008-10-30 22:21:10 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.7002636632957924" P_Z="0.29786238834709833" STUDIES="4" TAU2="0.0" TOTAL_1="149" TOTAL_2="249" WEIGHT="89.10567631528761" Z="1.0410283876705095">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="7.450631558527997" CI_START="0.014912978884848133" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="112" O_E="0.0" SE="1.585187847802434" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="2.5128205128205123" WEIGHT="11.49563375821922"/>
<DICH_DATA CI_END="16.58673887610161" CI_START="0.07743803372313825" EFFECT_SIZE="1.1333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2197610076438197" LOG_CI_START="-1.1110456829986344" LOG_EFFECT_SIZE="0.054357662322592676" ORDER="113" O_E="0.0" SE="1.3691273877625736" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.8745098039215686" WEIGHT="7.184771098887013"/>
<DICH_DATA CI_END="1.5825352054872504" CI_START="0.1346053792299069" EFFECT_SIZE="0.46153846153846156" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" LOG_CI_END="0.19935338022416468" LOG_CI_START="-0.8709375840705509" LOG_EFFECT_SIZE="-0.3357921019231931" ORDER="114" O_E="0.0" SE="0.6286942104524347" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.39525641025641023" WEIGHT="66.41921726971105"/>
<DICH_DATA CI_END="63.6312363433901" CI_START="0.11791120163472589" EFFECT_SIZE="2.739130434782609" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8036703615812775" LOG_CI_START="-0.9284449347092995" LOG_EFFECT_SIZE="0.43761271343598884" ORDER="116" O_E="0.0" SE="1.6048580492299167" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="2.5755693581780537" WEIGHT="4.006054188470334"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3182973946018792" CI_END="13.037451275681764" CI_START="0.2676362536001521" DF="1.0" EFFECT_SIZE="1.8679653679653676" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-002.09.02" LOG_CI_END="1.1151926983671214" LOG_CI_START="-0.5724550580489535" LOG_EFFECT_SIZE="0.271368820159084" NO="2" P_CHI2="0.5726327730990335" P_Z="0.528489858570245" STUDIES="2" TAU2="0.0" TOTAL_1="23" TOTAL_2="26" WEIGHT="10.894323684712369" Z="0.630312945360623">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="15.463493017511325" CI_START="0.07589560196923674" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.189307602575942" LOG_CI_START="-1.119783390057518" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="117" O_E="0.0" SE="1.3563714792576516" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="1.8397435897435899" WEIGHT="7.357205605260301"/>
<DICH_DATA CI_END="78.18735073936817" CI_START="0.15667495936567133" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="118" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="3.537118079452068"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-11-05 22:36:07 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="3">
<NAME>LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence</NAME>
<DICH_OUTCOME CHI2="1.2675524971016374" CI_END="2.021539415687536" CI_START="0.32369943000917417" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8089321087700342" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.3056822135641843" LOG_CI_START="-0.48985806533047704" LOG_EFFECT_SIZE="-0.09208792588314639" METHOD="MH" MODIFIED="2008-10-31 14:33:36 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.8668562075067828" P_Q="0.0" P_Z="0.6500072971028085" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="256" WEIGHT="100.0" Z="0.4537520548745455">
<NAME>Procedure specific complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.2834373091333267" CI_END="1.7879958639020224" CI_START="0.2449023947266613" DF="3.0" EFFECT_SIZE="0.6617283950617283" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.25236650982533176" LOG_CI_START="-0.6110069681970912" LOG_EFFECT_SIZE="-0.17932022918587975" MODIFIED="2008-10-30 22:21:51 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.9631127724763769" P_Z="0.41555447833389214" STUDIES="4" TAU2="0.0" TOTAL_1="153" TOTAL_2="243" WEIGHT="94.81361426256078" Z="0.8141579509920147">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="2.5811311926517133" CI_START="0.18897927338710277" EFFECT_SIZE="0.6984126984126984" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.4118100792423185" LOG_CI_START="-0.7235858251771071" LOG_EFFECT_SIZE="-0.1558878729673943" ORDER="122" O_E="0.0" SE="0.6669371745563405" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.44480519480519465" WEIGHT="44.246353322528364"/>
<DICH_DATA CI_END="7.450631558527997" CI_START="0.014912978884848133" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="123" O_E="0.0" SE="1.585187847802434" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="2.5128205128205123" WEIGHT="16.85575364667747"/>
<DICH_DATA CI_END="6.327720202056128" CI_START="0.07023768912854692" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.8012472673623147" LOG_CI_START="-1.1534297854736772" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="124" O_E="0.0" SE="1.1481869766433224" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="1.3183333333333334" WEIGHT="22.474338195569963"/>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528004" LOG_EFFECT_SIZE="0.0" ORDER="126" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="11.237169097784982"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="78.18735073936817" CI_START="0.15667495936567133" DF="0.0" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" NO="2" P_CHI2="1.0" P_Z="0.4292725427968822" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="13" WEIGHT="5.186385737439222" Z="0.7904371117779243">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="78.18735073936817" CI_START="0.15667495936567133" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="127" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="5.186385737439222"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.7196666567090135" CI_END="1.4835031306540984" CI_START="0.28704762919664345" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6525611515866213" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.17128846715057894" LOG_CI_START="-0.5420460357361543" LOG_EFFECT_SIZE="-0.18537878429278765" METHOD="MH" MODIFIED="2008-10-31 20:00:01 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.4452720763791508" P_Q="0.0" P_Z="0.30834700892298483" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="157" TOTAL_2="258" WEIGHT="100.00000000000001" Z="1.018696668228806">
<NAME>Severe postoperative complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.9189847712971677" CI_END="1.2311439435529072" CI_START="0.16768617347311032" DF="2.0" EFFECT_SIZE="0.4543630892678035" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="19" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.09030883297686813" LOG_CI_START="-0.7755027455745157" LOG_EFFECT_SIZE="-0.34259695629882375" MODIFIED="2008-10-31 19:59:48 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.6316042082845384" P_Z="0.12087909064350082" STUDIES="3" TAU2="0.0" TOTAL_1="124" TOTAL_2="225" WEIGHT="87.45225108072425" Z="1.551094284699236">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="14.207980025005401" CI_START="0.07038298183415555" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.152532337860481" LOG_CI_START="-1.152532337860481" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-10-31 19:59:36 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="129" O_E="0.0" SE="1.3540064007726602" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="1.8333333333333335" WEIGHT="6.57865479544064"/>
<DICH_DATA CI_END="15.463493017511325" CI_START="0.07589560196923674" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.189307602575942" LOG_CI_START="-1.119783390057518" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="130" O_E="0.0" SE="1.3563714792576516" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="1.8397435897435899" WEIGHT="6.315508603623014"/>
<DICH_DATA CI_END="1.176119819000932" CI_START="0.10591393158756404" EFFECT_SIZE="0.35294117647058826" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="0.0704515684069405" LOG_CI_START="-0.9750469103962011" LOG_EFFECT_SIZE="-0.45229767099463025" MODIFIED="2008-10-31 19:59:48 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="131" O_E="0.0" SE="0.6141309817499017" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.377156862745098" WEIGHT="74.5580876816606"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6870156158277236" CI_END="11.370546052819531" CI_START="0.3638176646411566" DF="1.0" EFFECT_SIZE="2.0339138405132906" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="40.72372593247418" ID="CMP-003.02.02" LOG_CI_END="1.0557813215067262" LOG_CI_START="-0.4391162182193934" LOG_EFFECT_SIZE="0.30833255164366646" MODIFIED="2008-10-31 20:00:01 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.19399492621321557" P_Z="0.4187963727729235" STUDIES="2" TAU2="0.0" TOTAL_1="33" TOTAL_2="33" WEIGHT="12.547748919275765" Z="0.808511192805415">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="8.687483415485351" CI_START="0.01740832881840793" EFFECT_SIZE="0.3888888888888889" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9388939885253562" LOG_CI_START="-1.7592429187034546" LOG_EFFECT_SIZE="-0.4101744650890492" MODIFIED="2008-10-31 19:59:54 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="135" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="9.108906639840885"/>
<DICH_DATA CI_END="116.5681402396685" CI_START="0.35042826609873" EFFECT_SIZE="6.391304347826087" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.066579867671753" LOG_CI_START="-0.45540087021058673" LOG_EFFECT_SIZE="0.8055894987305832" MODIFIED="2008-10-31 20:00:01 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="136" O_E="0.0" SE="1.4814239694380784" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="2.1946169772256727" WEIGHT="3.43884227943488"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.20104256818961" CI_END="1.412095226302453" CI_START="0.7773276354279661" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0476930100276534" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="83" I2="31.379562890675228" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.1498639848625287" LOG_CI_START="-0.10939589205197688" LOG_EFFECT_SIZE="0.020234046405275898" METHOD="MH" MODIFIED="2008-10-31 20:04:22 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="3" P_CHI2="0.1774640173954738" P_Q="0.0" P_Z="0.7596560930403831" Q="0.0" RANDOM="NO" SCALE="112.06898259086518" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" WEIGHT="99.99999999999999" Z="0.3059324311021769">
<NAME>Minor complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.184551661698313" CI_END="1.2370901649237056" CI_START="0.6271673209042321" DF="4.0" EFFECT_SIZE="0.8808305878272933" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="73" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="0.09240135419806003" LOG_CI_START="-0.202616579023732" LOG_EFFECT_SIZE="-0.055107612412836" MODIFIED="2008-10-31 20:03:40 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.7018585378662573" P_Z="0.46403463527184463" STUDIES="5" TAU2="0.0" TOTAL_1="165" TOTAL_2="256" WEIGHT="84.73183504483845" Z="0.7322194581435889">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="2.4630954998868235" CI_START="0.3411470557338875" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.39148125076310536" LOG_CI_START="-0.467058372541905" LOG_EFFECT_SIZE="-0.0377885608893998" MODIFIED="2008-10-31 20:03:17 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="137" O_E="0.0" SE="0.504310424569039" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.2543290043290043" WEIGHT="8.330665939036486"/>
<DICH_DATA CI_END="24.91862084290609" CI_START="0.3611756869185698" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3965240019963447" LOG_CI_START="-0.4422814925570199" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2008-10-31 20:03:21 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="138" O_E="0.0" SE="1.0801234497346435" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="1.1666666666666667" WEIGHT="1.5867935121974257"/>
<DICH_DATA CI_END="72.45938986445702" CI_START="0.14405130711161593" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.86009467278967" LOG_CI_START="-0.8414827966075424" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="139" O_E="0.0" SE="1.5869199785480734" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="2.518315018315018" WEIGHT="0.7640116910580197"/>
<DICH_DATA CI_END="1.1970398330607592" CI_START="0.5514906286050816" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="64" LOG_CI_END="0.07810860236184411" LOG_CI_START="-0.2584618630600201" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2008-10-31 20:03:35 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="140" O_E="0.0" SE="0.19770315743947658" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.039086538461538464" WEIGHT="67.70318985375683"/>
<DICH_DATA CI_END="2.9297807522256587" CI_START="0.19199388881665874" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4668351214936105" LOG_CI_START="-0.7167125947102104" LOG_EFFECT_SIZE="-0.12493873660829993" MODIFIED="2008-10-31 20:03:40 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="142" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="6.347174048789703"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.472059178715926" CI_END="3.8403658841666184" CI_START="1.0143631811835185" DF="2.0" EFFECT_SIZE="1.9737086297556454" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" I2="42.39729517687365" ID="CMP-003.03.02" LOG_CI_END="0.5843726029885743" LOG_CI_START="0.006193477033096494" LOG_EFFECT_SIZE="0.29528304001083544" MODIFIED="2008-10-31 20:04:05 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.17621899163039945" P_Z="0.04528963566369302" STUDIES="3" TAU2="0.0" TOTAL_1="48" TOTAL_2="50" WEIGHT="15.268164955161538" Z="2.0019544036991155">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="3.256291095371462" CI_START="0.04382779217299543" EFFECT_SIZE="0.37777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5127232216049622" LOG_CI_START="-1.3582504063991017" LOG_EFFECT_SIZE="-0.42276359239706973" MODIFIED="2008-10-31 20:03:47 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="143" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.2078431372549019" WEIGHT="4.462856753055259"/>
<DICH_DATA CI_END="4.712479375003825" CI_START="0.6668595729330961" EFFECT_SIZE="1.7727272727272727" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6732494624516998" LOG_CI_START="-0.1759656100431138" LOG_EFFECT_SIZE="0.24864192620429296" MODIFIED="2008-10-31 20:03:54 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="144" O_E="0.0" SE="0.49883313726585843" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="0.24883449883449876" WEIGHT="5.8182428780572275"/>
<DICH_DATA CI_END="11.043092400132222" CI_START="1.1974128275617295" EFFECT_SIZE="3.6363636363636362" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="1.043090706024852" LOG_CI_START="0.07824390631462287" LOG_EFFECT_SIZE="0.5606673061697374" MODIFIED="2008-10-31 20:04:05 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="145" O_E="0.0" SE="0.5667557862184746" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="0.32121212121212117" WEIGHT="4.987065324049052"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.731846923657034" CI_END="1.1427064248133" CI_START="0.7271330887923901" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9115369725125823" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="127" I2="28.07120729587535" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.05793466918783665" LOG_CI_START="-0.13838609197698853" LOG_EFFECT_SIZE="-0.04022571139457592" METHOD="MH" MODIFIED="2008-10-31 14:33:36 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="4" P_CHI2="0.20428565321474768" P_Q="0.0" P_Z="0.4218678195348412" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" WEIGHT="100.0" Z="0.8031850031355444">
<NAME>Total Complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8669370042550949" CI_END="1.0292430580797893" CI_START="0.6159813070464939" DF="4.0" EFFECT_SIZE="0.7962377058294332" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="112" I2="0.0" ID="CMP-003.04.01" LOG_CI_END="0.01251794649992604" LOG_CI_START="-0.2104324670072265" LOG_EFFECT_SIZE="-0.09895726025365024" MODIFIED="2008-10-30 22:22:10 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.9292555975613115" P_Z="0.08188137780535297" STUDIES="5" TAU2="0.0" TOTAL_1="165" TOTAL_2="256" WEIGHT="84.84185791225" Z="1.7398726744203974">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="1.5071432568227316" CI_START="0.449553658511318" EFFECT_SIZE="0.8231292517006803" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.17815453479018326" LOG_CI_START="-0.34721846365363523" LOG_EFFECT_SIZE="-0.084531964431726" ORDER="146" O_E="0.0" SE="0.3086066999241838" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.09523809523809523" WEIGHT="9.45507872800247"/>
<DICH_DATA CI_END="4.7248385182665125" CI_START="0.3762621242831433" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6743869701311649" LOG_CI_START="-0.4245094969145651" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="147" O_E="0.0" SE="0.6454972243679028" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="0.41666666666666663" WEIGHT="3.0873726458783572"/>
<DICH_DATA CI_END="6.528029811075431" CI_START="0.17978029284118263" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.814782129011123" LOG_CI_START="-0.7452579164926991" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="148" O_E="0.0" SE="0.9163752450517144" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="0.8397435897435896" WEIGHT="1.9759184933621485"/>
<DICH_DATA CI_END="1.02223461006909" CI_START="0.5619105697215061" EFFECT_SIZE="0.7578947368421053" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="95" LOG_CI_END="0.009550580891931466" LOG_CI_START="-0.25033279860709007" LOG_EFFECT_SIZE="-0.1203911088575793" ORDER="149" O_E="0.0" SE="0.1526567835612013" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.023304093567251456" WEIGHT="65.1778669685431"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="151" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="5.145621076463929"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.1219387212156775" CI_END="2.5569579268063847" CI_START="0.947952980632972" DF="2.0" EFFECT_SIZE="1.5568801778136996" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="15" I2="5.746571283916141" ID="CMP-003.04.02" LOG_CI_END="0.4077235820325337" LOG_CI_START="-0.02321320354597005" LOG_EFFECT_SIZE="0.19225518924328183" NO="2" P_CHI2="0.34612032304638407" P_Z="0.0803238943288128" STUDIES="3" TAU2="0.0" TOTAL_1="48" TOTAL_2="50" WEIGHT="15.15814208774999" Z="1.7488098457499668">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="3.256291095371462" CI_START="0.04382779217299543" EFFECT_SIZE="0.37777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5127232216049622" LOG_CI_START="-1.3582504063991017" LOG_EFFECT_SIZE="-0.42276359239706973" ORDER="152" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.2078431372549019" WEIGHT="2.8944118555109597"/>
<DICH_DATA CI_END="3.7565334804988004" CI_START="0.7287358612317042" EFFECT_SIZE="1.6545454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5747872638881639" LOG_CI_START="-0.13742985823446446" LOG_EFFECT_SIZE="0.21867870282684976" ORDER="153" O_E="0.0" SE="0.41835986306644546" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="0.175024975024975" WEIGHT="4.716819320091934"/>
<DICH_DATA CI_END="3.776474428962186" CI_START="1.004880732994098" EFFECT_SIZE="1.948051948051948" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" LOG_CI_END="0.5770865483743177" LOG_CI_START="0.002114519392080945" LOG_EFFECT_SIZE="0.28960053388319934" ORDER="154" O_E="0.0" SE="0.3377414159816116" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="0.11406926406926403" WEIGHT="7.546910912147095"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="11.02102256950485" CI_END="129.67731119616823" CI_START="53.360719467169965" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="91.5190153316691" ESTIMABLE="YES" I2="72.77929537771755" I2_Q="49.69479029770554" ID="CMP-003.05" MODIFIED="2008-11-05 22:36:07 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="5" P_CHI2="0.01161278668026311" P_Q="0.15856456022048415" P_Z="2.5916230212076174E-6" Q="1.9878656821390592" RANDOM="YES" SCALE="447.4711647396696" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="1008.131116352574" TOTALS="YES" TOTAL_1="58" TOTAL_2="58" UNITS="" WEIGHT="100.0" Z="4.700785763274152">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.7663361454259103" CI_END="144.29831579302885" CI_START="-7.045310135746163" DF="1.0" EFFECT_SIZE="68.62650282864134" ESTIMABLE="YES" I2="63.85110314039446" ID="CMP-003.05.01" MODIFIED="2008-10-30 22:22:16 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.09626636337082695" P_Z="0.07548856036252516" STUDIES="2" TAU2="2068.8555556277033" TOTAL_1="33" TOTAL_2="23" WEIGHT="42.242725673326014" Z="1.7774844907227723">
<NAME>High-quality trials</NAME>
<CONT_DATA CI_END="106.54006864662435" CI_START="-72.54006864662435" EFFECT_SIZE="17.0" ESTIMABLE="YES" MEAN_1="215.0" MEAN_2="198.0" ORDER="155" SD_1="141.0" SD_2="112.0" SE="45.68454795746503" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="12.245930070839067"/>
<CONT_DATA CI_END="128.82639117014142" CI_START="66.17360882985857" EFFECT_SIZE="97.5" ESTIMABLE="YES" MEAN_1="402.5" MEAN_2="305.0" ORDER="156" SD_1="35.96" SD_2="42.1" SE="15.983146331891813" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="29.996795602486944"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.26682074193988" CI_END="164.98633316784515" CI_START="41.058552195343225" DF="1.0" EFFECT_SIZE="103.02244268159419" ESTIMABLE="YES" I2="84.0429455192865" ID="CMP-003.05.02" NO="2" P_CHI2="0.01230206289852509" P_Z="0.001119332029113589" STUDIES="2" TAU2="1689.0783104575173" TOTAL_1="25" TOTAL_2="35" WEIGHT="57.757274326673986" Z="3.2586765561479774">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="158.2134640773819" CI_START="106.58653592261813" EFFECT_SIZE="132.4" ESTIMABLE="YES" MEAN_1="292.3" MEAN_2="159.9" ORDER="158" SD_1="39.0" SD_2="35.0" SE="13.17037674212138" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="32.0785681731808"/>
<CONT_DATA CI_END="111.39799217574674" CI_START="26.602007824253263" EFFECT_SIZE="69.0" ESTIMABLE="YES" MEAN_1="377.0" MEAN_2="308.0" ORDER="159" SD_1="58.8" SD_2="46.9" SE="21.63202615465217" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="25.678706153493188"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.702637967612797" CI_END="63.856757454971955" CI_START="-261.03780024083403" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-98.59052139293104" ESTIMABLE="YES" I2="62.999113755391875" I2_Q="62.999113755391875" ID="CMP-003.06" MODIFIED="2008-10-31 14:33:36 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="6" P_CHI2="0.10018242882741057" P_Q="0.10018242882741057" P_Z="0.23423613399756438" Q="2.702637967612797" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="8680.017893217893" TOTALS="YES" TOTAL_1="31" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.1895174392431196">
<NAME>Blood loss (mL)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.8909183357627595E-33" CI_END="109.50614838892508" CI_START="-149.50614838892508" DF="0.0" EFFECT_SIZE="-19.999999999999996" ESTIMABLE="YES" I2="100.0" ID="CMP-003.06.01" NO="1" P_CHI2="0.0" P_Z="0.7621316303911335" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="11" WEIGHT="52.65631241389697" Z="0.3026827697251883">
<NAME>High-quality trials</NAME>
<CONT_DATA CI_END="109.50614838892508" CI_START="-149.50614838892508" EFFECT_SIZE="-20.0" ESTIMABLE="YES" MEAN_1="218.0" MEAN_2="238.0" ORDER="160" SD_1="268.0" SD_2="102.0" SE="66.07577966251067" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="52.65631241389697"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-36.3486244862961" CI_START="-335.6513755137039" DF="0.0" EFFECT_SIZE="-186.0" ESTIMABLE="YES" I2="0.0" ID="CMP-003.06.02" NO="2" P_CHI2="1.0" P_Z="0.01484998487546344" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="18" WEIGHT="47.34368758610302" Z="2.436017042095729">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="-36.3486244862961" CI_START="-335.6513755137039" EFFECT_SIZE="-186.0" ESTIMABLE="YES" MEAN_1="177.0" MEAN_2="363.0" ORDER="161" SD_1="142.0" SD_2="262.0" SE="76.35414563437637" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="47.34368758610302"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5127910271563227" CI_END="-0.25125973195762397" CI_START="-2.7090447018010697" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4801522168793468" ESTIMABLE="YES" I2="33.897016702977446" I2_Q="0.0" ID="CMP-003.07" MODIFIED="2008-11-01 14:28:06 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="7" P_CHI2="0.21871409197092662" P_Q="1.0" P_Z="0.018240537882031112" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="35" UNITS="" WEIGHT="100.0" Z="2.3606988180950816">
<NAME>Time to regular diet (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.5127910271563227" CI_END="-0.25125973195762397" CI_START="-2.7090447018010697" DF="1.0" EFFECT_SIZE="-1.4801522168793468" ESTIMABLE="YES" I2="33.897016702977446" ID="CMP-003.07.01" MODIFIED="2008-11-01 14:28:06 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.21871409197092662" P_Z="0.018240537882031112" STUDIES="2" TAU2="0.0" TOTAL_1="25" TOTAL_2="35" WEIGHT="100.0" Z="2.3606988180950816">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="-0.16448784565546215" CI_START="-2.6355121543445383" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="7.0" ORDER="163" SD_1="1.3" SD_2="2.2" SE="0.6303749273405533" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="98.93130377494205"/>
<CONT_DATA CI_END="2.987396555302711" CI_START="-20.787396555302706" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="19.2" ORDER="164" SD_1="3.5" SD_2="25.3" SE="6.065109690315218" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="1.0686962250579541"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.029942122730977898" CI_END="-1.04210294941052" CI_START="-4.281761419163345" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.6619321842869326" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.08" MODIFIED="2008-10-31 14:33:36 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="8" P_CHI2="0.9851404498781581" P_Q="0.863509772542411" P_Z="0.001277933450449857" Q="0.02955241203177643" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="40" UNITS="" WEIGHT="100.00000000000001" Z="3.2208896457462">
<NAME>Hospital stay (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.8971069920146786E-4" CI_END="1.0658030396049152" CI_START="-7.041519127350501" DF="1.0" EFFECT_SIZE="-2.987858043872793" ESTIMABLE="YES" I2="0.0" ID="CMP-003.08.01" MODIFIED="2008-10-30 22:22:30 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.9842499109282669" P_Z="0.14855811538421662" STUDIES="2" TAU2="0.0" TOTAL_1="33" TOTAL_2="23" WEIGHT="15.967745226716273" Z="1.4446432586033866">
<NAME>High-quality trial</NAME>
<CONT_DATA CI_END="18.248728474244125" CI_START="-24.648728474244116" EFFECT_SIZE="-3.1999999999999957" ESTIMABLE="YES" MEAN_1="36.1" MEAN_2="39.3" ORDER="165" SD_1="31.4" SD_2="28.3" SE="10.94342990148235" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="0.5703420115505224"/>
<CONT_DATA CI_END="1.1480551567568105" CI_START="-7.108055156756811" EFFECT_SIZE="-2.9800000000000004" ESTIMABLE="YES" MEAN_1="11.92" MEAN_2="14.9" ORDER="166" SD_1="3.68" SD_2="6.3" SE="2.1061892919045366" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="15.39740321516575"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.8329606352074226" CI_START="-4.367039364792577" DF="0.0" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-003.08.02" NO="2" P_CHI2="1.0" P_Z="0.003928247285372883" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="17" WEIGHT="84.03225477328374" Z="2.8838669139678847">
<NAME>Low-quality trial</NAME>
<CONT_DATA CI_END="-0.8329606352074224" CI_START="-4.367039364792577" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="12.5" ORDER="168" SD_1="2.4" SD_2="2.7" SE="0.9015672628327654" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="84.03225477328374"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.6191683480032477" CI_END="1.711885742069477" CI_START="0.31947466286459547" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.739529661548713" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="0.23347477480102216" LOG_CI_START="-0.49556357949127683" LOG_EFFECT_SIZE="-0.13104440234512732" METHOD="MH" MODIFIED="2008-10-31 14:33:36 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="9" P_CHI2="0.7584508102730714" P_Q="0.0" P_Z="0.4810556228918468" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="172" TOTAL_2="275" WEIGHT="100.00000000000003" Z="0.7046057521112202">
<NAME>Reoperation</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.4071188985688341" CI_END="1.4115375066697298" CI_START="0.17562929245325543" DF="2.0" EFFECT_SIZE="0.4979029358897544" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" I2="0.0" ID="CMP-003.09.01" LOG_CI_END="0.14969242249235046" LOG_CI_START="-0.7554030482826217" LOG_EFFECT_SIZE="-0.3028553128951356" MODIFIED="2008-10-30 22:22:43 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.8158217858838064" P_Z="0.18963730803228473" STUDIES="3" TAU2="0.0" TOTAL_1="124" TOTAL_2="225" WEIGHT="85.2720566331906" Z="1.3116528034171415">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="7.450631558527997" CI_START="0.014912978884848133" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="171" O_E="0.0" SE="1.585187847802434" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="2.5128205128205123" WEIGHT="11.495633758219224"/>
<DICH_DATA CI_END="15.463493017511325" CI_START="0.07589560196923674" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.189307602575942" LOG_CI_START="-1.119783390057518" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="172" O_E="0.0" SE="1.3563714792576516" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="1.8397435897435899" WEIGHT="7.357205605260303"/>
<DICH_DATA CI_END="1.5825352054872504" CI_START="0.1346053792299069" EFFECT_SIZE="0.46153846153846156" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" LOG_CI_END="0.19935338022416468" LOG_CI_START="-0.8709375840705509" LOG_EFFECT_SIZE="-0.3357921019231931" ORDER="173" O_E="0.0" SE="0.6286942104524347" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.39525641025641023" WEIGHT="66.41921726971107"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3354853347707946" CI_END="11.250763895889246" CI_START="0.4064788283991694" DF="2.0" EFFECT_SIZE="2.1385035251307714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-003.09.02" LOG_CI_END="1.0511820108479628" LOG_CI_START="-0.3909620698703179" LOG_EFFECT_SIZE="0.33010997048882246" NO="2" P_CHI2="0.8455714265921221" P_Z="0.36956943761113825" STUDIES="3" TAU2="0.0" TOTAL_1="48" TOTAL_2="50" WEIGHT="14.72794336680942" Z="0.8972801840623618">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="16.58673887610161" CI_START="0.07743803372313825" EFFECT_SIZE="1.1333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2197610076438197" LOG_CI_START="-1.1110456829986344" LOG_EFFECT_SIZE="0.054357662322592676" ORDER="175" O_E="0.0" SE="1.3691273877625736" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.8745098039215686" WEIGHT="7.184771098887015"/>
<DICH_DATA CI_END="78.18735073936817" CI_START="0.15667495936567133" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="176" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="3.537118079452069"/>
<DICH_DATA CI_END="63.6312363433901" CI_START="0.11791120163472589" EFFECT_SIZE="2.739130434782609" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8036703615812775" LOG_CI_START="-0.9284449347092995" LOG_EFFECT_SIZE="0.43761271343598884" ORDER="177" O_E="0.0" SE="1.6048580492299167" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="2.5755693581780537" WEIGHT="4.006054188470335"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-11-05 22:36:18 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="4">
<NAME>LA-IPAA vs Open-IPAA - highest-quality trials versus other trials</NAME>
<DICH_OUTCOME CHI2="1.2675524971016372" CI_END="2.0215394156875357" CI_START="0.32369943000917417" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8089321087700341" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.3056822135641842" LOG_CI_START="-0.48985806533047704" LOG_EFFECT_SIZE="-0.09208792588314646" METHOD="MH" MODIFIED="2008-10-31 14:33:45 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.8668562075067828" P_Q="0.0" P_Z="0.6500072971028082" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="256" WEIGHT="100.00000000000001" Z="0.4537520548745458">
<NAME>Procedure specific complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.27483050249443153" CI_END="4.298059186507185" CI_START="0.08375873490298624" DF="1.0" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.6332723916571675" LOG_CI_START="-1.0769698908898802" LOG_EFFECT_SIZE="-0.22184874961635637" MODIFIED="2008-10-30 22:18:26 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.6001097389993743" P_Z="0.6111138435125529" STUDIES="2" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="28.092922744462452" Z="0.5084841647298487">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="7.450631558527997" CI_START="0.014912978884848133" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="181" O_E="0.0" SE="1.585187847802434" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="2.5128205128205123" WEIGHT="16.85575364667747"/>
<DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528004" LOG_EFFECT_SIZE="0.0" ORDER="183" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="11.237169097784982"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9421445360813178" CI_END="2.511582547789353" CI_START="0.3157747700755047" DF="2.0" EFFECT_SIZE="0.8905584773353367" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" I2="0.0" ID="CMP-004.01.02" LOG_CI_END="0.3999474566187073" LOG_CI_START="-0.5006225724110305" LOG_EFFECT_SIZE="-0.05033755789616156" NO="2" P_CHI2="0.6243324971084383" P_Z="0.8265680789066436" STUDIES="3" TAU2="0.0" TOTAL_1="132" TOTAL_2="224" WEIGHT="71.90707725553756" Z="0.21910522750234376">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="2.5811311926517133" CI_START="0.18897927338710277" EFFECT_SIZE="0.6984126984126984" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.4118100792423185" LOG_CI_START="-0.7235858251771071" LOG_EFFECT_SIZE="-0.1558878729673943" ORDER="184" O_E="0.0" SE="0.6669371745563405" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.44480519480519465" WEIGHT="44.246353322528364"/>
<DICH_DATA CI_END="78.18735073936817" CI_START="0.15667495936567133" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="185" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="5.186385737439222"/>
<DICH_DATA CI_END="6.327720202056128" CI_START="0.07023768912854692" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.8012472673623147" LOG_CI_START="-1.1534297854736772" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="186" O_E="0.0" SE="1.1481869766433224" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="1.3183333333333334" WEIGHT="22.474338195569963"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.7196666567090135" CI_END="1.4835031306540984" CI_START="0.28704762919664345" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6525611515866213" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.17128846715057894" LOG_CI_START="-0.5420460357361543" LOG_EFFECT_SIZE="-0.18537878429278765" METHOD="MH" MODIFIED="2008-10-31 20:00:56 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.4452720763791508" P_Q="0.0" P_Z="0.30834700892298483" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="157" TOTAL_2="258" WEIGHT="100.0" Z="1.018696668228806">
<NAME>Severe postoperative complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="14.207980025005394" CI_START="0.07038298183415558" DF="0.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="1.1525323378604808" LOG_CI_START="-1.1525323378604808" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-10-31 20:00:36 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="12" WEIGHT="6.578654795440639" Z="0.0">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="14.207980025005401" CI_START="0.07038298183415555" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.152532337860481" LOG_CI_START="-1.152532337860481" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-10-31 20:00:36 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="187" O_E="0.0" SE="1.3540064007726602" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="1.8333333333333335" WEIGHT="6.578654795440639"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.5864244691787412" CI_END="1.4909294423396164" CI_START="0.26460210406117485" DF="3.0" EFFECT_SIZE="0.6280947917709687" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" I2="16.351228757733384" ID="CMP-004.02.02" LOG_CI_END="0.17345709112058103" LOG_CI_START="-0.57740670671494" LOG_EFFECT_SIZE="-0.20197480779717947" MODIFIED="2008-10-31 20:00:56 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.3097250937320024" P_Z="0.29169014112149527" STUDIES="4" TAU2="0.0" TOTAL_1="145" TOTAL_2="246" WEIGHT="93.42134520455936" Z="1.0544211885244907">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="15.463493017511325" CI_START="0.07589560196923674" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.189307602575942" LOG_CI_START="-1.119783390057518" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="191" O_E="0.0" SE="1.3563714792576516" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="1.8397435897435899" WEIGHT="6.315508603623013"/>
<DICH_DATA CI_END="8.687483415485351" CI_START="0.01740832881840793" EFFECT_SIZE="0.3888888888888889" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9388939885253562" LOG_CI_START="-1.7592429187034546" LOG_EFFECT_SIZE="-0.4101744650890492" MODIFIED="2008-10-31 20:00:47 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="193" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="9.108906639840884"/>
<DICH_DATA CI_END="1.176119819000932" CI_START="0.10591393158756404" EFFECT_SIZE="0.35294117647058826" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="0.0704515684069405" LOG_CI_START="-0.9750469103962011" LOG_EFFECT_SIZE="-0.45229767099463025" MODIFIED="2008-10-31 20:00:51 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="194" O_E="0.0" SE="0.6141309817499017" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.377156862745098" WEIGHT="74.55808768166058"/>
<DICH_DATA CI_END="116.5681402396685" CI_START="0.35042826609873" EFFECT_SIZE="6.391304347826087" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.066579867671753" LOG_CI_START="-0.45540087021058673" LOG_EFFECT_SIZE="0.8055894987305832" MODIFIED="2008-10-31 20:00:56 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="195" O_E="0.0" SE="1.4814239694380784" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="2.1946169772256727" WEIGHT="3.4388422794348794"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.201042568189607" CI_END="1.412095226302453" CI_START="0.7773276354279661" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0476930100276534" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="83" I2="31.379562890675203" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.1498639848625287" LOG_CI_START="-0.10939589205197688" LOG_EFFECT_SIZE="0.020234046405275898" METHOD="MH" MODIFIED="2008-10-31 20:02:35 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="3" P_CHI2="0.1774640173954738" P_Q="0.0" P_Z="0.7596560930403831" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" WEIGHT="100.0" Z="0.3059324311021768">
<NAME>Minor complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.176689002744645" CI_END="3.57363512256199" CI_START="0.40295104301740897" DF="1.0" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="15.015777519167363" ID="CMP-004.03.01" LOG_CI_END="0.5531102078373842" LOG_CI_START="-0.39474771574213463" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2008-10-31 20:01:55 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.27803113559540715" P_Z="0.7433206106384418" STUDIES="2" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="7.933967560987129" Z="0.32745918273970004">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="24.91862084290609" CI_START="0.3611756869185698" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3965240019963447" LOG_CI_START="-0.4422814925570199" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2008-10-31 20:01:47 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="196" O_E="0.0" SE="1.0801234497346435" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="1.1666666666666667" WEIGHT="1.5867935121974257"/>
<DICH_DATA CI_END="2.9297807522256587" CI_START="0.19199388881665874" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4668351214936105" LOG_CI_START="-0.7167125947102104" LOG_EFFECT_SIZE="-0.12493873660829993" MODIFIED="2008-10-31 20:01:55 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="198" O_E="0.0" SE="0.6952217871538069" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.4833333333333332" WEIGHT="6.347174048789703"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.990946159982645" CI_END="1.4107495766055111" CI_START="0.7586961321803711" DF="5.0" EFFECT_SIZE="1.0345676619949502" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="78" I2="44.388500264251924" ID="CMP-004.03.02" LOG_CI_END="0.14944992860153825" LOG_CI_START="-0.11993212995597173" LOG_EFFECT_SIZE="0.014758899322783266" MODIFIED="2008-10-31 20:02:35 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.10942597176756585" P_Z="0.8299505872721378" STUDIES="6" TAU2="0.0" TOTAL_1="181" TOTAL_2="274" WEIGHT="92.06603243901287" Z="0.21476494224601256">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="2.4630954998868235" CI_START="0.3411470557338875" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.39148125076310536" LOG_CI_START="-0.467058372541905" LOG_EFFECT_SIZE="-0.0377885608893998" MODIFIED="2008-10-31 20:02:02 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="199" O_E="0.0" SE="0.504310424569039" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.2543290043290043" WEIGHT="8.330665939036486"/>
<DICH_DATA CI_END="72.45938986445702" CI_START="0.14405130711161593" EFFECT_SIZE="3.230769230769231" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.86009467278967" LOG_CI_START="-0.8414827966075424" LOG_EFFECT_SIZE="0.5093059380910637" ORDER="200" O_E="0.0" SE="1.5869199785480734" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="2.518315018315018" WEIGHT="0.7640116910580197"/>
<DICH_DATA CI_END="3.256291095371462" CI_START="0.04382779217299543" EFFECT_SIZE="0.37777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5127232216049622" LOG_CI_START="-1.3582504063991017" LOG_EFFECT_SIZE="-0.42276359239706973" MODIFIED="2008-10-31 20:02:11 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="201" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.2078431372549019" WEIGHT="4.462856753055259"/>
<DICH_DATA CI_END="4.712479375003825" CI_START="0.6668595729330961" EFFECT_SIZE="1.7727272727272727" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6732494624516998" LOG_CI_START="-0.1759656100431138" LOG_EFFECT_SIZE="0.24864192620429296" MODIFIED="2008-10-31 20:02:16 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="202" O_E="0.0" SE="0.49883313726585843" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="0.24883449883449876" WEIGHT="5.8182428780572275"/>
<DICH_DATA CI_END="1.1970398330607592" CI_START="0.5514906286050816" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="64" LOG_CI_END="0.07810860236184411" LOG_CI_START="-0.2584618630600201" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2008-10-31 20:02:25 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="203" O_E="0.0" SE="0.19770315743947658" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.039086538461538464" WEIGHT="67.70318985375683"/>
<DICH_DATA CI_END="11.043092400132222" CI_START="1.1974128275617295" EFFECT_SIZE="3.6363636363636362" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="1.043090706024852" LOG_CI_START="0.07824390631462287" LOG_EFFECT_SIZE="0.5606673061697374" MODIFIED="2008-10-31 20:02:35 +0100" MODIFIED_BY="Usama Ahmed Ali" ORDER="204" O_E="0.0" SE="0.5667557862184746" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="0.32121212121212117" WEIGHT="4.987065324049052"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.731846923657036" CI_END="1.1427064248133" CI_START="0.7271330887923901" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9115369725125823" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="127" I2="28.07120729587536" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.05793466918783665" LOG_CI_START="-0.13838609197698853" LOG_EFFECT_SIZE="-0.04022571139457592" METHOD="MH" MODIFIED="2008-10-31 14:33:45 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="4" P_CHI2="0.20428565321474745" P_Q="0.0" P_Z="0.4218678195348412" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" WEIGHT="99.99999999999997" Z="0.8031850031355444">
<NAME>Total Complications</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.34089218095327073" CI_END="2.3365822869012183" CI_START="0.42797551175747495" DF="1.0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="0.3685810800822915" LOG_CI_START="-0.36858108008229146" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-10-30 22:18:40 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.5593148689899288" P_Z="1.0" STUDIES="2" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="8.232993722342286" Z="0.0">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="4.7248385182665125" CI_START="0.3762621242831433" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6743869701311649" LOG_CI_START="-0.4245094969145651" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="205" O_E="0.0" SE="0.6454972243679028" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="0.41666666666666663" WEIGHT="3.0873726458783572"/>
<DICH_DATA CI_END="2.550748330704528" CI_START="0.25090676030089926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40666761110760385" LOG_CI_START="-0.6004876371237167" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="207" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" VAR="0.35000000000000003" WEIGHT="5.145621076463929"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.350991897977742" CI_END="1.1418901593713149" CI_START="0.7150369719777421" DF="5.0" EFFECT_SIZE="0.9036003994510219" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="119" I2="46.529736582476275" ID="CMP-004.04.02" LOG_CI_END="0.057624330290578965" LOG_CI_START="-0.145671501820187" LOG_EFFECT_SIZE="-0.04402358576480402" NO="2" P_CHI2="0.09585706092226742" P_Z="0.3959603431293661" STUDIES="6" TAU2="0.0" TOTAL_1="181" TOTAL_2="274" WEIGHT="91.76700627765769" Z="0.8488579590978905">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="1.5071432568227316" CI_START="0.449553658511318" EFFECT_SIZE="0.8231292517006803" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.17815453479018326" LOG_CI_START="-0.34721846365363523" LOG_EFFECT_SIZE="-0.084531964431726" ORDER="208" O_E="0.0" SE="0.3086066999241838" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" VAR="0.09523809523809523" WEIGHT="9.45507872800247"/>
<DICH_DATA CI_END="6.528029811075431" CI_START="0.17978029284118263" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.814782129011123" LOG_CI_START="-0.7452579164926991" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="209" O_E="0.0" SE="0.9163752450517144" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="0.8397435897435896" WEIGHT="1.9759184933621485"/>
<DICH_DATA CI_END="3.256291095371462" CI_START="0.04382779217299543" EFFECT_SIZE="0.37777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5127232216049622" LOG_CI_START="-1.3582504063991017" LOG_EFFECT_SIZE="-0.42276359239706973" ORDER="210" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.2078431372549019" WEIGHT="2.8944118555109597"/>
<DICH_DATA CI_END="3.7565334804988004" CI_START="0.7287358612317042" EFFECT_SIZE="1.6545454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5747872638881639" LOG_CI_START="-0.13742985823446446" LOG_EFFECT_SIZE="0.21867870282684976" ORDER="211" O_E="0.0" SE="0.41835986306644546" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="0.175024975024975" WEIGHT="4.716819320091934"/>
<DICH_DATA CI_END="1.02223461006909" CI_START="0.5619105697215061" EFFECT_SIZE="0.7578947368421053" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="95" LOG_CI_END="0.009550580891931466" LOG_CI_START="-0.25033279860709007" LOG_EFFECT_SIZE="-0.1203911088575793" ORDER="212" O_E="0.0" SE="0.1526567835612013" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.023304093567251456" WEIGHT="65.1778669685431"/>
<DICH_DATA CI_END="3.776474428962186" CI_START="1.004880732994098" EFFECT_SIZE="1.948051948051948" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" LOG_CI_END="0.5770865483743177" LOG_CI_START="0.002114519392080945" LOG_EFFECT_SIZE="0.28960053388319934" ORDER="213" O_E="0.0" SE="0.3377414159816116" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="0.11406926406926403" WEIGHT="7.546910912147095"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="11.02102256950485" CI_END="129.67731119616823" CI_START="53.360719467169965" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="91.5190153316691" ESTIMABLE="YES" I2="72.77929537771755" I2_Q="0.0" ID="CMP-004.05" MODIFIED="2008-11-05 22:36:18 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="5" P_CHI2="0.01161278668026311" P_Q="0.5306890117440086" P_Z="2.5916230212076174E-6" Q="0.39307277071598357" RANDOM="YES" SCALE="484.8065719840476" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="1008.1311163525743" TOTALS="YES" TOTAL_1="58" TOTAL_2="58" UNITS="" WEIGHT="100.0" Z="4.700785763274152">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="128.82639117014142" CI_START="66.17360882985857" DF="0.0" EFFECT_SIZE="97.5" ESTIMABLE="YES" I2="0.0" ID="CMP-004.05.01" MODIFIED="2008-10-30 22:18:45 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="1.0" P_Z="1.0595197306948122E-9" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="12" WEIGHT="29.996795602486944" Z="6.100175645983691">
<NAME>High-quality trials</NAME>
<CONT_DATA CI_END="128.82639117014142" CI_START="66.17360882985857" EFFECT_SIZE="97.5" ESTIMABLE="YES" MEAN_1="402.5" MEAN_2="305.0" ORDER="214" SD_1="35.96" SD_2="42.1" SE="15.983146331891813" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="29.996795602486944"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="10.627949798788867" CI_END="144.61200401179588" CI_START="21.449161555742116" DF="2.0" EFFECT_SIZE="83.03058278376899" ESTIMABLE="YES" I2="81.18169507887669" ID="CMP-004.05.02" NO="2" P_CHI2="0.004922333839794124" P_Z="0.008226471753323071" STUDIES="3" TAU2="2244.8759711301773" TOTAL_1="46" TOTAL_2="46" WEIGHT="70.00320439751306" Z="2.6426306607794565">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="106.54006864662435" CI_START="-72.54006864662435" EFFECT_SIZE="17.0" ESTIMABLE="YES" MEAN_1="215.0" MEAN_2="198.0" ORDER="216" SD_1="141.0" SD_2="112.0" SE="45.68454795746503" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="12.245930070839067"/>
<CONT_DATA CI_END="158.2134640773819" CI_START="106.58653592261813" EFFECT_SIZE="132.4" ESTIMABLE="YES" MEAN_1="292.3" MEAN_2="159.9" ORDER="217" SD_1="39.0" SD_2="35.0" SE="13.17037674212138" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="32.0785681731808"/>
<CONT_DATA CI_END="111.39799217574674" CI_START="26.602007824253263" EFFECT_SIZE="69.0" ESTIMABLE="YES" MEAN_1="377.0" MEAN_2="308.0" ORDER="218" SD_1="58.8" SD_2="46.9" SE="21.63202615465217" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="25.678706153493188"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.702637967612797" CI_END="63.856757454971955" CI_START="-261.03780024083403" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-98.59052139293104" ESTIMABLE="YES" I2="62.999113755391875" I2_Q="0.0" ID="CMP-004.06" MODIFIED="2008-11-01 14:27:50 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="6" P_CHI2="0.10018242882741057" P_Q="1.0" P_Z="0.23423613399756438" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="8680.017893217893" TOTALS="YES" TOTAL_1="31" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="1.1895174392431196">
<NAME>Blood loss (mL)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.702637967612797" CI_END="63.856757454971955" CI_START="-261.03780024083403" DF="1.0" EFFECT_SIZE="-98.59052139293104" ESTIMABLE="YES" I2="62.999113755391875" ID="CMP-004.06.01" MODIFIED="2008-11-01 14:27:50 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.10018242882741057" P_Z="0.23423613399756438" STUDIES="2" TAU2="8680.017893217893" TOTAL_1="31" TOTAL_2="29" WEIGHT="100.0" Z="1.1895174392431196">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="109.50614838892508" CI_START="-149.50614838892508" EFFECT_SIZE="-20.0" ESTIMABLE="YES" MEAN_1="218.0" MEAN_2="238.0" ORDER="219" SD_1="268.0" SD_2="102.0" SE="66.07577966251067" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="52.65631241389697"/>
<CONT_DATA CI_END="-36.3486244862961" CI_START="-335.6513755137039" EFFECT_SIZE="-186.0" ESTIMABLE="YES" MEAN_1="177.0" MEAN_2="363.0" ORDER="220" SD_1="142.0" SD_2="262.0" SE="76.35414563437637" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="47.34368758610302"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5127910271563227" CI_END="-0.25125973195762397" CI_START="-2.7090447018010697" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4801522168793468" ESTIMABLE="YES" I2="33.897016702977446" I2_Q="0.0" ID="CMP-004.07" MODIFIED="2008-11-01 14:27:53 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="7" P_CHI2="0.21871409197092662" P_Q="1.0" P_Z="0.018240537882031112" Q="0.0" RANDOM="NO" SCALE="27.05" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="35" UNITS="" WEIGHT="100.0" Z="2.3606988180950816">
<NAME>Time to regular diet (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.5127910271563227" CI_END="-0.25125973195762397" CI_START="-2.7090447018010697" DF="1.0" EFFECT_SIZE="-1.4801522168793468" ESTIMABLE="YES" I2="33.897016702977446" ID="CMP-004.07.01" MODIFIED="2008-11-01 14:27:53 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="0.21871409197092662" P_Z="0.018240537882031112" STUDIES="2" TAU2="0.0" TOTAL_1="25" TOTAL_2="35" WEIGHT="100.0" Z="2.3606988180950816">
<NAME>Low-quality trials</NAME>
<CONT_DATA CI_END="-0.16448784565546215" CI_START="-2.6355121543445383" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="7.0" ORDER="222" SD_1="1.3" SD_2="2.2" SE="0.6303749273405533" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="98.93130377494205"/>
<CONT_DATA CI_END="2.987396555302711" CI_START="-20.787396555302706" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="19.2" ORDER="223" SD_1="3.5" SD_2="25.3" SE="6.065109690315218" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="1.0686962250579541"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.029942122730977898" CI_END="-1.04210294941052" CI_START="-4.281761419163345" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.6619321842869326" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.08" MODIFIED="2008-10-31 21:08:16 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="8" P_CHI2="0.9851404498781581" P_Q="0.8695864255283021" P_Z="0.001277933450449857" Q="0.02695634205210047" RANDOM="NO" SCALE="16.39423594422801" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="40" UNITS="" WEIGHT="100.00000000000001" Z="3.2208896457462">
<NAME>Hospital stay (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1480551567568105" CI_START="-7.108055156756811" DF="0.0" EFFECT_SIZE="-2.9800000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-004.08.01" MODIFIED="2008-10-30 22:18:59 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="1.0" P_Z="0.15710439372492405" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="12" WEIGHT="15.39740321516575" Z="1.4148775760346375">
<NAME>High-quality trial</NAME>
<CONT_DATA CI_END="1.1480551567568105" CI_START="-7.108055156756811" EFFECT_SIZE="-2.9800000000000004" ESTIMABLE="YES" MEAN_1="11.92" MEAN_2="14.9" ORDER="224" SD_1="3.68" SD_2="6.3" SE="2.1061892919045366" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="15.39740321516575"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.002985780678877428" CI_END="-0.8429717432803723" CI_START="-4.365117966017809" DF="1.0" EFFECT_SIZE="-2.6040448546490906" ESTIMABLE="YES" I2="0.0" ID="CMP-004.08.02" NO="2" P_CHI2="0.9564234664079535" P_Z="0.0037538454538480546" STUDIES="2" TAU2="0.0" TOTAL_1="36" TOTAL_2="28" WEIGHT="84.60259678483426" Z="2.898138695259689">
<NAME>Low-quality trial</NAME>
<CONT_DATA CI_END="18.248728474244125" CI_START="-24.648728474244116" EFFECT_SIZE="-3.1999999999999957" ESTIMABLE="YES" MEAN_1="36.1" MEAN_2="39.3" ORDER="226" SD_1="31.4" SD_2="28.3" SE="10.94342990148235" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="0.5703420115505224"/>
<CONT_DATA CI_END="-0.8329606352074224" CI_START="-4.367039364792577" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="12.5" ORDER="227" SD_1="2.4" SD_2="2.7" SE="0.9015672628327654" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="84.03225477328374"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.6191683480032473" CI_END="1.7118857420694769" CI_START="0.31947466286459547" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7395296615487129" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-004.09" LOG_CI_END="0.23347477480102213" LOG_CI_START="-0.49556357949127683" LOG_EFFECT_SIZE="-0.1310444023451274" METHOD="MH" MODIFIED="2008-10-31 21:07:51 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="9" P_CHI2="0.7584508102730715" P_Q="0.0" P_Z="0.48105562289184656" Q="0.0" RANDOM="NO" SCALE="764.2679635385352" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="172" TOTAL_2="275" WEIGHT="100.0" Z="0.7046057521112206">
<NAME>Reoperation</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.450631558527997" CI_START="0.014912978884848133" DF="0.0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-004.09.01" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2008-10-30 22:19:12 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="1.0" P_Z="0.4882790296766242" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="12" WEIGHT="11.495633758219222" Z="0.6930486441661347">
<NAME>High-quality trials</NAME>
<DICH_DATA CI_END="7.450631558527997" CI_START="0.014912978884848133" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8721930876152056" LOG_CI_START="-1.8264355970545303" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="230" O_E="0.0" SE="1.585187847802434" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" VAR="2.5128205128205123" WEIGHT="11.495633758219222"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.3363680105281417" CI_END="1.906410158900877" CI_START="0.329269540942735" DF="4.0" EFFECT_SIZE="0.7922895921756503" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" I2="0.0" ID="CMP-004.09.02" LOG_CI_END="0.28021634361810904" LOG_CI_START="-0.4824484418125751" LOG_EFFECT_SIZE="-0.10111604909723303" NO="2" P_CHI2="0.6741558378944587" P_Z="0.603262872424507" STUDIES="5" TAU2="0.0" TOTAL_1="160" TOTAL_2="263" WEIGHT="88.50436624178077" Z="0.5197140821904981">
<NAME>Low-quality trials</NAME>
<DICH_DATA CI_END="15.463493017511325" CI_START="0.07589560196923674" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.189307602575942" LOG_CI_START="-1.119783390057518" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="232" O_E="0.0" SE="1.3563714792576516" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" VAR="1.8397435897435899" WEIGHT="7.357205605260302"/>
<DICH_DATA CI_END="16.58673887610161" CI_START="0.07743803372313825" EFFECT_SIZE="1.1333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2197610076438197" LOG_CI_START="-1.1110456829986344" LOG_EFFECT_SIZE="0.054357662322592676" ORDER="233" O_E="0.0" SE="1.3691273877625736" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" VAR="1.8745098039215686" WEIGHT="7.184771098887014"/>
<DICH_DATA CI_END="78.18735073936817" CI_START="0.15667495936567133" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8931364979646812" LOG_CI_START="-0.8050004092641299" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="234" O_E="0.0" SE="1.584898975299297" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" VAR="2.5119047619047614" WEIGHT="3.5371180794520685"/>
<DICH_DATA CI_END="1.5825352054872504" CI_START="0.1346053792299069" EFFECT_SIZE="0.46153846153846156" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" LOG_CI_END="0.19935338022416468" LOG_CI_START="-0.8709375840705509" LOG_EFFECT_SIZE="-0.3357921019231931" ORDER="235" O_E="0.0" SE="0.6286942104524347" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" VAR="0.39525641025641023" WEIGHT="66.41921726971105"/>
<DICH_DATA CI_END="63.6312363433901" CI_START="0.11791120163472589" EFFECT_SIZE="2.739130434782609" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8036703615812775" LOG_CI_START="-0.9284449347092995" LOG_EFFECT_SIZE="0.43761271343598884" ORDER="236" O_E="0.0" SE="1.6048580492299167" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" VAR="2.5755693581780537" WEIGHT="4.006054188470335"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-11-05 22:36:37 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="5">
<NAME>LA-IPAA vs Open-IPAA - sensitivity analsyses</NAME>
<CONT_OUTCOME CHI2="36.29459083549411" CI_END="105.32771964226126" CI_START="59.98811495101302" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="MD" EFFECT_SIZE="82.65791729663714" ESTIMABLE="YES" I2="77.95814798888313" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2008-11-05 22:36:37 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="1" P_CHI2="1.5508322329771396E-5" P_Q="1.0" P_Z="8.910997455945417E-13" Q="0.0" RANDOM="YES" SCALE="282.6982442818558" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="824.9722988224081" TOTALS="YES" TOTAL_1="223" TOTAL_2="324" UNITS="" WEIGHT="100.0" Z="7.1463587758086815">
<NAME>Sensitivity analysis 1: Imputing means and standard deviations in operative time (minutes)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-IPAA</GRAPH_LABEL_2>
<CONT_DATA CI_END="106.54006864662435" CI_START="-72.54006864662435" EFFECT_SIZE="17.0" ESTIMABLE="YES" MEAN_1="215.0" MEAN_2="198.0" ORDER="237" SD_1="141.0" SD_2="112.0" SE="45.68454795746503" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="4.594099792514004"/>
<CONT_DATA CI_END="128.82639117014142" CI_START="66.17360882985857" EFFECT_SIZE="97.5" ESTIMABLE="YES" MEAN_1="402.5" MEAN_2="305.0" ORDER="238" SD_1="35.96" SD_2="42.1" SE="15.983146331891813" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="12.382300455709027"/>
<CONT_DATA CI_END="62.791098158524015" CI_START="12.208901841475985" EFFECT_SIZE="37.5" ESTIMABLE="YES" MEAN_1="161.25" MEAN_2="123.75" ORDER="239" SD_1="39.51" SD_2="21.76" SE="12.903858620881286" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" WEIGHT="13.493186080997969"/>
<CONT_DATA CI_END="158.2134640773819" CI_START="106.58653592261813" EFFECT_SIZE="132.4" ESTIMABLE="YES" MEAN_1="292.3" MEAN_2="159.9" ORDER="240" SD_1="39.0" SD_2="35.0" SE="13.17037674212138" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="13.399271132610417"/>
<CONT_DATA CI_END="139.74734383309712" CI_START="-1.7473438330971192" EFFECT_SIZE="69.0" ESTIMABLE="YES" MEAN_1="500.0" MEAN_2="431.0" ORDER="241" SD_1="62.55" SD_2="110.97" SE="36.096246865321575" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" WEIGHT="6.287033245050994"/>
<CONT_DATA CI_END="117.9150598052863" CI_START="88.0849401947137" EFFECT_SIZE="103.0" ESTIMABLE="YES" MEAN_1="333.0" MEAN_2="230.0" ORDER="242" SD_1="68.17" SD_2="47.83" SE="7.609864223493084" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" WEIGHT="15.152924490444029"/>
<CONT_DATA CI_END="132.9016375362985" CI_START="62.098362463701505" EFFECT_SIZE="97.5" ESTIMABLE="YES" MEAN_1="330.0" MEAN_2="232.5" ORDER="244" SD_1="75.0" SD_2="30.0" SE="18.062391868188442" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="11.620908776101063"/>
<CONT_DATA CI_END="111.39799217574674" CI_START="26.602007824253263" EFFECT_SIZE="69.0" ESTIMABLE="YES" MEAN_1="377.0" MEAN_2="308.0" ORDER="245" SD_1="58.8" SD_2="46.9" SE="21.63202615465217" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="10.347339251034038"/>
<CONT_DATA CI_END="96.9995149402605" CI_START="38.0004850597395" EFFECT_SIZE="67.5" ESTIMABLE="YES" MEAN_1="232.5" MEAN_2="165.0" ORDER="246" SD_1="52.5" SD_2="45.0" SE="15.051049495270783" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" WEIGHT="12.722936775538457"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.569971581088013" CI_END="-40.85624059440886" CI_START="-234.64119610875116" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-137.74871835158" ESTIMABLE="YES" I2="34.35407755236491" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2008-10-31 21:07:02 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="2" P_CHI2="0.20613331283803515" P_Q="1.0" P_Z="0.005329480784308021" Q="0.0" RANDOM="YES" SCALE="711.0722042739934" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="3331.9006916965227" TOTALS="YES" TOTAL_1="62" TOTAL_2="62" UNITS="" WEIGHT="100.0" Z="2.7864136941803683">
<NAME>Sensitivity analysis 2: Imputing means and standard deviations in blood loss (mL)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_DATA CI_END="109.50614838892508" CI_START="-149.50614838892508" EFFECT_SIZE="-20.0" ESTIMABLE="YES" MEAN_1="218.0" MEAN_2="238.0" ORDER="247" SD_1="268.0" SD_2="102.0" SE="66.07577966251067" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="31.747618234132336"/>
<CONT_DATA CI_END="6.180966402952379" CI_START="-507.6809664029524" EFFECT_SIZE="-250.75" ESTIMABLE="YES" MEAN_1="442.25" MEAN_2="693.0" ORDER="248" SD_1="271.68" SD_2="369.01" SE="131.08963655944245" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" WEIGHT="11.91195163887054"/>
<CONT_DATA CI_END="-37.71505057352226" CI_START="-312.28494942647774" EFFECT_SIZE="-175.0" ESTIMABLE="YES" MEAN_1="325.0" MEAN_2="500.0" ORDER="249" SD_1="150.0" SD_2="275.0" SE="70.0446286306095" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="29.66567332662732"/>
<CONT_DATA CI_END="-36.3486244862961" CI_START="-335.6513755137039" EFFECT_SIZE="-186.0" ESTIMABLE="YES" MEAN_1="177.0" MEAN_2="363.0" ORDER="250" SD_1="142.0" SD_2="262.0" SE="76.35414563437637" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="26.674756800369806"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.738403126606455" CI_END="-0.45717196970840024" CI_START="-3.4530043360705758" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.9550881528894881" ESTIMABLE="YES" I2="70.31937741891639" I2_Q="0.0" ID="CMP-005.03" NO="3" P_CHI2="0.03441721654141938" P_Q="1.0" P_Z="0.010522905746593798" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="1.1574992755492912" TOTALS="YES" TOTAL_1="141" TOTAL_2="231" UNITS="" WEIGHT="100.0" Z="2.5581553956688143">
<NAME>Sensitivity analysis 3: Imputing means and standard deviations in time to bowel movement (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.7341203988304557" CI_START="-6.665879601169545" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="5.4" ORDER="251" SD_1="1.5" SD_2="4.9" SE="1.513231684135027" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="16.94302768847838"/>
<CONT_DATA CI_END="-0.7727413519471213" CI_START="-1.2272586480528787" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" ORDER="252" SD_1="1.0" SD_2="0.83" SE="0.11595042043908249" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" WEIGHT="49.88187862481683"/>
<CONT_DATA CI_END="-0.9778699624436995" CI_START="-4.0221300375563" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="5.5" ORDER="253" SD_1="1.75" SD_2="3.0" SE="0.7766112283504534" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="33.1750936867048"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.998551027126894" CI_END="-0.6871740611641819" CI_START="-2.2540521508540676" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4706131060091248" ESTIMABLE="YES" I2="42.845312058228785" I2_Q="0.0" ID="CMP-005.04" MODIFIED="2008-10-30 22:17:10 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="4" P_CHI2="0.1359650027760686" P_Q="1.0" P_Z="2.340606716451061E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.30176264049030366" TOTALS="YES" TOTAL_1="148" TOTAL_2="261" UNITS="" WEIGHT="100.0" Z="3.679097617021296">
<NAME>Sensitivity analysis 4: Imputing means and standard deviations in time to regular diet (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.102032123451476" CI_START="-4.102032123451476" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="6.5" ORDER="254" SD_1="2.04" SD_2="4.29" SE="1.3275918047351754" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" WEIGHT="7.740148434365172"/>
<CONT_DATA CI_END="-0.16448784565546215" CI_START="-2.6355121543445383" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="7.0" ORDER="255" SD_1="1.3" SD_2="2.2" SE="0.6303749273405533" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="22.853518868231742"/>
<CONT_DATA CI_END="0.440508247162696" CI_START="-1.640508247162697" EFFECT_SIZE="-0.6000000000000005" ESTIMABLE="YES" MEAN_1="3.8" MEAN_2="4.4" ORDER="256" SD_1="1.16" SD_2="1.44" SE="0.5308813097434916" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" WEIGHT="27.37793831509772"/>
<CONT_DATA CI_END="-1.4375927829080306" CI_START="-2.5624072170919696" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="5.0" ORDER="257" SD_1="1.67" SD_2="3.3" SE="0.286947730431868" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" WEIGHT="41.5975813706864"/>
<CONT_DATA CI_END="2.987396555302711" CI_START="-20.787396555302706" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="19.2" ORDER="259" SD_1="3.5" SD_2="25.3" SE="6.065109690315218" STUDY_ID="STD-Otani-2001" TOTAL_1="10" TOTAL_2="18" WEIGHT="0.4308130116189699"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.330215644997693" CI_END="-1.1210546143907385" CI_START="-3.124461179867943" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.1227578971293406" ESTIMABLE="YES" I2="43.22889232809269" I2_Q="0.0" ID="CMP-005.05" MODIFIED="2008-10-30 22:17:13 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="5" P_CHI2="0.09020932699583795" P_Q="1.0" P_Z="3.274933281345303E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.7448966118142887" TOTALS="YES" TOTAL_1="213" TOTAL_2="306" UNITS="" WEIGHT="100.0" Z="4.153454518883906">
<NAME>Sensitivity analysis 5: Imputing means and standard deviations in hospital stay (days)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_DATA CI_END="18.248728474244125" CI_START="-24.648728474244116" EFFECT_SIZE="-3.1999999999999957" ESTIMABLE="YES" MEAN_1="36.1" MEAN_2="39.3" ORDER="260" SD_1="31.4" SD_2="28.3" SE="10.94342990148235" STUDY_ID="STD-Araki-2001" TOTAL_1="21" TOTAL_2="11" WEIGHT="0.21676150318574078"/>
<CONT_DATA CI_END="1.1480551567568105" CI_START="-7.108055156756811" EFFECT_SIZE="-2.9800000000000004" ESTIMABLE="YES" MEAN_1="11.92" MEAN_2="14.9" ORDER="261" SD_1="3.68" SD_2="6.3" SE="2.1061892919045366" STUDY_ID="STD-Berdah-2004" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.041668564390197"/>
<CONT_DATA CI_END="2.9496981814306076" CI_START="-2.4496981814306076" EFFECT_SIZE="0.25" ESTIMABLE="YES" MEAN_1="8.75" MEAN_2="8.5" ORDER="262" SD_1="3.54" SD_2="3.33" SE="1.3774223418009117" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" WEIGHT="9.885943978463262"/>
<CONT_DATA CI_END="-0.8329606352074224" CI_START="-4.367039364792577" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="12.5" ORDER="263" SD_1="2.4" SD_2="2.7" SE="0.9015672628327654" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="16.768436734855076"/>
<CONT_DATA CI_END="-1.8411609071720907" CI_START="-14.358839092827905" EFFECT_SIZE="-8.099999999999998" ESTIMABLE="YES" MEAN_1="24.3" MEAN_2="32.4" ORDER="264" SD_1="6.64" SD_2="8.97" SE="3.1933439298868915" STUDY_ID="STD-Hashimoto-2001" TOTAL_1="11" TOTAL_2="13" WEIGHT="2.387106113147518"/>
<CONT_DATA CI_END="-2.1028298311881337" CI_START="-3.8971701688118663" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="7.0" ORDER="265" SD_1="3.17" SD_2="4.67" SE="0.4577482932791776" STUDY_ID="STD-Larson-2006" TOTAL_1="100" TOTAL_2="200" WEIGHT="27.36767345814953"/>
<CONT_DATA CI_END="-0.12119445665178263" CI_START="-3.3788055433482174" EFFECT_SIZE="-1.75" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="9.75" ORDER="267" SD_1="2.5" SD_2="2.75" SE="0.8310385069297331" STUDY_ID="STD-Marcello-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="18.19584701740998"/>
<CONT_DATA CI_END="0.35654829635361573" CI_START="-2.556548296353615" EFFECT_SIZE="-1.0999999999999996" ESTIMABLE="YES" MEAN_1="9.35" MEAN_2="10.45" ORDER="268" SD_1="1.5" SD_2="3.0" SE="0.7431505414602934" STUDY_ID="STD-Schmitt-1994" TOTAL_1="22" TOTAL_2="20" WEIGHT="20.136562630398704"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6036230188011613" CI_END="-5.895226325194573" CI_START="-9.675110308393075" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.785168316793824" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.06" MODIFIED="2008-11-01 11:16:32 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="6" P_CHI2="0.4371991805573653" P_Q="1.0" P_Z="6.825112774265989E-16" Q="0.0" RANDOM="NO" SCALE="13.349536306678317" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="27" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="8.073607328861181">
<NAME>Sensitivity analysis 6: Imputing means and standard deviations in incision length (cm)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_DATA CI_END="-4.262259961949256" CI_START="-9.737740038050745" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="9.5" MEAN_2="16.5" ORDER="269" SD_1="3.23" SD_2="3.75" SE="1.3968318089749039" STUDY_ID="STD-Brown-2001" TOTAL_1="12" TOTAL_2="13" WEIGHT="47.65544554707846"/>
<CONT_DATA CI_END="-5.887762132854606" CI_START="-11.11223786714539" EFFECT_SIZE="-8.499999999999998" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="23.9" ORDER="270" SD_1="3.9" SD_2="3.6" SE="1.3327989125057353" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="52.34455445292155"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.504273712823089" CI_END="1.7570106656477071" CI_START="-1.3786450239364767" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.1891828208556152" ESTIMABLE="YES" I2="71.46341633244207" I2_Q="0.0" ID="CMP-005.07" MODIFIED="2008-11-01 11:16:32 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="7" P_CHI2="0.061210807879626294" P_Q="1.0" P_Z="0.8130445936176229" Q="0.0" RANDOM="YES" SCALE="7.373579630067805" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.9147317290552581" TOTALS="YES" TOTAL_1="48" TOTAL_2="50" UNITS="" WEIGHT="100.0" Z="0.236500146749128">
<NAME>Sensitivity analysis 8: Imputing means and standard deviations in defecation frequency day (times/day)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5561474923891017" CI_START="-1.756147492389101" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="6.3" ORDER="273" SD_1="1.3" SD_2="2.0" SE="0.5898820088066133" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="50.676073696524064"/>
<CONT_DATA CI_END="2.212290814335872" CI_START="-0.21229081433587194" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="6.0" ORDER="274" SD_1="2.75" SD_2="2.25" SE="0.618527087180309" STUDY_ID="STD-Larson-2005" TOTAL_1="33" TOTAL_2="33" WEIGHT="49.32392630347594"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.502075878051376" CI_END="0.025600420878220786" CI_START="-1.3458028654924301" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6601012223071047" ESTIMABLE="YES" I2="77.78802430062935" I2_Q="0.0" ID="CMP-005.08" MODIFIED="2008-11-01 11:16:29 +0100" MODIFIED_BY="Usama Ahmed Ali" NO="8" P_CHI2="0.03385377941289247" P_Q="1.0" P_Z="0.0591886515359192" Q="0.0" RANDOM="YES" SCALE="4.422698220684536" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.19058065953654185" TOTALS="YES" TOTAL_1="48" TOTAL_2="50" UNITS="" WEIGHT="99.99999999999999" Z="1.8867894436751742">
<NAME>Sensitivity analysis 9: Imputing means and standard deviations in defecation frequency night (times/night)</NAME>
<GROUP_LABEL_1>LA-IPAA</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-IPAA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours LA-IPAA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Open-IPAA</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.18601651835272176" CI_START="-0.7860165183527219" EFFECT_SIZE="-0.30000000000000004" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.3" ORDER="276" SD_1="0.7" SD_2="0.7" SE="0.24797216795122667" STUDY_ID="STD-Dunker-2001" TOTAL_1="15" TOTAL_2="17" WEIGHT="48.556968241842185"/>
<CONT_DATA CI_END="-0.5735175797670972" CI_START="-1.4264824202329027" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="2.0" ORDER="277" SD_1="1.0" SD_2="0.75" SE="0.2175970699446223" STUDY_ID="STD-Larson-2005" TOTAL_1="33" TOTAL_2="33" WEIGHT="51.4430317581578"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-01" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Flow-chart of the selection process</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAe0AAAJQCAIAAAAsaquaAABBNklEQVR42u2dW7aiOhQAz5idDjNh
HKx158AkvCqQ7FdCUFSwqz66PRjyAooQYPt3BQCAM/MHADuCU+A7HqcXAPY6nOgEwOMAeBwAjwPg
ccDjAIDHAY8D4HEAPA6AxwF28fjYX/66wS8fumCxXHhf8c6lH3Vufuk3uVXZNeRey+cqKHO7f75z
/zsqJe5rXe7zNbm2FvrJjsXjAJ/3+Kxdfzg+voj0tywc++6hH30auB3bDyu9pKdtMtmuksm/W6oX
lHJr4daW+nK31yRXprjpPsJ3S8fjgMcbxuND3/duPB4uvGkleyjntQj9/TZ5RiXbTjNRKc+dqHYY
j8vKMB7H44DHS5Z6jPjsvEq48LZ2PwQjdil3Kay++xMjejUvMyUY5oV27iLJTuST6YY0n2OtqESZ
U+kMXTXGNGfS51VuddKVzBWVpQTzTVG5snpDWiU1LBxzj6oys0l1eeFsl1m5kDJKIDZZ/jqdql3p
eBzgGB6f1ayVHS6cZacP4aELrrflVLKel5hH7kuCNFexWDM7Yzo/qHzSkDDXaxyGsTCVkQeQ90/J
VVE1Uq7LwvT3XzBxJEsxGZbK1XIVYp1OHMLcnRakn6CX9QlKFyvKLvIpUwLdFbmrpd3Hcm/gcYCv
e3zok33EvHe0UI3ApXcey2rjYj1CzcM9ZcaH0fQwPBKoEH3kkpxeqE3lVq6GGJuLa4jIXJUMw3IL
3TIlFcv8xLz1uPrc+9IL57SxkFKemmXdhu6vtSZ4HODbHh/0jEVSoF/oB3p5kBeN8p347AyNFvR0
Rd/qcVH3Qrb6Jq1YWK7Gkx73GbrVqx5PubjBeIvH6zpduiicTcvTNZHH7UkSjwMcd17F67m60D6K
KCdPyx6/ukGn9N1sDTFF4y/r9bxKnxeVRCmuEvRCV40XPO4zjMstnTaCKZMNHh8qQ3nTRS6lmgeq
nzKnSTY8DnAQj+sJ4XaP25tebr4kmgbWqc0ydaUvBvh/YSIxQX7/q+vi2YT4HuDf5XKx9xLNvbx5
dl7dfEzTFvPqLgtTir89KcsNJpjMfeXYjEuTB3lLIU9mRz1tL7SqfbnUMjXSbwtZoi4djwN8ZTx+
FP6Ne2UbuqOjM/A4AB4/L8+83wR4HPD4d731909cm7d2BBbH4wDnG48D4HEAPA6AxwGPAwAeBzwO
gMcB8DgAHgfA46faTmwpPA5Q9gMA7ANOgS94nC440cmWrgAAPI7HAQCPAx4HADwOeBwA8DgeBwDA
43gcAPA44HEAwOOAxwEAj+NxAMDjgMe31gcAjvACMB7H48/Uh40CcJxDiQMSj+NxADwOeBwA8Djg
cQA8jsfxOB4HwOOAx/E4AB6Hn/F4qVA8DoDH4Uwe90W31GTsL3/dYJfcufTjtGDoRP4ibVo+L1tW
NPmFRd4yv6++kvIJ5sw3pmlZ69O8o3+WTRbnG5X4pp55bjPhcfhHPC4rsFqT2bzy2B377nHoZL8P
w5AP9Jx0SSjyupg1Kyp50/HZkrlP89YqHYdlCxk/yo2q+6kb3tQzz22mUiWfr0X7ungcj3/B4+01
KVp36NwxJNU9j+xSmqTx6bva8ffWcdbvjMc/0zOl7b8sP/R4fGXI8NyOj8fx+PleJi7szmPfD35Z
Z46qx3jej8ILHk/zLg//D+oozd/l7OJJG5Hg0vfdkkJnPoYzRFEaqYxBptezRu7KZaXCpnpursou
EXNNcx7SYv7bYMbLNCl9l8bgfmpMLFUliuWXi5Kpb0itQ3ydy5uglIPaKDJN1/nKLx1us7IbSDcc
j8NhPX59dn7cj7VLGl8SP9YXk6uhx/P32T5yBL8c6MMw5gySWlKC6StrNJ15Wnf6MOcWpdEKEapI
8k19o5tfr3Dv5KVq4pboc4btH/+tyc1vRDEr1ulTS3GzmHmMZblayzfEd0ipRWubwOYQbhTf7brL
8g6os4r3KMbjcOB5lU07X+26Opw4L08zitFh6As9utTjcWWRfLSWzy/KLy5zMwKdFeDSFC7h/UHv
J1NXKmxH0/pGcbyk3D9j+DlPZdmNGKZf8bjv0rBi4R3vtQ2Ux+blTbCyidX5YVlaqrzLKtij8Dgc
1eNP7HzlaUKz75fuCt0ycIbrhtppIfK4OPKUctVX9/XlYE35xR7PpmFhmjWPp1zK1yKFCtvq+UeC
/JKtHg9mn0S93uTxkvpWN9A8Q1LcBPUc1EZZur1aeZVVYY/C43Asjz+981XuczZp3NwOLR4dZird
eHzo8yFoHkl8zNTn4zA8yF3mwWA6TNOg3fi5ibUKu+rpYb1b8ozHgzvRzonxxcWTHq9cn9Q30Py5
ugnWc7iLu9jtMrHP6uo2EB6Ho3n8+Z3PPgJeGeFF0wr+nlvl+YKU9f3WmZmAEVMyU4b2RlW+a/dY
OWXh6j1/o+99mjxlGlu5YMIgusCoV9g9Se8frVdL5B968uLe+uhbtTyqt92QucKmLfMXXW/uYOp7
qOWG2A7xG0jUubYJTA6mK2wr1Lx4qrxNlrLye1Ral/uccHaPwzrFGwNfr9j9Vl95fgsOeChxQOJx
PP4NXnnT5L2nl4u8+EHjeBzwOBTmnI5rRzWv8vNvo+JxwOMAgMcBjwPgcTyOx/E4AB4HPI7HAfA4
4HEAwONwFo8DwGdCh+JxPA4A/4Ai6AI8DgB4HPA4AOBxwOMAgMfxOADgccDjAIDHAY8DAB4HPA4A
eByPAwAeBzwOAHgc8DgA4HE8jscBAI/jcQDA4/Atfb8pRhoA4HH4jsfpGQDA4+dWOd0CAHj8xB6n
TwAAj59b5XQIAODxE3uc3gAAPH5uldMVAIDHT+xx+gEAVq/aAeAQP38OsNnj9ALAXocTnQB4HACP
A+BxADwOeBwA8DjgcQA8DoDHAfA4wE4eH/vLPWU3TH8OnXjQalm4JBJLfot7q59p2r1fLv0Y5PZS
Z8XZtiR+tiHPr/glNnURHoef9vjDOPLwHYYhf7d8cTtmpkPmfvB85GDPZR/d/n/WJktnPS+aMNtd
Ep+0n/duNR6HH/J43TRj383fJY1PB9D7j56PnS7eMCrcZZz4/Hj8R/uZ8Tjg8cpR3HWFGYCscXW4
W49Ph1MvhvXLFMw92fTtMC8RhaTZm0s+Vyz5mGmdNKWjCjblykKXWk7F3paMywe1tswzSWH+4CZG
TP4iA5WxXNwNcWN9j12v0foyczH89F0qjWY/q6roVouybt+7yZlg64zRfFF9B2jYFqY4Vcb0R7gb
4HHA40njwyJB4xShcTV3qj3uD+w0dhfz7Mk/c7p8XlimdUw+cq729nnxwzCMcbmy0KybJKvlQ6pl
ylOmF57KEknOkPmL+uU0pXGiaay3vPaZzHbwgl7ykF2aS5SzDWlDpa9Nq2WBcsXy1rHdsroDtGwL
X5zeVH06G+jK43HA42uzJUrjgZVL2tIDyq6PbsGF48fyzbp4KjQeeMohahrF6Q+2Sbr0Yt1k/qK3
VudVfIZDSUAu26Gto/ooWT79RRPL1uMtPVBocn0HWN0WY6HyyzmlH9Y2GR6Hf348XpgtKd3/8nYI
DmORwkpnOUq3eFwcwYWcvaNXPJ7u7rrBXdFipminv1KH+MaWPO6zbfJ4IVlwH8O1OvT46tZZ9/iW
bREWt6RYBuPVTYbH4Z+fHzfX4FWNh0+mRdMIaWL0MVT0MzLiIRl/9e/mVfq8tKQPXejQ4A45d7vq
cZt/miBouc/pGlsUkM9Wz2e5+akgQz3Hkge9/RC0OvT46tape3zrtgiLu7oHqSqbDI/DP+3xa/FB
Z6vx4lNe0WPlcpm6yo7SiBlzO0Gex18+A1euWpCeiM+PxuuH5PONtcsl/Xv7v+t81bPIovrOq5pJ
oEJlVY9E1zsu2y5llwqyXRp1t6nzn7ljMeUlOnc63wYr+q1jbmKu7QDr2yK4H7ssVc/Dxpvsg4/b
4HE4qsffzccHTb8PXfq9w4lOADwOdCkeBziZx/XzakCX4nGA843HAfA4AB4HwOOAxwEAjwMeB8Dj
AHgcAI8D4PEf3U5sKTwOUPYDAOwDToEveJwuONHJlq4AADyOxwEAjwMeBwA8DngcAPA4HgcAwON4
HADwOOBxAMDjgMcBAI/jcQDA44DHt9YHgBEGHoezepyNAuwPeBzwOOBxwON4nOMW2B8Aj+Nxjltg
f8DjgMcBjwMeBzwOeBzwOB7nuAX2BzwOeDwod/txO3TiyeJumJeO/WVacunH4qr3RLXvy+nvhaay
4CU2bgU8jsfh6B73pa/UZBiGbPSk1ptnH2qoOWI6AbQbZGt6u/Z3vP+tcq/v6lU8jsfhNB5PdWiu
ydh3iw3u+p70tQh95/H4M2POb/j0W+UyHsfjcAyPn+w9bKHxeVrlJrChiwyRJl2mkaAcEi6fh4dc
hjnhrMJkHKOenJ9ImKd1RHG375e/bMWmPPvO57Lk4eqjppVExeZMVLm6SuVyTfUe58Gp2NuScfkQ
zWvdFy9/PCo4/THVNWi12Qp4HI/Dj3q8/bhVGk9+icaieW77/sl52ellOSekZGYqIA35Uy63JeZq
IJV5S5OWSHkpAS71kKeWqD76uiO4S5DLTVW6jsMwXkvlmurN36aT0fJB3YYQFZhPU3l6q5+aGLQ6
2Ap4HI/Dj82rbDxurcYffyf3GI1LZYceX8bjo7ZhmD4b0p8u1DBfjnatb6+VMf4jZV+tT1xtZ8vQ
l6VzWC4incP0h2tUgVGd1/qhkG24FfA4Hoef8fhTx62+nZfGf36CWIxmt3hcJzMeD04VUxluPF6Z
rw48LlKOUX3kSHbN4+Lcoitg2+6/LXvcV2DMKZbBeClbtxXwOB6HH/D488eteSpDX+4HCjETITLZ
5KZBiMZPnIzR6Pi6DEHV5IGfV8lf1sbjJmUf1UfOHU0Lx5LHs1TtLQO1iqte3eO+AvGclm91uBXw
OB6Hk3v8lePWP1xXe348f3e5/OWR859a+OfmP+xq2n5/f/ZmaUop8hf3OYPLhD9vP7dWKU0h66Xc
rivP5qilasH8R7pLmsvwD+r/mQui4OxZeML/cvn7a38cH4/jcfhNj+/P848Y/hv1+df2B8DjeByP
43E8jscBj3+SNDFykHdojlYfPI7HAY9z3AL7Ax4HPA54HPA44HHA44DH8TjHLbA/4HHA4xy3wP6A
x+HHPQ6wOf4l4HE8ztECAHgcjwMAHgc8DgB4HPA4AOBxPA4AgMfxOADgccDjAIDHAY8DAB7H4wCA
xwGPAwAeBzwOAHgc8DgA4HE8DgB4HI6lb8LLAQAe/ymP0zMAgMfPrXK6BQDw+Ik9Tp8AAB4/t8rp
EADA4yf2OL0BAHj83CqnKwAAj5/Y4/QDAKxetQMAvxwP5/Q4vQCw1+FEJwAeB8DjAHgcAI8DHgcA
PA54HACPA+BxADwOgMcB8Djg8aGbH43thmXR2F/sorz00o8/2Vf3flDtbeTeLb5Pll59JsfVzH+i
3/A4wF4eH/vOauLmjkkdd4mkI/R2uD6WqoXv9cMZ7DD52qh26cFXLRxmvmtHnaOT8Tjg8YbBuFRF
0riQ9+PTfMR/RuQfO13sUlOt2h0H0etZvdJR5+lkPA54vOFwzraQB3fyeLhQuabv8izCMi9zTzZ9
O8xLhDXSfM6Smcgn81ghzfPYE44sVxa61HIq9rZkXD7oRosVkjHnD25ixOQvMlAZy8W5tbqxvsfq
tRpU0SJN111EWTrboNPyIvW9qkS1V1WnzFcLl0vU/MeiOXk32B3ipJNzeBwO7HE93pYTntLjwSD9
eo0mglPaodOiexzBU7p8XhhmY5h85KyruBYYhjEuVxaaLay8YaeJUvkpvdB3VpXpgLn1uX45TWkQ
bRob2TOu1aJF4e9uML2RKuI7UGelT8rJs7oW9V51c223r+2JQqfP+43Yg4b+pLdY8Dgc3ONqptQK
uOZxpy05IL0JoZffLuKQq9iBsDuZlOaJbSbakEk4/kM4qxRWQy2U+Ys+WJ1X8RkO1dmSsFbX4Jxj
O8rXRGYlztTya7us3qta6f2wnn4pdsgj/H447+GEU+DIHr8dgm58KI/8yvx4oC3xvbVzGghu8Lhw
UiFn7+gVjyetyJFv3eOm6LI9zRLf2KLHy7WyZ9DUGyWPu6zs6bfR4/6qYV46j6pX088TXN3jBHSf
sTnvjDweh2N7fOjWjnF/pVybRkiT1I/xuBvKZctEl/tuXqXPSwvjXFPo6nhc1aTB4zZ/Mcm7fp/T
NbZ097JSK+fPpTcKHvdZqS6dBsVrHve96hrUkD6f9PwUFB4HeNnjwbPj5afd4ufHo2fN5TJ1rR2l
ETPmdoI8jyj/1p9xVwvmP9IdtlwRnf10n275V945FFU3txdNfedVzSRQobKqR/zA1NTKdJ+bY5fz
4tMJM0iWsgruF4tObulVf/Vmb/4WdocunYq6M799gMfh6PPj7+IEb7IA4HHA43gc8DjAj3o8nLgB
wOMAJxqPA+BxADwOgMcBjwMAHgc8DoDHAfA4FLcTWwqPA5T9AAD7gFPgCx6nC050sqUrAACP43EA
wOOAxwEAjwMeBwA8jscBAPA4HgcAPA54HADwOOBxAMDjeBwA8Djg8a31AYAjvACMx/H4M/VhowAc
51DigMTjeBwAjwMeBwA8DngcAI/jcTyOxwHwOOBxPA6AxwGPAwAeh7N7fOjmKndDceHYX6Y/L/24
U83uWbbl1pKyPbcm7s2X3fGGorcUEW6veOVCtjv3z0E2Ex4HPD4fWZ0/rszC9OddEvschpOMWvJq
Sdme20pRDwPOJ602ye5U9AZZPsryQpwrH7boA5XcdTOFbdmwBfE4/Fsenwd3VgmlsfddHzsdKYcb
j8u2fWA8vm+nhRtGLDzTePzpnWzHvROP4/HTzY8/BqD28CotLGokqT+NZ/XwPc3N/KVR7+1LOUYz
47W8gs5Y1sqliaeMlq9UoVLVIp/7wsnjurygdJHnYL/NOcrC0xJhNJ8ybsIg2qp0JSp/uVxMdafE
UqDjelXj5XHv1TZBnEOtr7rOtKXv/Oyea+LcQrt/qd5+VfF4HI8ff1LvdnD6/dwtHLpI48nut/Ty
w9j3g8hKySCbxSrmkudwpsLn04EvxaeJR2fDrAI96W9XkWNwcUaZqxSUrlwlzLLkngpPKy7mGyZZ
+eXDeK02oTienSpvToSiRXnFcGOFFTBNiHuvuglcJ6z01VQB2RZpX18fvUfZLVjqVTwOP+vx6vxq
1eJqQPZXuJD3p4kVjwtd6kGcdklwAggu4dfOGaHH1ec+amM0V6A0ryeolGXNGas4i+U7oeJxU5nI
49HGqs1byyYEvVfdBPUc9JlEVCBsi8ut9wMPNRu2+z0BPI7Hj+/x20HjPa4WFu8hhdOSN+MU9dbg
VnkhnBWmS/Fp7CT/vh6vNN83dLkGsC2f9OJH1svya7UJ+3g8bIivgGtCfF6pTMFXc7BdkypQ8rjO
rXd7VHBXI+pVPA4/6/FwqC0WZqMHD7ioseV8BM7/RU65PuZb1NB7+SqbS0zP55kNXUqQJpRIMKmz
2eODL700ajaXCnnQ2ee+kEbWy+tNGF/2uN9YpQr4JgS9V90E6znMbdMVKHjc5ub2KL3Vyr2Kx+HH
PN7y7LhYUHyEPF2tL8efuPOUjzV740neVcy3ttyNqrRQraTzlCsGEz7mPpm4LeYGhGJqdpn/LZUe
zCuZy/pUMzk7L6ZpZAnhwFE1IacMb2X4TbS0qFdVtw0pVcA0Ye5i23u1TeA7od5XYu79r6FL3f3Z
tAVtntznhH9kfhwA8DjgcQA8jsfxOB4HwOOAx/E4AB4HPA4AeByP43EAPI7H8Tgef/B0iNddSvlM
6Qn5MJ1+h/Wv/uj4mzruhTyOFaW2Hu8XjwMe/z2eiWG7p3Lkyzzy6ej4xdnCK5rlrz7mzYN4vBzv
F48DHv9Rno1h+1aPR2+zPF5kjGtY+eqDvXgMj+9REzyOx4/q8TgSqQv3Gl/3By/a5fcIl0mB9Maf
DmCb5wzKIUmXmKW9OghLL/HpSEzhRXR63U++zLm8Wa7fXF+JYRtesMsK6NbJeotYj8Ur/djjQSTh
OaJk9Psela+CwlY21nhdDUfcGkzYvBx8j1OrgtPq/iyENS51cnGLlF+ExeNwco+HkUh9uNfQMEHg
JRMeVkrSplKH2LRKFCI1v2AttSbjkfp8K5FpZcQXEfvlHoqjHPE1iGEbj9z9m/Fi/Cyjxa5V0nn8
r6ShFBg4CvfYN/2CRMvGMucUGY54azBhfVbqujAQfDFUrzn/uYhqcQ6Mx+HfGI+bYXI5Emkl/Gzo
dv/hWo7ltBIiNZp23Vr/3IJ0jC9WKtWq+LmhA1X4qj8dXmWlktG8SvE87Ie+la+Kc0jrGyv8c0sw
YX0itT9w0b5BixurIV4xHoff93gfhXsNBZMPohc9voyw6iFSfSBAc4nf5vFlGqGbY2f3XRR2tdnj
K6FlZXPEeuMuHs8h/fzJrvzVax434YjHjcGEr6WfhWrrz6LHqzngcfjnPD5G4V61t3yw0Cg8bF0N
Ygyufo1g1eNBjNNiZNf46FW/Q6N/W2y7x+PQsrp1Jveh22U87uIH57pVvnrJ40E44u3BhEth6Ev9
GYY1jju5lAMeh5N4vFRotSaFOK7BncxwPOV/d1Lds0z3Bm0IW3UxbuaWqyFSzYSBzU2GRY0j01oD
yk+XMOJrIYbtygAzms/OVeurlSw8Px7/IKcP4OuLtl+FtS9sLHdDuBKOuCmYsK9nuaN8XF0fwTjc
S20OtXi/eBwO53Ff9BGfOzzW6yH/WOvkTcpvFK9+LDP8EaqjdjIex+Mf9bisAB6ndfF8zZf65qIn
7k/0pige/xc9fhyO55LXr3EPy2+3bp+zXNNTNMfrZDyOx/E4wOkPbTyOx79jcDwOgMfhSY9/9/yx
+84HwKGNx/H4d8o9gMe/F6qp8m7Mk/l8NezUuTofj+NxPL7XTvY1jw/dt/WhY4O4d2OezAfwOB7H
4yfd+Z4YwX5/GCjG4y89Nv3bD0oCHofze9xFnQ2DgpoXD2Vc2cG846njvrr33YOydARX/8boVVXB
vPY9hDHz/kzSrPEozGzf1d8L9NG7osqoKtfee41WKbXank76LnjX0vzazRJ+xoU3SOmrIXwL9efQ
xuN4/Jg7XzHqrI5jYcKT+njlJp5FmpaVkxLlslS4ExOZVp5voti2LlRKEDc1a7wQZrb+e265YlKb
JnyuCd8a9klllVKr3ek2n1dNieoa6HEzwHS+Tl8M4Wt6u1QfPI7H8fhBdr6xLSho78KThqEQ9ejQ
Br1bLWv5XJuQXo9tG8RNzXZaCTNrSqrV1oXPjU4Kqk9WVlmfho8G1/Z8ai4/VM2DoDZxCN+rqy3g
cTx+3J1vPchn+rUYH15Jz5bIqLOhx1fLCmZgZKFtsW2DuKniQZWVMLN2TqV2KpKVDG4H+D5ZXSVs
dcXj0U+5PZYG560wfSmEb2N98Dgex+PH2PlKQT7NEM+FJ5VO8VFnQ4+vBhR12lVBTltj27q4qX1f
C4tavIcZxV8VbdGVdP0T9Ul1lUKri+dOHzDWts93i0tfCOF79bXlyMbjePzIO5+PUhsGBVXhSU2s
UhN1Nv8aW56RsffyTMxZGcH1Uvg1xebYtjZu6l85zKwPuhqlnPNZspMhbMOmxH1SX0V9O31TCI9b
Dhg7L3UBZE23qBixXeG5zNX64HE8jsePvPPxmN0R+HKA2cPXB48DHsfjh+bbAWaPXh88Dnh87ZAl
8ioAHsfj//r7nAB4HI/jcTwOgMcBj+NxADwO/7bHRQCT7ZPl1bXWbqXen17mdivgccDjr+18hRez
dwhIu/bK9/1Z5n4ljX75hXuygMcBjzeOmncKSFsda89PKtfSyGocI0Yu4HE8jse/tvO5gKs2Xuug
X3kPXkHUL8dPgVV7ZeFCyNnoq/TCifF4rucgqtHrKunmuJi0xGIFPA6/53Ef/tTEazXaS1+Wg9Bm
xV9cEFQfGsXFR/Wx+oJ6ysl3+VkmC8MPEosV8Dj8mMeDcKYuXuvgwtgOG4LQZgohZ63yizFmZT0L
HjfJelsHYrECHoef9HgQjkmFKgw9/kQQ2lLI2SxYFXK1Gqa14nEVBSqaYScWK+Bx+LV5FRPO1MVr
DT3eGoT2er3WQ87q+KgyxmwtTGtlXkUks+NxYrECHocf9HgUztTFfZWTEemHHduC0Mq5kzDkrJzI
7kVIvZUwrbka+rNI1ruG6UlzeeUBgMfhxB4HADwOeBwAj+NxPI7HAfA44HE8DoDHAY8DAB5nY+Nx
ADyOx/E4HgfA44DH8TgAHocf8TgA7AIex+MAAHgcjwMAHgc8DgB4HGr6ftOcGgDgcfiOx+kZAMDj
51Y53QIAePzEHqdPAACPn1vldAgA4PETe5zeAAA8fm6V0xUAgMdP7HH6AQBWr9oB4BDhMgA2e5xe
ANjrcKITAI8D4HEAPA6AxwGPAwAeBzwOgMcB8DgAHgfA4wB4HP51j4/95fFc7KUf07KhEw/MdsPv
dcu9gU+2695fsq90j23LtLqWLCgu9IS9h8cB9vf42HcPPdxFkQ7NYRjyIfuRA/ZDxeyjsD+r1Fvn
PZZss219LVlQWOizXXearsbjAM3j8XR4R55YNP9e1Enk6HjtPjdYXl2raTy+tetO1dV4HGCLx8e+
Hyqj9cAvfTfPB5h5menbYV64KCNN1Ggx9Z165fmReslPD0BNoVdd7i37pczbn+PyQa0t8wwUqac4
gsmmnEdx8VyzWmNN5Ze1otH3sOpxkcstE1Xn+Y9uuOcmc7GTZfWONVM/c9Uul6gH0ubsBpnF4/Nx
5oTwOPyox+dDNfJEtzYRvEwOTCpNNswumQUzJR9mXZhM5Hzr7fOS9TCMcaGmXGHNJA09T9Tl8lMl
zerJU9OJQDZKV1GKMRhZrza2MB73p5ahZTye6uXrPH0wZ2gztV3v2Esw5Xb7Wu0sOv2w/JWX39f5
EYvjcTj4vMri3IZJFWscPZ5WxnlYo4985JMNSi1WWoH1RLn9oprRfQjPVqUpC30xoQVfVmo9t9IM
+L4e9xsiXsvdoqx3bDrPLkrvh5UdYDlnDvl6rR9+6XDCKXBcj8uBcF7S9ByFTmQFPV1tb/C4kK5Y
FujGfFvxeHLKIqR1j/tGleUolwyrjX3J4/nqw1zKhPPej8GzLrjF436rz0vngXV9B5jH5d3juue+
9X9pOh6Pw7E93qxxP42Qph7SwFCP44Y8+aou1kOP54twdefVqlCXWx+Pq9mRBo+PrlFyknflPudq
Y0stEp0wnQw2z6u4DTH/VyilpWOH69U1a2UHEHuAn4LC4wD7ezxfFvvBXHk0rlYwC9SFtktjE+k7
g/mOn5+0dbXMy/rlnl66uZdv88nspzt0y79iQt3fKPQFpiXz2mYe6C+6hxk3Nl5LzfRfdB+GOei1
bCp5b0KtKLp6tWON7wu3gIM9okunn+6nNI7H4ejzKjtxrDdWAPA44HE8DoDH4V/yuH6MDwCPA5xv
PA6AxwHwOAAeB8DjAHgc8DgA4HHA4wB4HGAHjwPAXuAU+ILH6YITnWzpCgDA43gcAPA44HEAwOOA
xwEAj+NxAAA8jscBAI8DHgcAPA54HADwOB4HADwOeHxrfQDgCC8J43E8/kx92CgAxzncOCDxOB4H
wOOAxwEAjwMeBwA8jsfxOAAeBzyOxwHwOOBxAMDjcGqPj/1lqu+lH+XyoZvb0Q3n3Rj3xpl2vZCy
Nbel657suerqqQ7tTfsQ92qfeV/B43Baj499N7ngfhQKLaTlH5PAGxQwCbHdvPWUjbnd/Co8229t
l159LNWhWpmtnfmWzsfjeByPf3bHWgZ66XCeh4SfGu+pss89HldptrdrtYj18fjWQt/W+Xgcj+Px
L3jcaOEx42JVsQwz83X/MjFzTzl9O8xLhB3SLI0aqz7SpIkd/Yd3VC5oLqAbzFWEmCWaCp9lJ0ev
ZiQrSs91M+W7NNeowNs3MmHXy3bZbH03mnK6Lq7zisdVZ9qts/wh+s2lD7eyrrya95n+mBu41Eel
n5PnbbvsKKnHfuksgsfx+Fc9PnTR6O52EMqjzE/dJv0nU0tDZJdMn0QimUmaWs3FjcMwxueZW5pJ
zQ8N9IOu7ZRmkUpoPfE5z+nOZjOlhGnC/lnSK72mVX3lCzPghXoGDSmOx+U8tW+O7zc/r22q5zPR
1279bZk8O7r0eYggBguP1RiPAx7f0eOxxa9+7tToQw4h5zGos5j30WAcpFUZzueYgoZIZOakU5qF
yJ+zrM2VhB5wRmINvFf2eEvl3+FxX27Qiuj+ZDS4VpkIpfeDr6FNv2yZIY/w++FXD388jse/s2OV
b3TdDspVj4sE1mLpwrrV48KLvlwzaryN7bTJhHKbPC4v6nPFfLklA0oxVcfjY5jtbh7PVzlzTWSF
3Za1/dbi8fjC4bY0j6pVxXyh3aN3u/lCqv/ZO6t4HI9/Z8fKqvYPqfhhuhWQ0sk0J2yHbFl2+bK+
4PGsBVeyK2gWZOl88BjxqaG3qJiYH9AzMbqUIUwTTeSsz6vobFs8HtZ587yKK9f225rHfSbmFGZT
henz+TCYncLjgMdf2bHUhHU6vIrPjqdrZjMGt3fzimlUIuOEdHOvMncsbiHmnMKC5G3HZZg6f3O5
qBuheqGvnU8T9N/8nZ9PiBoddaMfWAd1TqWkD8G4Nhdqt9gY9ptKH27luL7yWk3fCY13ky4N8PNw
gfucgMf3mx/ficO9nAKAxwGP43EAPI7H/xmP/8Sr/AB4HIiTBYDH8Tgex+MAeBzwOB4HwOOAxwEA
j+PxX/H4cgvzop/8bQiKaCJf6be2/wqxWQs3Sj8S4vqFQrY9rhMW9EoTDx4BfN/qPV71f3639K+d
mrv0xUgVeByPn3s8Ph0j6t2OtigZ5oX58E3P9OX9tfH4eK98dRRPPf+q4v3VR/9e0/vXfX+vvCey
vFX3pt0yeoHMBdx/KqAvHsfjx/d436v37172uHuf75FjPHCrfHUUnn98PjnjiQa+su4nemT3Kpl4
aM/tlrpmhYD7PvIaHsfjP+DxQcXHsOFPSxe0RY/bEOdzhlEIjspX17gOYYzva4rZdJEv7+vRnXq7
3EY53xCgfDX0tnmNfY5MoNNX29iyrg8Q7/sk3IJhNPlqIHU9iTa6COwqqEtQlo7oGwejd4HyC7ul
ncELIjgE0TH/bN6XbSdmPI7Hz+FxFbSpt4H1hkgR3uPhoRUEQW35yh2YxfzNyCsdt3ZVE7JRnq42
Bigvht72BcnfZShFwgr7ub5uFCA+GGP6nNXcs4jMUgmk7qKxh3WrlKUiacXB6KPYkaXd8okrBTsC
3zoix+N4/PMeXxmzFDyeDutlQSna6vq8SjwgLI5sy3dHG6KcuyPYf7iGgXnL8dYbApQXQ2/HoQ3l
3IibJylGUS+vWwsQv5azr2HfFgVe/3ZQN5SzrS4MbzhEv1sV7pbbx+Nz9W2XbxqQ43E8fpbxeL4G
vfRuHPq8x9UvxOhsKl9JfbzB4yZa97g1QHk59PYTHo/7edXjpQDxazn7aPJDPZC6i8Yeeny1rGAG
JvgBqvXd8pnxuA24j8fx+K95XA9VRh1r/M9eUm/0uHtgICug8pUdB9ainG/3eBCte2OAct1Rat7l
CY/H/Vxf1weIL18LmZxHH02+GkjdR2MPPV4sy86Vh8Hogx8UKe6W2z3unjZkXgWP/5LHw+dyxRFk
fuA4mrop/7BvJea3vyQWX0U/DF2Jci4TyQf1xFNo7oakj3K+LUC5Pg/JT5c45HtaGv+IZ9TPK+ua
uO2luTOfcxhNvhZI3URjF2HfU9H27qyPkp56RkR0N6JeeVy84VFH97B4OeA+9znx+G+Nx+Hf4qhR
iLc/Dfi5kvA4HsfjgMcb/fr+ivEeEB7H43ByDh5N3v0C+DEG/Xgcj+NxgNMf/ngcj+NxADwOeByP
A+BxwOMAgMfxOPHHP8uXH67Iz3Bv76J9Il8DHgc83qbKp+KPv6LHrjUy7hdPKSaA49ZY2PtEvgY8
Dni8xeNPxh9/5cTR6rPvjcflE2rbu2i3yNeAx+H0Hi8VeoT449Hb5KsRqPsgenUOnF1avTTbUQrA
bfKR4/rl8xCF4ZZNcwHUoy6qht/bI/I14HH4EY/7og8Qf9wHQ2qPQK1t25WLCzyupztEtI/WfNzv
Q/ggTC6e4DOxsMMROCNyPA7/tMdlBb4ff9wLqTUCdRgtryVYth3SZttuyieIf2tjEJphc7GLGrr6
xcjXgMfhjT79OnuPx/NMQFP8cR8MozUCdcHj68Gyy/M5m/KJPa5KKXp8SyzsJTkex+OAx9/s8Wfj
j8sxbJ5AbolAHXt8dfVUbhwMvJqPrO0k+sGH4S7OqzwXCzusLPMqeBzw+Gzwb8cfN9/6qedKBOrp
fmQUOLu2enHWKP8GcTGfZHcXArvUOj15szkW9n6RrwGPw/4e/+75Y9OO9aPIn+d9IUDe2hONbxk4
MxrH4/Ave/yJHes3LW5nrp+Nc7r+ZPre4bB5DwiPwz/r8ad3rN81uX54/MmBcUsY7h3DYTMUx+Pw
r3r8lR0LAPA44HEAwON4HI8D4HHA43gcAI8DHg+xz2K33Ta0b7F/h3eFQgxb91qTj/sT9V/kldju
8/pzlJ73dy0ex+NHH4/rdx7LtmoNGr73ujULvP8Ivtd8tsuzTfhuFPX3bYJXCnoptntazQVGw+OA
x2tvnL9yrLznOPvEIDfV/Ozj8Y89u95U0Gux3R859Pe3gtXbuu9sHh7H4+fxuIiXrV+5H4Og4fpF
fJGDjDY+XM26wWW1vBjQ8cPVy/wi/ynOeK/kaGMEjJXw4nNR+YX+1Mbbh9w6WfOus+kL81PzS/+1
WOdp7ajOJnsTYzcKpD6uboU+3gQ2aLvOp9iBesOpTNS29lEbcrnrsd2rgSQfQ36t7vcGPMDjePwE
HneHSjpGkuRN0PAknvStEIeKNh4OZsPI5moodxtwjaX8faxaW2H1w6PBVYYKn5ICJfZalIVWxyHR
FxMOwxjHVlSyXvIUa9nG6g6pxY9s2Qp+E5ig7WZrluKzmw33F4axiVpXHLFvj+0+JzBD8LeOyPE4
Hv/8jrUt/njx9XP122RRkEJdzjL49qFunURK4cKFwfyYrJx/VOGxFl78Ku+Spaz78PTg51Xi3Nxw
2Hg8V1WdG//+bDwu2Vi/UukksdJL0byQ6UBTgT7qh7Wmyc4p3RZoi+1e3ocfZ3gv7rcOyPE4Hj/R
/Lj20vxTO3WP+3F2g8eLkc3nHOdDtTX/qMJjLbx4Wjbcfw358anvSqF0WzwuZD5NKDR53K3lRsyt
Hl/tpUaP64kK34F+w5U9rlrX4vG22O76R/3UroPHoVXl/4TH1SMsZY/LY316SqHR45XI5uqZmcb8
owqPtfDicvhnTitPeXwZIs4PwYWxzmW19cByXss11hbqOnOud0svNXjc9HYfdqDbcGPJ46Z1xXmV
p2O7M68CeNxdSxduQl4ueaCrbpqZe4Hqlqa9QZluLEYl+1+HM6PCav52tnapsLouLz2C0yXZdfF9
2+Annf28skqlf+Y53fYUIc/9b1KXw62r4s0N4ZSrCcBej/k+hD0bLCt1oNpwQSbLtu66Uve/GNs9
Fjf3OeHfHo//Jr/26s3eQXS/2oH7j5157hDwOB7H45/twF2bw3tAgMd/kcbw4qdrzsdU/oEO3Cu2
+ycCu+NxPI7HAU5/7ONxPI7HAfA44HE8DoDHAY8DAB7H47/l8eDl5+iWUe2NnhbKa9UeingpPrV+
hOETIaoBjwMe/9Z4XBkvvxBjfRq81/7yUwKVwNwvxacO4oV/LG4r4HHA49/1eDmJjz26hxcL4/HX
41MH9fvE82mAxwGPf9XjbjBugl/LQKk+zm0pJrWSdRwl3AfzXo9Pfa2HdYzOM+99dRvwOODxb3o8
/HlOHYE0+BED78xCKHO5lg6OFXn85fjUxesFRuSAx9mWPxl/vDQeNz/3ZrQbhj8sxDI1si5GCY+H
zYX41E+MxxmQAx5nW/5T8+P2d2zLHl+NSa3XKkcJX/N4W3xqPA54HP5tj+egF+bHOsseX41Jnf6M
o4SvzKs8F5+aeRXA4/BveLw+AZMf1tZBtH1I8VpMahnR20QJT1G5Kz+e+VR86jjKE8NxwONsS97n
/BRvGTgzGgc8Dnj8sybfdezMe0CAxwGPf5y94lMzFAc8DngcAI/jcTyOxwHwOOBxPA6AxwGPAwAe
x+N4HACP43E8jscB8DjgcTwOgMcBjwMAHsfjeBwAj+NxPI7HAfA4/JseB4CPgcfxOAD8uh/oAjwO
AHgc8DgA4HHA4wCAx/E4AOBxwOMAgMcBjwMAHgc8DgB4HI8DAB4HPA4AeBzwOADgcSC+CsAPxkXB
43j8m5VhiwAc5zDhgMTjeBwAjwMeBwA8DngcAI/jcTyOxwHwOOBxPA6Ax+FnPF4qtKUmY3/564YD
9eC9Qpd+bEk6dFPLj1L/e30+XZem7ipUbENXV3JLW6Frbf6T5eJx+Ac87otercn9gNrXg0P3WmaT
FFoO8lvdH8kOJoXP9mR7d+2xblClJ7bCK3XG4/BveFxW4OPj8T0yazTCr+p7a0++0g/b1o2q9Fzp
jMcBj7d4vP1FtaIwpoNtmEbsjyTTkr4TI/jlmvp+WM6DezHAl9/K8b+8BAjT+INcJxNF/UVDRF2p
23+VGZhSBfQqKVVOWq15ayZhtbsu92QnRq9yJCu7QBQ0lWSus2yXmnXVsvvfQeXFKpfLJdwKphSZ
YaVcPA7HlPi5XjgueHw5ht0BKxLnVYfZ7XLmNPw2OyhlrNOEHm9MlmrurflYcl+wmrMW4rxKqnla
obSiFO5qJmG1r+MwjLIng9OD+Do16rGRUq5j3y0ttfMYwbppeqTWadN6OrdcN1OKzHBeGJWLxwGV
rxl8h/G4cEHX+wFXMPws2qfvbEGRoQJBNyYLTkPT9UR5pL+a8/w5WWnprtYVq5nUpo3rHs9ylN+K
j3om227KsObC333YkKVKK810I+98QqhfcuFxYF4lGoPv6nHtRDOq8h733/adPXiDHKKDvDGZ9OG9
Eq7OT+QcmM4N7Vs9Hk4rhTLXVzY+q0EMvVWj0lmmq56u3LpmJxh38bhu41iqMx4HPK49/sQOWvW4
kHKea/bGTIMtOa9S/3bs+yFKEx7kjcnMcLPB46s5p/OTLapxxXomKsM+nzP1GfHqz46PbRP2Q/gw
iHO9W1cP5V8fjwfXBuU643HA45Udcb0meiLXe9zcxrJJ3QBzzm/6yw8/1S3IMIeolCBZnsYtzE/M
9+OC+hdvL/oKpFXEjcfgzp9ecblR2JRJUG0x4jefc5u6IZWQlviJdtNCbXK7bq5yH1Ve3dhdlsit
UC5FzNmX6ozHAY+/Zwf98Qf7tvXF/daj7JlnFLRLJg2brWOj4XHA43jc9YR5au8JA++SyTqvvoeF
x/E4/I7HKxMu/6bJ/15+8nmXTNY2GJsLjwMeB8DjeJx9Ao8D4HE8jsfxOAAeBzyOxwHwOOBxADyO
x/E4HgfA43gcj79YGQB4MSwoHsfjAAB4/Azu/u55HgDwOOzvcXoGAPD4uVVOtwAAHj+xx+kTAMDj
51Y5HQIAePzEHqc3AACPn1vldAUA4PETe5x+AIDVq3YAOM0rfADK4/QCwF6HE50AeBwAjwPgcQA8
DngcAPA44HEAPA6AxwHwOAAeB8DjgMevY3/564aWhV9l6KYnePeq1b2Fl35sTHAvvVyy+NZnu1rQ
bm0MK1mv+XW/gvA4wJc8fpeME0e48K2KXivqVqOHCjc4scWYlaxWEzSu1Z7Ps22ce+/TG43xOADj
8S1F7abvp8fjL2TbmM+TbZS9948Ok/E44PGNHp9003fz0G8eBS4Gmr4d5oXSLzKVzCQjR5VyCJsX
pRxNhnLMu3weJi36mQqZnfOmbI4Uq5HsoGp+6Tqbcijkc3U91tpG1/NmtfuiyeO6AFF60LcN21T1
4Ny7l3KL5uS6Go/Pe5+I8Tjg8ec8brS4TAXclwtppumBe7qc0zCLwmQiR5G3z0vWwzDGY1Wf4dU5
V0vxnm7+NhcmFtqZjak5Q8rTzI1MjU1V6TprW+nQv643lZc9VhqPr3aa2iL6fCknZ8wZLurblW1q
94Vbr1zsaVanTwvEp9tqp7c4HodfG48HxkxDOX1vsI9GteVbiPF0cmloHGaYR8R+FWHPeAJENKcv
jceVqJZTVZztvTw7Wv+zI+8n2lj2uP0s1ipO1de3qVZ6P6ynX84YQx7h98NvHE44BX7S4/4OqR63
9t3fFo8LmYtlMv2wlmHF48s1QtnjhUILcyOFq4G6xwsz2Jva+JTH475d3aZi6TyqXk0/X890jwuC
+z7wG7P2eBx+0eN6sJemVvUgLk9+6Cv10OP58nvojDdVepuhzGSSYDweFxO1gRZ1c4rjcVW1taH0
NFFc7rFrcxtf9Xihb1e3qatRQ/q8HwTTV3gcYGePp9tpUirhQjUQdXfapgV+btqPXl0m6daYuoFo
FGKmcCuJLhddB3/fTyYLn7icZ1XiHMxUgr1pam5ZrvVYaxvj1WTvybsT6fPl4pZFEzoNNbwt1TXx
N6LVxUyXTmbdj2gcj8OBx+N78o4HBA+Hvk2Y/Ab/wOFEJwAe/wmL54cw0DgeB/g1jxenY37O5H/l
R9ABjwOcejwOgMcB8DgAHgfA4wB4HPA4AOBxwOOAINhMADt4HAD2AqfAFzxOF5zoZEtXAAAex+MA
gMcBjwMAHgc8DgB4HI8DAOBxPA4AeBzwOADgccDjAIDH8TgA4HHA41vrAwBHeLkXj+PxZ+rDRgE4
zmHCAYnH8TgAHgc8DgB4HPA4AB7H43gcjwPgccDjeBwAjwMeBwA8Dqf3+Nhfpjpf+nHsu378fDWH
bqpBN5x8+98bsr0RDc2/b6TLvGnk55b0K7Vavg2zbSkLj+NxPP7dHfShkPkYn4T+cZfein2Y4vTK
mE+IGzuwpfmT6Kdv5ef6iWFTZ4arPJHPnufEj+2KeBzO7HHvjg8ePL844ts+Hm9s/kvj8Rdq8rWt
cy8YjwMeX99BHwPIwsEyHcB9Gq4v1/7LUZ1mY/7SaFJ9X85qSXpPmFdbKiK/ra+bLePmJXK2j0Vm
rcK00vy1Thx9G9RnKXvyeKU83Y2++bVaVT0e94xLn8pXm0BcEAzlfCo92bKZlpyXhto9Smbyp7ul
tnfhcfjHPX4/kuIDw5gxD46WeZjb/8t3wzDaP+tZpfkBP59gvq2vm0SQTjQ65+wPs9xUT9bcF5Ha
7etjChrVRERgW9+NpQGvKXfV45VeNXMyQq33EkyF1enLTZqPhZ5s20y5kFu6cI8yfSuNX9q78Dgw
Hq9cNJfEsXw2U6e1mVS7uh5s7fnt4lI5tvVrRacsd5VhlBLZ2RQU2Ed/H9a2sg1K5fpVGnsmG1Z4
tFCTWdX1/n9iE0/d0q92heq9d8/T43E4sceDAfnY90N4MR5KZDq+zOGWh3nzX/Yg9zMIe327eFy2
qWmidam5TZzGzdG4OBjfVz0edmNxPF4uN/Z4Q8/4GafNHq/OwrVspinjfrUr/J0Gs7PhccDjThjz
X/Ia2vhaXegPff7ufu2s/6wM+8Uf0z3Vvb7VMwnZUn1v19IdoGuui+i6/MeKa6YTYNXjQTcWPD5U
yy3M2DT1TOnuxVhwcb3/N2xiMxe12hWqJ2t7Fx4HPH5Vt778jUI5arM39MSCKI/VrNzA3X1bX1f+
Ub076bKptT6u3uVySf+G3ZLnmvTn0u1L243R2DMst9CYpp7RUx72lmz5pnPc/42b2My0lPYom8nc
BSt7Fx4HPA7/Fvo24c2cn3my7/CPluJxwONwEounu5yf1Tgex+N4fEO5eBxWhaoeHv8E+vFQPM5u
iMdXyzVF43EAPA7n87isAB4HwONwVo8fbaYeAI/j8ZN5/Djs2bytN6wOfYPruRizgMfxOB7/rMF3
3UG3vh39trepPx+UEfA4Hmde5cPnj3ftoIcYj380oingcTyOx79c7mpNCvFRg3iH8eNqTXFlbWG2
ABE5Y60+fa6JDYZVrEZcVhR1RMQsjN51DCP01oL/Ah7H43j85R1xrSaFuKw6EmyeSLZxtV6JSauG
1UsEjZb6lCIolatx9WXJOZ+o2vlElKJi9Uua98ZQBTwOR1H5mXbQlfioIqxfHGnv2aizQrP9sKk+
YRCXanhVX5aKD2XTL7Ye8gi/Vz9/8Pu/WYnH8TgeP8kO2hAfdRDzBuse3xJ1dlmUw9k1xWtt8bif
53BlKY/7MIjdo+ndfBrru4/FUAU8Dnh8yw7aFB81Tw2veHxr1NmrDZvbVp81j5fCq5qy1K8r+PR5
2ltPJr09hirgccDj28fj9fioi8lzqpbwtutRZ9Mi97sNa/XpO59JY3hVV3MT51akH++DcfPpWopz
y8gcj+NxPP4LOygAHsfjeByPA+BxwON4HACPAx4HwON4HI/jcQA8jsfxOB4HwOOAx/E4AB4HPJ75
QqRB9YJPPWK4+HblfaWvU2jIk5U0uaVoM11rgPXD/w4yHgc8vp9RP/0u+nOxTPxa346J0hQwfXsl
g2yXwF4b1EzAGDwOjMc/Nx5/Ya1vDjmbu21bJaNs9+ouPI7H8fg/5/EwavmWoN7RyD8lKURbFG/I
3xN3XRjhK8jn6uKkm4bUw6kv2QZTGTImzJzJGARMt96MwrsHnSC7V6xyD17gAjeaAOtxk8th5fE4
Hsfj/5jHwyjhm4J6RzMDS8jBi/o1CDlXLuz6mAu2EpS/89BXIqG7hsRxzJdvszPz+SqHZ//zP3MR
zl9fVIxHG95dFq1zzGmm9QbX8LC7giaXw8rjcTyOx0/jcR14OwgstXU8Lj7/ty2od6lSyr/xr1Is
tSqP3O/qsqP1Qovbw6knDcaRfu3poVjKNQrv3tQJ5QqMDW25VsPK43E8jsf/1XkV4/GtQb2jMirz
KtlN6Rfh2j1eOF+1h1NPHpSD2Sc8Pkbh3Zs6YavHfVvKj/fgcTyOx/H4FOu2Oah3Ia/bisXxuIv+
XVdYS4Dya0s4dfcDQzKuef7FuvbxeBjevaUTtng8aHI1rDwex+N4/Dc9rqfBo6mQQtTy9aDepfz6
OOfSpFD8rVh3PUB5NZkq04yXy2WJm7wqtTa5De/e0AlqOv6SfnTU308uNLkYVh6P43E8zvucn0D/
yrH5OYp3lfmvj1vxOB7H43h8T6OaB/c+MZjE43gcj+NxPL6vUz/78HNxXgnwOB7H43gcAI8DHsfj
AHgc8DgAHsfjgMcB8Dgex+N4HACPAx7H4wB4HPA4AB7H43gcjwPgcTyOx3epDADUweNwXI8DwLH8
QBfgcQDA4/Dp6Qs6BwDw+Ik9Ts8AAB4/t8rpFgDA4yf2OH0CAHj83CqnQwAAj5/Y4/QGAODxc6uc
rgAAPH5ij9MPALB61Q4Ap3kVG0B5nF4A2OtwohMAjwPgcQA8DoDHAY8DAB4HPA6AxwHwOAAeB8Dj
AHgc8Ph17C9/3WAWPLj040EaMnR/uo7rTWqrfEvKIM3G+jy5yqHyBzwOR/X47GwhgLHvJmfdxfAZ
kw/drgK6V7yt6i0p23OrNM13M+BxgDeOx1e/2Jc3FPP28fgTTWO8jMcBvuJxr69Jan03jy6XOZg5
4fTtMC+UClMTNSKTjBy4mhGwNOn8eclzKiOvlnKZ0svRtPycV9C1iv724/HV+pjV7wsnj9syXKFN
/awKm5t1UScblX5Orkt/fD7OzBkeB3iLx4fOHebGVsn0t+XCZY9lD0/c0uXsh1lKJhM5UL19XrIe
hjGY2UinhKSwqdxs58VRxrPqcy4yTx6ZtoRpGuujUuqTWeqauNC2frYb7XbevNiTg06fT8ni5Dz0
WByPw297PLB4pEU9nlZTEA+L9ZFSfbIhcGR1/KsHrab+Kx4X0lRVkm2J0rTmX/S4/ew7sLGftdL7
YT39coYc8gi/Z5YHj8NPe7x469H6Qiezgp5mBjZ4XMhc3Xtd8bgRfz39MF8puCqZEl2at3j8qX4W
S+dR9Wr6x9YY7jex5+3CZD0eh1/2+G1JUlhXGRrLPybxS/2J+Yk8Jrw46WjB9Xmpme2tj69TDo9h
Zin/ed5DTA2rKQ7ZljDN3h73HdjYz+J8F51swvR523zuSSQ8DvAJj+sJXrkguv2WrtiVHKL7jVEa
m0jYVdwM/CvdMEx35+avxXJ1e7SQ/3wzUN3wy0sqbZFpGutjevcxTZO+U5Pfrkeb+tmecIu3T8Mn
SoPTM+BxOPV4fE+ef0QPAI8D4HEAPA54/DXcHA0AHgc42XgcAI8D4HEAPA6AxwHwOOBxAMDjgMcB
8DgAHgfA4/DPexwA9gKnwBc8ThcAAOBxAAD4Gv8D6Otr9FWAzHsAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-02" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnel plot of trials reporting total complications, including 95% confidence interval lines. There are no indications for bias.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqcAAAGQCAMAAACkrDm+AAADAFBMVEUAAAAAAFUAAKoAAP8AJAAA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>